ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001072.1|Simocyclinone_1 # 1 # 927 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.721	BGC0001072.1|Simocyclinone_1 	1	927	-	Loose	700	26.1794	CMY-89	44.0	3002102	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	GTGCTGCGCTGGTTCGTCGACGGCACCCGGCTGGCCCAACTCGCGGGGGACAACGGCATCTCACTGCAGACCGCCTACCGCTACCTGCACGAGGGCCTGGAGCGGGCGCACGGCGGGTACACCCACCCCAACCTGGACGGCACCGTGATCCGCACCGACCGCGTGGCCGCCGCCGACCCCAACGGCGCGGACCTGTGGTGGTCCGGCAAGCACAAGCATCGCGGAGGGAACGTGCAGGCCATCGCGGCCCCGGACGGATGGCCGATCTGGGTCTCCCCGGTCCGCCCGGGCCGCGAACACGACACCACCTGCGCCCGCGCCCACGGCCTCGTCGACGCCCTCAACCGGCTCGCCGCCACGCTGGGCATCCCCACCCTGACCGATCTTGGCCACGAGAACGCCGGAGACGGCTTCCGCCACCCGGTCAAAAAGCCCACGGGCGGTGAACTCGCTGACTGCGACCAGGCGTTCAACGCCGTGCTCCGGGGCGTCCACGCCGTCGCCGAACGCGCCGACGCCCTGCTGAAGGTCACCTTCAAGGCCCAACGCAGGGTCAGCCTCGACCCCGCGGCCGTCACCCGCATCGCCCGCGCCGCCCTCGTCCTGCTGAGTTCGGGGCGTGGTGGCCTGGCGGTTCGGCTGGTGGTTGATCAGCAGGCAGCCCGCCGGACGAGCACGAGCACCATGTCTGGCACGAGCGGCGCCGTCGCCAGTCCTCAGCACGGATCCCTCGCTGGGGACCCTGCCCGAGTCGAGGTGGCCGAGGGCAGGAGCACATGCCGTCGCCGCCATCGCGCGGAGCTCCCACACCACCACCTCCGTGCTGACCCGCTCGGACAGCACCCGCACAATCGCCGCGTGCCAGCCGGTCGGAGGGTTCCACCTTGGCCGCCGAGTGACAAGCCGGCCCGAGTCGTTGGCACCTTG	MLRWFVDGTRLAQLAGDNGISLQTAYRYLHEGLERAHGGYTHPNLDGTVIRTDRVAAADPNGADLWWSGKHKHRGGNVQAIAAPDGWPIWVSPVRPGREHDTTCARAHGLVDALNRLAATLGIPTLTDLGHENAGDGFRHPVKKPTGGELADCDQAFNAVLRGVHAVAERADALLKVTFKAQRRVSLDPAAVTRIARAALVLLSSGRGGLAVRLVVDQQAARRTSTSTMSGTSGAVASPQHGSLAGDPARVEVAEGRSTCRRRHRAELPHHHLRADPLGQHPHNRRVPAGRRVPPWPPSDKPARVVGTL	MMKKSLCCALLLTASFPTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANKHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPVPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	81.10	gnl|BL_ORD_ID|2923|hsp_num:0	3938			210	285	
BGC0001072.1|Simocyclinone_2 # 1227 # 1475 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.566	BGC0001072.1|Simocyclinone_2 	1227	1475	+	Loose	50	24.2534	vanW gene in vanG cluster	29.82	3002965	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGGCGACGATGGCGCCAGAGGACAAGCGGCTCGTCAAGGGAATCGTCTGTGACATTCTGGAGCTGGAGAGCGACGAGATCACCGACGTCAGCCTGTTCATCGAGGACCACGATGCCGATTCGATGCGGCTCATCGAAATCCTCTCCTCGCTCGAAGTGAACTTGAAGGTGACGATCGAGCAGGCCGAACTTTCCCGCATGGTCAACCTCGAGGGGATTTACGAGGTAATCGGGAACATCGCTCGATGA	MATMAPEDKRLVKGIVCDILELESDEITDVSLFIEDHDADSMRLIEILSSLEVNLKVTIEQAELSRMVNLEGIYEVIGNIAR	MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV	29.18	gnl|BL_ORD_ID|4741|hsp_num:0	1622			552	717	vancomycin
BGC0001072.1|Simocyclinone_3 # 1472 # 2551 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.715	BGC0001072.1|Simocyclinone_3 	1472	2551	+	Loose	675	29.261	mdtE	24.82	3000795	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGATGTCAATTCGGCGGGTCCCGGCCTCGCCATCATCGGATGGGCGGTGACGTCGCCCTTCGGGATCGGCCGGGAAGCGTTCTCCGAGGGGCTGGCTGAACGGCCGGTCCACCGCCAGGCGGTGGAGGCCGGCGAGGGGCCGGCCGGCACGGTGTGCCTGGTGCCGGACTTCGACCCGCGGGCCGTCCTCGGCAAGAAGGGCACACGGTCGATGAACCGGGTGACTGGCCTGGGGGTATCGACGATCGGGGACCTCCTCAAGGAGGTGAAGGGTGAGCGGTTCGTTCCGGAGAGGACCGGACTTGTCCTCGGGACGACGGTCGGCAGTGCGCAGAGCACCATCGACTTCACCCGCGGCTCGCTCACCGGCGAGAAGCCGTACCACGTCGAGCCGGGCCTGATCCCGTACGCAGTGATGAACGGCGCGGCCGGACAGTGTGCCATCTGGCATGGCGTCAAGGGGCCGAACGCCACGCTGGCGGCCGGCCGGGCCGCAAGCCTGCTCGCGCTCAACTACGCCCGCCGGCTGCTGCTCACCGGCCGGGCCGACACAGTGCTGTGCGGTGGCGCGGAGGAGTACTCCGCGGCCCGTGCGTGGATCGCCGAGCGCAGTGCGAAGAACGATGCCCCTAGCACTGCGCTCGGTGAAGGCTGCGCGATGTTCGCCCTGACCACCGAGCCGACGGGCCGGGCGACGCTCGCCACGCTTCTCGCCGTCAAGGCGATGACCTGCAGCGACGGGGATTGGCGCGAGACCGTCCGGCGGTGCGTCGAGGAGGCGCTGGAGGCGGCCGACGTGAAGCCCTCCGATGTGTGGGTGGTCAGCCCGTCGGACCCGCTGGTGCGCCCGGTCAGGCCGAGCGGGCGGTGCTCGACGACCTCTTCGACGTCGGTGGCCGTCGTCTCCCCGGTGACTGAGCTGCTCGGGGAGACGCACGCGGCCGTCCGGGCCCTGCAGCTGGCGGCCGTGCTGAGCCTGGCCGGGCGCAGCCCGGAGTCCGCCGGGCAGCCCGCGGTGCTTACGTCGATCGATGAGAGCGGCACCGTCGTGGTCGCGGTGTTGAAGCTGTCCTGA	MSDVNSAGPGLAIIGWAVTSPFGIGREAFSEGLAERPVHRQAVEAGEGPAGTVCLVPDFDPRAVLGKKGTRSMNRVTGLGVSTIGDLLKEVKGERFVPERTGLVLGTTVGSAQSTIDFTRGSLTGEKPYHVEPGLIPYAVMNGAAGQCAIWHGVKGPNATLAAGRAASLLALNYARRLLLTGRADTVLCGGAEEYSAARAWIAERSAKNDAPSTALGEGCAMFALTTEPTGRATLATLLAVKAMTCSDGDWRETVRRCVEEALEAADVKPSDVWVVSPSDPLVRPVRPSGRCSTTSSTSVAVVSPVTELLGETHAAVRALQLAAVLSLAGRSPESAGQPAVLTSIDESGTVVVAVLKLS	MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYEVAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARITFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVSGKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPVQLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQNVLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGLQRIRPGIKARAISSSQENASTESKQ	93.25	gnl|BL_ORD_ID|1756|hsp_num:0	1903			255	615	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0001072.1|Simocyclinone_4 # 2602 # 3843 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.696	BGC0001072.1|Simocyclinone_4 	2602	3843	+	Loose	750	177.563	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	35.45	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGTGTTGGTCCGCCCACGAGCGGCCTGCCAGTGACCGGGTCGTGATTACCGGCCTCGGTGTGTTCTCCAGCATCGGTATCGGTGTGGAGGACTTCACGACCGGGCTGCGGGAAGGCCGCAGCGGCGTCTCACCGATCTCCGTGTTCGACACCGACGGGTTCGCACACGCCAACGGCTGCGAGGTGCGCGACTTCAAACCGGAGGAGTGGCTCGAGCGCTGGTCGGTGGACAACCTCGGTCGGACCAGCCAGTTCGCGGTCGCGGCGGCCCGCATGGCGGTGCGCGACGCCGGTCTCACGGACGCCGGCCTGCACGACCGGCGGGTACAGGTCTCGATCGGCACCACCGACGGCGAGTCGCAGGACCTGGACCATCTGGCCGAGCGCTGGGTGGAGTCGGGGCCGGAGAGCTGGGACCCGGACGTGACCCGCCGGGTGGGCGCCGGACGGCTGTCGGCGGCCGTCGCCTGGGAGCTGGGGCTGCGCAACGCCGAGGCGCTGACGCTGGCCACGGCCTGTTCGGCGGGCAACTACGCGATCGGCATGGGCTTCGACGCGATTCGGGTCGGCGACGCGGACATCGCGCTGTGCGGTGGCGCTGACACGATGTGCCGGAAGTCGTTCACCGCGATCTACCGCCTGGGCACCATCGCGCCGGACTTCTGTCGTCCCTTCGACAAGGACCGCCAAGGCATCCTGAACGGCGAAGGCGCGGGCGTGCTCGTGCTGGAGAGGCTGGACCACGCACTGGCCCGGGGCGCGCGCATCTACGCCGAGGTGCTCGGGTACGGCCTGAGCTGCGACGCGTACCACCCAGTGCAGCCGGAGCAGTCGAGCATTGCGCGCTGCATGCGGTCGGCCTTGGCGGACGCCGGCGTGCGGCCCGAGGACGTCGACCTGATCTCGGCCCACGGCACTGGGACGAAGACCAACGACGTGACCGAGTCAAGGGCGATCCGCGAGGTATTCGAGGAGCCTCCGCGCACGGTCTCGCTCAAGTCCATGCTCGGCCACACCATGGGGGCCGCGAGCTCCCTAGGGGCGATCGCGTGCTCCCTGGCCATCACCAACGGGTTCATCCCGCCGACGATCAACCACCGGGAGACCGATCCCGAGTGCGAGATCGACTGCGTGCCCAACGAGTCGGTCACCGCGGACCTGCGGGTGGTGCAGAACAACGGACTGGCATTCGCCGGAAACAACGCGGTCGTCGTTCTGGGCAGGCATCAGCCGCGGGCCTGA	MCWSAHERPASDRVVITGLGVFSSIGIGVEDFTTGLREGRSGVSPISVFDTDGFAHANGCEVRDFKPEEWLERWSVDNLGRTSQFAVAAARMAVRDAGLTDAGLHDRRVQVSIGTTDGESQDLDHLAERWVESGPESWDPDVTRRVGAGRLSAAVAWELGLRNAEALTLATACSAGNYAIGMGFDAIRVGDADIALCGGADTMCRKSFTAIYRLGTIAPDFCRPFDKDRQGILNGEGAGVLVLERLDHALARGARIYAEVLGYGLSCDAYHPVQPEQSSIARCMRSALADAGVRPEDVDLISAHGTGTKTNDVTESRAIREVFEEPPRTVSLKSMLGHTMGAASSLGAIACSLAITNGFIPPTINHRETDPECEIDCVPNESVTADLRVVQNNGLAFAGNNAVVVLGRHQPRA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	99.28	gnl|BL_ORD_ID|1968|hsp_num:0	1943			354	1248	isoniazid
BGC0001072.1|Simocyclinone_5 # 3873 # 4139 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.712	BGC0001072.1|Simocyclinone_5 	3873	4139	+	Loose	2090	26.5646	mdsB	46.43	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCGCTCACCTGGCTGCGCACCCGCCCCGGCGCGATGCACCCGATCCTCGGGGCGACCACTGAGGCCCAGCTACGGGACAACCTCGCCTGTCTCAACGTGCGGCTGGGCGAGGCGGAGCTCACCCGGCTGGACGAGGTGAGCCGGATCGACCTCGGCGCGTCGCACGAGCAGCTGCGGCTGCCCAAGTTCACGACCTCCTGCTACAGCGACCGGTGGGAGGACATCGCGGATCTGCGAGGCCGGGGTGTGGTCGCCATCCGCTGA	MALTWLRTRPGAMHPILGATTEAQLRDNLACLNVRLGEAELTRLDEVSRIDLGASHEQLRLPKFTTSCYSDRWEDIADLRGRGVVAIR	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	8.34	gnl|BL_ORD_ID|1269|hsp_num:0	1385			756	840	chloramphenicol
BGC0001072.1|Simocyclinone_6 # 4212 # 5369 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.728	BGC0001072.1|Simocyclinone_6 	4212	5369	+	Loose	700	48.521	oleI	34.41	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGAATCCTGTTCGTCGCCGCCGGCAGTCTCGCCACCGCCTTCGCGCTCGCCCCGGTCGCGACGGCCGCGCGCAACGCCGGACACGCCGTCATCATGGCCGGTAACGACGACGTGATCCCGGCGATCACCGGGGTGGGGCTGCCCGGGGTGTCGGTCTCCTCGCTCACGATCCAGGACTTCTACACCGACCGGGCGGGGCGACCGGTCGAGATTCCCACCGTGCCCCAGGAGCAGATTCTCTTCACCGGGCGCTGGTTCGGGCGGATGGCCGCCGCCTGGCTGGACCCGCTGCGGGAGTTGGCCCGGGCCTGGAAGCCGGACGTCGTCGTCGGTGGGACGATGTCGTACGCGGCCGGGCTGCTCGCGGCCGAGCTCGGCGTTCGTTACGTGCGCCACGCCTGGGACGCGATCGAGGCGACCGGCATCGACGTCGGCGCGGTCGACGTGCTGGAACCGGAGCTGACCCGGCTGGGGCTGGACCGGCTGCCGGTGCCGGAGCTCTTCATCGACGTCTGCCCGCCGAGCCTGCTGCCGCCCGAGCCGCATCCGGCGAAGCACACCCTGCGGATGCGGTGGATCCCGGTCAACGGGCAGCGGCAGTTGGAGCCCTGGACGTACACCCGCACCGAGCGGCCGCGGGTGTGCCTGACCACCGGCAGCCGGGTGGCGCACGACGCGGGCGAGCAGGACCTCCCGCGCCGCTCGTACGAGTTTCTGTGCGCGCTCTCGGCCTCGTTCAAGGACCTGGACGTGGACCTGGTCGTGGCCACCACGGACCCGGCGGGCAAGGCTCTGGAGGCGCGGGTGCCGGGCGTGCGGGCAGGGTGGGTTCCGCTCGATGTGCTGGCCCGGACCTGCGACGTGATCGTGCACCACGGCGGCGGCACCACCAGCCTGACAGCCATGGCCGCGGCCGCCCCGCAGGTCGCGGTTCCCCAAGGGGCCGTCCCGAACCTGAGCGCCCAGCGGCTCGCCGAGTACGGGGCCGCCATCTCGCTGTTCGGCTCCGAGGGATCACCGGAGGTGATCGTCGACGCCTGCACGAAGATCCTCGGCGACCGCTCGTACGCCGAGCGCGCCCGCGACCTCTCCCACGAGATCGCCGGACTCGCCCTGCCCTCGGAGGCCGTGGACGTCGTGGCCGAGCTGGTCTAG	MRILFVAAGSLATAFALAPVATAARNAGHAVIMAGNDDVIPAITGVGLPGVSVSSLTIQDFYTDRAGRPVEIPTVPQEQILFTGRWFGRMAAAWLDPLRELARAWKPDVVVGGTMSYAAGLLAAELGVRYVRHAWDAIEATGIDVGAVDVLEPELTRLGLDRLPVPELFIDVCPPSLLPPEPHPAKHTLRMRWIPVNGQRQLEPWTYTRTERPRVCLTTGSRVAHDAGEQDLPRRSYEFLCALSASFKDLDVDLVVATTDPAGKALEARVPGVRAGWVPLDVLARTCDVIVHHGGGTTSLTAMAAAAPQVAVPQGAVPNLSAQRLAEYGAAISLFGSEGSPEVIVDACTKILGDRSYAERARDLSHEIAGLALPSEAVDVVAELV	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	90.80	gnl|BL_ORD_ID|1684|hsp_num:0	1824			933	1209	oleandomycin
BGC0001072.1|Simocyclinone_7 # 5379 # 6137 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.731	BGC0001072.1|Simocyclinone_7 	5379	6137	+	Loose	1300	25.7942	mdtO	31.58	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAGATCATCGGTCGCGGCTTCCTGGCCGGGCACCTTCGGACCCTCGCGGCGGAGCATCCCGACGCGGTGGCGCTGGCCGCCGGAGTCTCGTGGGCGAGCGGGACCTCCGCAGCCGACTTCCAGCGGGAGGTCGACCTCCTGCACCGGGTGATGGACGACTGCCGGGCCTCCGGTCGGACCCTGATCTTCTTCTCCACGGCCTCGGCCGGCGTCTACGGCCCGGACCGGCCGGGCCGGGAGGACGAGCCCGTCGAGCCCCGCAGCTCCTACGGGGCGCACAAGCTCGGCATGGAGCAGGCGGTAAGGGAGTCCGGGGTCGATCACCTGGTGCTGCGGCTGGGCCATCTCATCGGCCCGGGCCAGCCCGCCCACCAGATGCTCCCGACCCTGCTGCGGGCACTGCGGGGCGGGCAGGTCACCGTCCAGCGCGCGGCGACCCGCGACGTCATCGACGTGGCCCACGTGGTGGACGTCATCGATCTGCTGCTGCGCCGCGGCGTCCGAGGCGAGACCGTCAACGTGGCCACGGGCAGCTCCGTTCCGGCGGAGCGCATCGTCGACCACCTGGAGCTGCGCCTCGCCGTGTCGGCCACCAGGCAGTACCAGGACGCCGGGACGGCGCACCGCGTGTCGGTCGACAAGCTGCACCGTCTGCTGCCTGAGGTGCGGGAGTTCGGCTTCGGGCCCGACTACTACCGGGCGGCGCTGGACTCCTGCCTCGCGCGGATGCGGGACGGCGAAGGCACGGCGCCGTGA	MEIIGRGFLAGHLRTLAAEHPDAVALAAGVSWASGTSAADFQREVDLLHRVMDDCRASGRTLIFFSTASAGVYGPDRPGREDEPVEPRSSYGAHKLGMEQAVRESGVDHLVLRLGHLIGPGQPAHQMLPTLLRALRGGQVTVQRAATRDVIDVAHVVDVIDLLLRRGVRGETVNVATGSSVPAERIVDHLELRLAVSATRQYQDAGTAHRVSVDKLHRLLPEVREFGFGPDYYRAALDSCLARMRDGEGTAP	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	36.90	gnl|BL_ORD_ID|1893|hsp_num:0	2056			333	447	acriflavine; puromycin
BGC0001072.1|Simocyclinone_8 # 6191 # 7102 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.719	BGC0001072.1|Simocyclinone_8 	6191	7102	+	Loose	1900	27.335	mexN	37.78	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCCCGGCGATGGCCGCGGCCGACGACATCGAGGTCGTCGCGGTCGCCAGCCGGGACGGGCGGAAGGCCGCCGAACTCGCCAGGACGTACGGCTGCCGGCCGGTCACCGGCTACGACCGGCTGCTCGCGCATCCCGAGGTGGAAGCGGTGTACATCCCGCTGCCGCTGGCCATGCACGCCCAGTGGGTCGAGGCGGCCCTGTCGGCCGGCAGACACGTGCTGGTGGAGAAGCCGATGTCGGTGGATCCGCAGGAGGTCCGTCGGCTCTTCGCACTGGCGGCCGCGCGGGGGCTGGCGCTGATGGAGAACGTCATGTTCGTCCACCACCGCCTGCACGAGACGGTCCGGCGCCTGCTCGAGGACGGCGAGATCGGTGAACTTCGCGCGATGCATGCCGAGTTCAGCATCCCCCGGCTGCCCGACCACGACATCAGGTACCAGCCGGAGCTGGGCGGCGGGGCGCTGTGGGACGTCGGCCTCTACCCGGTCCGTGCGGCGATGCACTTCCTCGGCGGCGACCTTCGGGTGGTCGGCTCGGTGCTCACCGTCGGCCGGGGGCGGGGGGTCGACACGGCCGGAGCCGTGCTCCTGAGTCGGAAGGACGGCGTCACCGCTCAGGTGGCCTTCGGGATCGAGCACGCCTACGCCTCCCGTTACCGGCTCGTGGGCAGCGCCGGGCAGATCGGCGTGGAGCGCGCGTTCACCCCGCCCGCCGACCACGCCCCGGTGATCGGCGTGGAGACCGCCTCCGGTCGTCGGGAGCTGCTGCTCGCGCCGGACGACCAGGTCGCCAACACTCTCCGGGCATTCACCGCGGGCGTGCGGGCCGGATCGGTGCCGGAGGCGTTGACCGACAGTTGCGTACGCCAGGCGGATCTCCTGGATCAGGTGAGGAACGGAGCCTCTTGA	MLPAMAAADDIEVVAVASRDGRKAAELARTYGCRPVTGYDRLLAHPEVEAVYIPLPLAMHAQWVEAALSAGRHVLVEKPMSVDPQEVRRLFALAAARGLALMENVMFVHHRLHETVRRLLEDGEIGELRAMHAEFSIPRLPDHDIRYQPELGGGALWDVGLYPVRAAMHFLGGDLRVVGSVLTVGRGRGVDTAGAVLLSRKDGVTAQVAFGIEHAYASRYRLVGSAGQIGVERAFTPPADHAPVIGVETASGRRELLLAPDDQVANTLRAFTAGVRAGSVPEALTDSCVRQADLLDQVRNGAS	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	29.25	gnl|BL_ORD_ID|2021|hsp_num:0	2217			1611	1734	chloramphenicol; thiamphenicol
BGC0001072.1|Simocyclinone_9 # 7106 # 8059 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.666	BGC0001072.1|Simocyclinone_9 	7106	8059	+	Loose	275	26.9498	AAC(6')-Ir	28.85	3002561	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGATCACGTTGGAAGCAGTTGAATCCTTCTTCCCCGATCGCACGGTCACGGTGGAGGAGCGCGCGGCCGAGCTCGAGCTGAACGAAGCGCAGACACACATGTTCCGCCGGGTCCACGGGCTCGACCGGATGCAGTATGACCCGGACCTGAGCCTGTACGACCTGGTGCTCCCGGCGGCCAGGAAGGCCCTCTCGCAGGTCGATCCGAAGTCCGTGCGGTACCTGCTGTACTGCCACGCCCTGCACGGTGGCCGCAGCGTCGGACCGGAGGCCGCGCAGAACATCAAGCAGCAGCTGGGCCTGGAGAACGCGACCGCGTTCGCCCTGACCCAGCAGAACTGCGCCATCGCACTCAGCGCGATCGACATCGCCGGCACCCTGCTGCAGGCCGACGGGGACCCGGACGCCCGGGTTCTGGTGGTGACCGGCGACAAGCCCCGCCACCGGGCCGCGCAGCTGGTGATGAACACCTGCGTGGTCGGCGACGGGGCTGCGTCCGCTCTGGTCTCCTGGAACGGTTCGGGAGCGGTCGTCAACTCCTTCGTCTCCAAGACCAGGGGTGAGTACTCGGACGGGATGATGAGCTCTCCCGCTCTGCTCAGGGCCGAGTCCGAGATGCGGCCGCGCCTCATGGTCGAGGTGATGCGGGAGGCGGCGGACCGGGCCGGCTGCACGCTGGACGACATCCAGGTCGTGCTGGCACCCAACCCGAACACCACTCTCTGGGTGGACACCATCAAGGACGACGCGCTCCGCAGCAAGTTCTTCTTCGACAACATCCCGCGATACAGCCACTGCCTTGCGTCGGATGTGCTCATCAACTACGCGACGCTGTGCGAGGAGAAGCGCTTCGAACCCGGCCGCCCCGCGATGTTCGTGGCGATCGGGGTAGGCATGACCTTCTCCGCCATGGTGTTCACGCCGTCCTCGACCACGGGGGGAACCTGGTCATGA	MITLEAVESFFPDRTVTVEERAAELELNEAQTHMFRRVHGLDRMQYDPDLSLYDLVLPAARKALSQVDPKSVRYLLYCHALHGGRSVGPEAAQNIKQQLGLENATAFALTQQNCAIALSAIDIAGTLLQADGDPDARVLVVTGDKPRHRAAQLVMNTCVVGDGAASALVSWNGSGAVVNSFVSKTRGEYSDGMMSSPALLRAESEMRPRLMVEVMREAADRAGCTLDDIQVVLAPNPNTTLWVDTIKDDALRSKFFFDNIPRYSHCLASDVLINYATLCEEKRFEPGRPAMFVAIGVGMTFSAMVFTPSSTTGGTWS	MKIMPVSEPFLADWLQLRILLWPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAVAMLEASIRYEYVNGQQSSPVAFLEGIYVLPEYRRLGVASTLVQQVEHWAKQFACTEFASDAALDNTISHAMHRALGFQETECVVYFKKNIS	217.12	gnl|BL_ORD_ID|1682|hsp_num:0	1821			66	222	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0001072.1|Simocyclinone_10 # 8085 # 8855 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.754	BGC0001072.1|Simocyclinone_10 	8085	8855	+	Loose	500	28.1054	mphK	32.35	3004541	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GTGGCGGAGACCGTCGCCGACCCGACCGCCCAGGCGCCCGACGGCGCCGGGGACTCCGTCGTGGCCGTCGGTGAGACGCCCGGCCAGCGGACCGGGAGTGCCGGAACCGGCGAACCGGTCGGCCACACCCGGCTGGTGGACCTGCTGCTCGACCAGGCCCCCGGGACAGTAAAGGAGCCGGACCTGGTGGTGCTCGCTTACGCCCGGCCGGAGACCAACGGTTTCAAGACCGTCGCCTCGTACCTGAACATGCGCACCGGCGGTGAGGCGCACAGCTTCGCGCTCTGCGGCCAGGGCATCGGCGCGTCGTTCAGCGCGGTCCGCGTGGCCGACGCGTACGCGCGGACCGGGCGGAGCGAGCGGTCGCTGATCGCGGTGGTCGACTGCGCGGAGCCGGGGAGCGCCGAGCAACAGGGCGACCCGGCCGTCGACTCCGGCGTCCTGCTGGGCTTCGACACCGGCCCCGGCCCCGGCGCCGTGCGACCGTCGCCGCCGTGGAACGGCCCGCCGAGCTGGCGGAGCGCCTCGCCGCTCTGGTGCCCGACAGCGGGCGCCTGCTGGTGGTGCTCGGCGCGGGCACCGATCCCGGGGTCGTGCCGGCCCAGGGCGCGGATCTTGCACCGGGCGGCGCCCGCCGGGACCGGCGTGTGGACGGAGCTGGCGTGCCACTGGGCGCAGTGGGAGAGCGCCTATCCGGTGGTCGCCCTCTGCGATACCGACGGCGGCTCCGGAACCGGTCATCTGCTGGTGCTGCACGGAACGCTCGACTGA	MAETVADPTAQAPDGAGDSVVAVGETPGQRTGSAGTGEPVGHTRLVDLLLDQAPGTVKEPDLVVLAYARPETNGFKTVASYLNMRTGGEAHSFALCGQGIGASFSAVRVADAYARTGRSERSLIAVVDCAEPGSAEQQGDPAVDSGVLLGFDTGPGPGAVRPSPPWNGPPSWRSASPLWCPTAGACWWCSARAPIPGSCRPRARILHRAAPAGTGVWTELACHWAQWESAYPVVALCDTDGGSGTGHLLVLHGTLD	MTNLNEKQLITEIVGLARSQGLTVHSENAQLNETGMDFQVVFAKDDTGMPWVLRKPRRSDVVERASAEGITLAFLRANLTADVPDWRIHTPELIAYPMLKGTPAAGIDLEQKQYVWNMDHQPPSDDFVRTLADILAELHGTDQISAGQSGIEVIRPEDFRQMTADSMVDVKNKLGVSTTLWERWQKWVDDDAYWPGFSSLIHGDLHPPHILIDQNGRVTGLLDWTEAKVADPAKDFVLYQTIFGEKETARLLEYYDQAGGRIWAKMQEHISEMQAAYPVEIAKLALQTQQEEHINMALEALGVTSD	83.66	gnl|BL_ORD_ID|2624|hsp_num:0	3217			735	837	telithromycin; azithromycin
BGC0001072.1|Simocyclinone_12 # 9344 # 10198 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.736	BGC0001072.1|Simocyclinone_12 	9344	10198	+	Loose	450	25.409	HMB-1	25.33	3004092	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	HMB beta-lactamase	ATGAAGATTCTTGTGACCGGAGCCCGGGGCAGCATCGGCAGTAGGGTCGCCGGGAAGCTGGTCGAGCGCGGCCTTCCGGTCCGGGGAGGCGTCCGCGATCTCGCGGCGCCCGGGCTGCCTGAGGGCGTCGAGGCCGTCCAGGCCGACCTCACGCGACCGGAGACGCTGGCGCGGGCGCTCGAAGGCGTCGACAAGGTGTTCCTGTACACCGTCCCCGAGGGCATCGCGGGTTTCGTCGACGAGGCCCGCGCGGCCGGGGTCCGGCATGTGGTGCTGCTCTCCTCGATCGCCGTGACCTGGCCGGACGCGGACCGGGACCCGATCGGCCGGATGCACCTCGCCGTCGAGCGCCCGATCGAGGAGTCCGGGCTTGGCTGGACCTTCGTCCGGCCCGAGGCGCTCGCCACCAATGCGCTGGGCTGGGCTCCGGAGATCCGCGGCGGCGACATGGTGCGCTGCGCCTACCCGGGCGCGTACACCACTCCTGTCCACGAGGAGGACATCGCCGACGTGGTGGTGGCGGCCCTCACCACCCCGGGCCACCGGTCCGCCGCCTACGCGCTCACCGGCCCCGAGACGCTGACCCAGGCTGAGCAGGTGGCGCTCATCGGGGAGGCGCTGGGGCGGGCCGTACGGTGCGAGCGGATGCCGGAGCAGGAGGCCCGCGCCGTGCTGGAGGGGCTCTACCCGGCCGAGGTGGTGGACGCCATCCTGGCCGGCCAGGCAGCCCGTGACGGCCGCCCGGCCGAGGTGTTGGACACCATCCGGGCCGTTACCGGACGCCCCGCCAGGACGTTCCGCGAGTGGGCAGGGGACCACGTCGCCGCATTCCGGCCGGCAGCTCAGAGCATTTAG	MKILVTGARGSIGSRVAGKLVERGLPVRGGVRDLAAPGLPEGVEAVQADLTRPETLARALEGVDKVFLYTVPEGIAGFVDEARAAGVRHVVLLSSIAVTWPDADRDPIGRMHLAVERPIEESGLGWTFVRPEALATNALGWAPEIRGGDMVRCAYPGAYTTPVHEEDIADVVVAALTTPGHRSAAYALTGPETLTQAEQVALIGEALGRAVRCERMPEQEARAVLEGLYPAEVVDAILAGQAARDGRPAEVLDTIRAVTGRPARTFREWAGDHVAAFRPAAQSI	MKIHLWISLGLLLLTNIVLAEEPLPELEVKKIDEGVYLHTSYENYPSWGLVASHGLVFVDGKDAYIIDTPATVKDTEVLVQWINDQGFKPKASISTHFHDDSTIGIAYLNSKSIPTYASEQTNELLNKEVAAQATHSFKKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPEGLGNLSHAVVSEWPASAEKLINRYSDAKIVVPGHGTMGDASLLEKTKQRALEAVAKKK	117.84	gnl|BL_ORD_ID|4714|hsp_num:0	2753			63	276	
BGC0001072.1|Simocyclinone_13 # 10932 # 12410 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.659	BGC0001072.1|Simocyclinone_13 	10932	12410	+	Loose	600	41.2022	Streptomyces venezuelae rox	29.6	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAAGGGTGAGTTTGTGACTCAGGTAATCGTGGTCGGCGGCGGTCCGGCTGGTTCGACCGCTGCCGCGCTGCTGGCCAGGGCAGGGATATCGGTCACCGTGCTGGAGCGGGCTACATTCCCGCGGTATCACATCGGGGAATCCTTCTCGACCTCCTGCCGCGTGATTATCGACTATCTCGGGGCACTCGAAAAGGTCGACGCCCGAGGCTATACGTCGAAGACGGGTCTGCTGGTGCGATGGGGGCAGGAGAAGGATTGGGCCATCGACTGGACCGACCAGTTCGGCTCCGACGTCCGGTCCTGGCAGGTCGACCGCGACGATTTCGACACCGTGCTGCTGGATCACGCGAGTGAGAGCGGCGCCAAGGTCGTGCAGGGGGCGCATGTCCACCGGGTCATCTTCGAGGGTGACCGCGCGACCGGTGTGGAGTGGACAGCGCCTGGCGAGACGGCCAAACAAATCTCGCGGGCCGACTTCGTCCTCGATGCCTCGGGCCGGGCCGGCCTCATCAGCGCTCAGCACTTCAACAACCGGCGACCCCACGAGATCTTCCGCAATGTGGCGATCTGGGGGTATTGGGAGGGCGGTGAACTGCTGCCCGGCAGCCCGTCCGGCGGTATCAACGTCATCTCCTCGGATGACGGCTGGTACTGGGTCATCCCGCTGCGGGACAACCGCCTCAGTGTCGGGTTCGTCTCCCACAAGTCGATTTTCGGCGAGCGCCGCCGGGAATTCGGCTCGCTCGACGAGATGCTCCTGAAGATGGTCGACGAGTCGCCCGCCGTACGAGAGATACTCGCCAAGGGCACCTTCCAGCCCGGAGCCCGGGTGGAACAGGACTTCTCGTATTCCGCCGACAGCTTCTGTGGCCCCGGTCACTTCCTGCTGGGAGACGCGGCGTGCTTCCTTGATCCGCTGCTCTCCACCGGTGTTCACCTCGGCATGTACAGCGGGTTGCTCGCGGCGGCCTCGGTCATGGCAATCACCGACGGCGACGTCAGCGAGCGCGAGGCGCTTGCTTTCTACGAGTCGTTGTTCCGCAACGCGTACCAGCGACTCTTCACTCTTGTCTCCGGGTTCTACCAGAAGCACGCCGGCAAGGACCGCTACTTCGCGCTGGCCGAGACCCTGGCCCGGCAGGAACCGGAGCACTGGCACTCCTCGGCGCAGTCGTTCGGTGAGATCACCGCGGGCCTGACCGACATGCGTGAGGCTGCGGACGCAGGGGGCCGGGGCGGGCGACCGATCCAGGAGATCATCGAGAGGGCGGCGACCGGAGAGCCCACACCGGTGCAGCAGTTGCTCATCGCCGCGGCGTTGGCGGAGTCGCGGGCGCAGGGTGACACCGCGCCCGGCGCGCGTCTCACCAACGCACCGGGGGTCATCGACGCCAATGACCTCTATGACGCCGGGACCGGCCTGCATCTGGTCATGCAGCCGCGGCTGGGCATCGGGTCCGTGACTTCCCAGAAGTAG	MKGEFVTQVIVVGGGPAGSTAAALLARAGISVTVLERATFPRYHIGESFSTSCRVIIDYLGALEKVDARGYTSKTGLLVRWGQEKDWAIDWTDQFGSDVRSWQVDRDDFDTVLLDHASESGAKVVQGAHVHRVIFEGDRATGVEWTAPGETAKQISRADFVLDASGRAGLISAQHFNNRRPHEIFRNVAIWGYWEGGELLPGSPSGGINVISSDDGWYWVIPLRDNRLSVGFVSHKSIFGERRREFGSLDEMLLKMVDESPAVREILAKGTFQPGARVEQDFSYSADSFCGPGHFLLGDAACFLDPLLSTGVHLGMYSGLLAAASVMAITDGDVSEREALAFYESLFRNAYQRLFTLVSGFYQKHAGKDRYFALAETLARQEPEHWHSSAQSFGEITAGLTDMREAADAGGRGGRPIQEIIERAATGEPTPVQQLLIAAALAESRAQGDTAPGARLTNAPGVIDANDLYDAGTGLHLVMQPRLGIGSVTSQK	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.36	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	357	rifampin; rifaximin; rifapentine
BGC0001072.1|Simocyclinone_14 # 12945 # 14186 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.703	BGC0001072.1|Simocyclinone_14 	12945	14186	+	Loose	1080	38.891	rosB	33.33	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACCAGTTTCCAAGTCCAGTTGGTCTTCGCCGATCTGGCCCTGATCTTCGGCCTCGCACAAGGGCTGGGCCGTCTCGCGGTGCTGGTGCGGCAGCCGCCCGTGGTCGGCGAGATCATCGCGGGAGTGCTGCTCGGCCCGACGTTGTTCCACGGCCAGCTCGCTGCCAGGCTCTTTCCGGCCGACATCCGGCCGCTGCTGACCGGGGTGTCCTACGTCGGCGTCGCCCTGTTCATGTTCCTTGTCGGCCTGGAACTGGACGCCGGTGCCCTCCGCGGAAGGGGCAGGATCACCGCCGGTGCCGTCGTGGGGTCCACCGTGGTCCCCTTCGCCCTGGGGATATTGCTGGCGCTCAGCGCGCTCCGCTCCCACGAGGGGCAGCACGGTGCCGCCTTCGTGATCTTCATCGGCCTTTCGGTGTCGGTCACCGCGTTCCCCGTCCTGGCCCGCGTCCTTGCCGACCGGGGTCTGGCCGGGACGACGCTCGGCGGCATCGCCCTGTCCACGGCGGCGGTGGTGGACGTACTGGCGTGGGCGGCACTGGCCGCGGTCCAGGCGGTGGTGAGCGGCGGTAGCCACCACTGGCGCGTGCTGCTCTTCCTGCCCTACGTGCTGGCGATGTTCCTGGTGGTCAGGCCCCTGCTGCGCCGCCTGCCCGGGTCCGTGCCCTTCGTCGTCGCGGTGGCCGGGACCCTGCTCTCGGCCGCGGCCACCGAGGCGATGGGCATGCACTTCATCTTCGGCGCCTTCCTCTTCGGCACGGTGATCCCGCGCCGCTCCACGCCCGCATCGCGCGTCGCACTCCACGAGCGCACCAGCCAGATCACCGCACTGCTGATGCCCGTCTACTTTGTCGTCGCCGGCCTCCAGGTCGACCTGGGCGGTCTCGACCTCGCCCAGCTCGGAAGTCTCTGCCTCATCCTCCTTACCGCTGTCCTGGGCAAGATCGGCGGTACTTACCTCGGTGCGCGCACCCAGCACCTGCCACCGAGGCCCGCCGTCGCCCTCGCCGTCCTGATGAACACCCGCGGTCTCACTGAGCTGGTGATCCTGGGCGTCGGCCTCCAGCTCGGACTGCTCGACCGGAACCTCTACTCCCTGATGGTCGTCATGGCGCTGGTAACCACAGCCGCGACCGGCCCGCTGATCGCCCGCGTCTACGCCAGACCCCTGGAGATCCCAGTCCCCGCCGCCTCGGCCGACAGTCGGCGGGAGTCCGCGGGTCAGCACGCCGGGGGCTGA	MTSFQVQLVFADLALIFGLAQGLGRLAVLVRQPPVVGEIIAGVLLGPTLFHGQLAARLFPADIRPLLTGVSYVGVALFMFLVGLELDAGALRGRGRITAGAVVGSTVVPFALGILLALSALRSHEGQHGAAFVIFIGLSVSVTAFPVLARVLADRGLAGTTLGGIALSTAAVVDVLAWAALAAVQAVVSGGSHHWRVLLFLPYVLAMFLVVRPLLRRLPGSVPFVVAVAGTLLSAAATEAMGMHFIFGAFLFGTVIPRRSTPASRVALHERTSQITALLMPVYFVVAGLQVDLGGLDLAQLGSLCLILLTAVLGKIGGTYLGARTQHLPPRPAVALAVLMNTRGLTELVILGVGLQLGLLDRNLYSLMVVMALVTTAATGPLIARVYARPLEIPVPAASADSRRESAGQHAGG	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	73.36	gnl|BL_ORD_ID|466|hsp_num:0	507			60	477	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0001072.1|Simocyclinone_15 # 14573 # 15829 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.653	BGC0001072.1|Simocyclinone_15 	14573	15829	+	Loose	500	27.7202	mphF	35.0	3003071	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAGCCAAGCCCAGTCGAACGGTCCGCTCCACGCCAACCCGCTGTACGCACTGCTGGATCCGGCCGCGCTTCGGGACCCCTATCCGGTTCTCGCGAGGATCCGTGAGGCAAGCCCGGTGGTGGTGGACGACGGCATGCTGATCGTCGGTGATTACAAGACCTGTCTCGACCTGCTGCGCAGCCCGGTCATGGGCAGCGAAACCCTGGCGTCCGACCGGCTCAAAGCCGCGCTTCCGGCTGATTACCGGGAGCAGATCAACGTGATCGACTCGATCTTCTTTCTGGATCCGCCGGACCACACGCGCCAGCGGCGCTTGATCTCGAAGGCGTTCACGCCCCGTATCACGGCCAAGTACGAGCCGTGGATCCAGAGCATTGTTGACGGGCTGTTCTCCGGATTCGCCGAGAAGGGTTCCTTCGACGCGGTCCGCGACCTCGCGACTCGACTCTCCATGGGCACGATCTGCGAGCTGATGGACATCCCGTCCGGCGATATGGCGATGCTCAGGAAGTGGTCAGACGATCTGGCGCTCGCCACCGAAGTGCCGCTGCTGGCCGCCTTGGGCAGTTCGGAGATGTTTTCGACGGACGAGTTGGCGGGATTCGGCAGGACGGCCGTGTCGATACACGCCTATTTCGCCGACCTGATCCACAAGCGGCGCAAGAAGCCGGGCGACGACCTGATCACCAGCCTGCTCCAGACCGAGGACCAGGGCCAGACACTGGCAAGGCACGAGGTGACGAATGTTCTTCTCAACCTCTTCATCGCCGCGCACGTGTCGGTGACCAACCTCATCTCCAACGGGATATTGGCGCTCTGGCGCAACCCCGACCAGCTGGAGCTGCTGCGCAACGACCCCTCGATCGCCCCGCTCCTGGTCGAGGAGGTTCTGCGGTACGACGCGCCGGTCCAGTTGGCCGCCCGACTTGCGCTGGCCCCCACCCAGGTTGGCGGCGTGGACGTCGAGCCGGGGACGTTCGTGGTGCTGCTGCTGGCCGCGGCCAATCGTGACGAGGCGGAGTACCCCCAGGCCGACCGGTTCCTGGGTAGCCGGCGGACGAAGGGCATCGGGCTGGCCTTCGGGGCCGGACCGCACTACTGCATCGGCGCGAGTCTGGCCAAGCTGGAGGCCGAGATCGCGCTGAAGGCCGTTGCCGGGCTCACCGACTTCGCGGTCGACGAGGAATCCCTGGCCTATCGCCGGCATGTCGTCGTACGCGGCATGCAGAGCATGACAGTCAACTTCCGTCCCTGA	MSQAQSNGPLHANPLYALLDPAALRDPYPVLARIREASPVVVDDGMLIVGDYKTCLDLLRSPVMGSETLASDRLKAALPADYREQINVIDSIFFLDPPDHTRQRRLISKAFTPRITAKYEPWIQSIVDGLFSGFAEKGSFDAVRDLATRLSMGTICELMDIPSGDMAMLRKWSDDLALATEVPLLAALGSSEMFSTDELAGFGRTAVSIHAYFADLIHKRRKKPGDDLITSLLQTEDQGQTLARHEVTNVLLNLFIAAHVSVTNLISNGILALWRNPDQLELLRNDPSIAPLLVEEVLRYDAPVQLAARLALAPTQVGGVDVEPGTFVVLLLAAANRDEAEYPQADRFLGSRRTKGIGLAFGAGPHYCIGASLAKLEAEIALKAVAGLTDFAVDEESLAYRRHVVVRGMQSMTVNFRP	MLHDTDRILKLAREAGLELAPGSLRLNEMGLDFQVAFGRDGDAVEWVLRMPRRTDVACAAVKEAKILDYFRSRLPVAVPDWKVFSDDLIAYPSLPGNPGLTFDASTYETTWHFDQNSPVYVETLGAALAQLHGLDTDDAISAGLSNLSIDAVRENWTRDLETVEKSFEVPAARLALWRAWLADLSFWPTHAASVHGDLYVGHVMVKSDGTVCGIIDWSEAHIGDPGIDLAGHLKVFGEASLRDLLGHYEAAGGQTWPRIVEHCKMLQSAEGIRYAMFALKTGSAEHLEGAQGLLSAPGI	139.80	gnl|BL_ORD_ID|444|hsp_num:0	473			441	558	erythromycin; roxithromycin; clarithromycin; tylosin; azithromycin
BGC0001072.1|Simocyclinone_17 # 22560 # 26555 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.700	BGC0001072.1|Simocyclinone_17 	22560	26555	+	Loose	600	28.1054	clbB	41.18	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGTCCGATGACCCGAAGCTGGTCGCGTACTTGAGGCGGGTAACAGCCGAGCTGTACGAGACGCGAGCGCGACTGCACGCGGCCGAACAGGGTGATGAGGACGATCCCGTGGTGGTGGTGGGGATGGGATGTCGTTTTCCGGGGGGTGTGCGTTCTCCGCAGGATCTGTGGGAGGTGTTCGCCGAAGGCGGGGACGTCATCACCGAGTTCCCCCGGGATCGTGGGTGGGACGTTGACGCCTTGTACGACCCCGAGACGGAGGCGCCGCGTTCGGATCGGACGTATGTGCGTGAGGGCGGGTTTCTGGCCGATGCCGCCGAGTTCGATCCGGTGTTCTTCGGTATCAGTCCGCGTGAGGCTCTGGTCATGGATCCGCAGCAGCGGTTGCTGCTCGAGGTGTCCTGGCACGCGCTGGAGTCGGCCGGGATCGACCCGGCGGTTCTGCGGGGCTCGCAGACCGGGGTGTTCGTCGGTCTGACCGCGGGTGACTACGCCGTTCAGGCCGAAGGGATTCCGGCCGACCTGGTCGGGCAGGTGGGTTTCAACAACACGGGCGCCATCTCGTCCGGGCGGCTTTCCTACACGTTGGGGCTGCAGGGTCCGGCGTTGACGGTGGACACGGCGTGTTCGTCGGCCTTGGTGTCGATCCATCTGGCGGCGCAGTCGCTGCGCAGTGGCGAGTCGAGTCTGGCGTTGGCCGGCGGGGCGACCGTGATCGGCAGTCCGGTGCGGTTCGTCGAGTTCTCGCAGCAGCGCGCGCTGGCTCCTGATGGTCGGTGCAAGCCGTTCTCGGCGGCGGCCGACGGCACTTCGTGGAGCGAGGGTGCGGGTGTGGTGGTGCTGGAGCGCCTGTCGGACGCCCGACGCAACGGCCATCAGGTTCTTGCCGTGGTGCGTGGTTCGGCCGTCAACCAGGACGGTGCGTCCAATGGGTTGACCGCTCCCAACGGTCAGGCGCAGCAGCGGCTGATACGTGACGCGCTTTCCCAGGCGGGTCTGGGTGCGCATGATGTCGATGCCGTTGAGGCTCATGGCACCGGGACGATGCTGGGTGACCCGATCGAGGCTCAGGCGTTGGCGGGTGTCTACAGTCAGGGGCGTGAGCCGGGCAGGCCGTTGTGGATCGGTTCGGCGAAGTCCAATCTGGGTCACACCCAGGCTGCGGCGGGTATCGCGGGTGTGATCAAGATGGTGATGGCCATGAACCATGGTCACCTTCCGGCGACTTTGCACGTGGATGCGCCGAGCCCGCATGTGGAGTGGGCTGGTAGCGGGGTGGCCGTGTTGAGCCGGGCGCAGGCTTGGCCCGATGCCGGACGTGCGCGTCGGAGTGCGGTCTCCGCATTCGGTATGAGCGGCACCAACGCGCATGTGATCCTTGAGCAGTCGGTTGAGCAGAAGGGTGACCGGCTCGGGGACGGGGAGCGGTGGCCCGCCGTGGTGGATCGGTCGACCGTTCTGCCGGTGTTGCCGTTCACGGTGTCGGCGCCCACGGCGGGGGCGCTGGCGGTGCAGGTCCGTCAGTTGCTCTCCCATGTGAGCGAGCGTCCTGACACCGATGTGCTGGACCTCGCCTATTCCCTGGCCACCACCCGTGCCCATCATGCCCATCGTGCGGTCGTGCTGGGCCGGCGTCTGGACGAACTGACCGCCACGCTCGCCCGTCTCGGCAATGACGAGCCCACGCCCGACGCGATCACCGGCCGGACCGTCCCCAACGCCACCACTGCCTTCCTCTTCCCCGGCCAGGGCAGCCAATGGCACCGCATGGGCGCCGAACTCCTGGAATCCTCGGCGGTCTTCCGCGACCAGGTGGCAGCGTGCGAGGAGGCACTTGCCCCGTTCGTCGACTGGTCGTTGACCTCGGTGCTGCGAGGAGAGCCGCAAGCCGCGTCGCTGGAGCGCGTGGACGTGCTCCAGCCGACCCTGGTGGCCGTGATGATCTCCCTCGCCGAACTGTGGCGTTCCTACGGCGTGACACCGTCAGCGGTCGCGGGTCACTCCCAGGGCGAGATCGCGCCCGCCTGGCTGTCGGGCGCGCTGTCGCTGTCGGACGCGATGCGGGTCGTGGCGCTGCGCAGCCGTGCGTTGAAGGAACTGTCCGGCCTCGGCGGCATGGCGTCGGTGGCGTTGCCGGCGGAACAGGTGCGGGAGATGCTGGCCGCGTGGGGCGGCCGACTGGAGGTCGGCGCGCTCAACGGTACGCAGTCCACCGTGGTGTCCGGCGATCCGGACGCGCTGGCGGAACTGCTTGTCGAGTGTGCGGCGCGCGACATCCGGGCGCAGCGGATCCCGGTCGACTACGCCTCGCATTCGTCGCAGGTGGAGCGGATCCGCGACCAGGTCGTCGACTCCCTGGAAGAGGTCCGGCCGCGGCCCGTGGAGGTGCCGTTCGTCTCCGGCGTCACCGGTGACTGGGTCGATGCCGAGGCGGGCCGCCTGGACGCGGAGTACTGGTACCGCAGCCTTCGGGAGGCCGTCCGGTTCGAGCGCGCGACCAGGAGCCTGCTCGCGGACGGGCACCGGGTCCTGGTCGAGGTGAGCCCGCATCCGGTGCTGATCGGCGGCGTGCGCGAAACCGTCGACGATGGAGGGGGCACCGCATCCGTGCTGGGCACCCTACGCCGGGACGAGGGCGGGATGACCCGGTTCCTCCACGCGTTGGCCGAGGCGCATGTCGCCGGGGCCGGAGTCGACTGGCACGCGGTCTTCGAGGGCACGGGTGCCCGCCGGACGGAGCTGCCCGGCTATGCCTTCCAGCGGGACCGCTACTGGCTGGACTCGGTGATGCCCGCGATCGGTCCCACGATCGCGCAGGCCGCGGACTCCCCGGGGGCGCTGGCGGGACGCTTGGCGGCACTCTCTCCCGCCGAGCGGGCCGACGCGCTGGAGAGCCTGATCGCCGGTTATGTCGCGGTCGTGCTCAAGTACCCCTCCGCAGCGGACGTGCCGGTCGAGGAGACCTTCCGCGACCTCGGTTTCGAATCAGTGACCGCCATCGAGCTGCGCAACCGGATCGCCGCGGCGACCGGAGTGGACGTGAAGCTCACCGATGTCCTCAACTATCCGACGGTGACCGACCTCGCCGAGTTCGTCGGGGAGCGGCTGCCCGAGGCGGACCTGGCCGGGCCCGGTCTTCCGGCCGCGGCCGACGCGCCCGCCGAGTCCAGCGACAGCATCGCCACGCTGTACCTGAGGGGAGTCGAGGCCGGCCGTACCAGGCAGGCCATGGGCCTGGCGCGCGCGGCCTCGCTCCTGCGGACCACCTTCGGCCCGGAGCAGGACGGCGCGAAGGCCTCCCTCTCCCGGCTGACGACGGGGACCGCCGGGCTGCCGCTGGTGTGCACGGTCGCACCGGTGGCGCCGCTCACGGACGCGGCGTACTCGTTCCTCGCCTCCGCGCTGCCTGAGCCGCGGGACGTCTGGACGGTGCGACCGCCCGGCTTCGGCGAGGGCGAGCCGCTGCCCGCCACGCTCACCGACCTCTTCGAAGCGCAGCGCAGGGCGCTCGTGGAACAGCTGGACGGGGACGCGATCGTGGTGGTCGGATACTCGTCCGGCGGCTGGCTCGCCCACGGGCTGGCCGCGCATCTGGAAGCGGCCGGCCGGCCGGCCGCCGCCGTGGTGCTCTTCGACGTCTATCTTCCGGTCTCCCAACTGGACACCGTATGGACGAGGTTCCTGCAGGAACAGGCGTCGCGAAGCGGGACGCTGTCGGGCGGCCGCTCCGCCACGCTGAGCAACGAGCTCAGCGCGATGGGCGGATACCACGGTCTGTTCGACGGGTGGCGGCCTGGCCGGATCAGTGCGCCCACCCTCCACATCAGGGCGTCCGAGGCGCTCCCCGGTCTCTCCTTGCCCGCGCCCGATGCCATGTTCCCGCCGGAGCTGTGCCACAGCTCGGCGAGCCTGCCGGGGAATCACTTCACCATGCTGTCCCAGCACTCCGAGGCCGCCGCCAAGACCGTGAACGACTGGCTCGCCGAGGTTCTGTAG	MSDDPKLVAYLRRVTAELYETRARLHAAEQGDEDDPVVVVGMGCRFPGGVRSPQDLWEVFAEGGDVITEFPRDRGWDVDALYDPETEAPRSDRTYVREGGFLADAAEFDPVFFGISPREALVMDPQQRLLLEVSWHALESAGIDPAVLRGSQTGVFVGLTAGDYAVQAEGIPADLVGQVGFNNTGAISSGRLSYTLGLQGPALTVDTACSSALVSIHLAAQSLRSGESSLALAGGATVIGSPVRFVEFSQQRALAPDGRCKPFSAAADGTSWSEGAGVVVLERLSDARRNGHQVLAVVRGSAVNQDGASNGLTAPNGQAQQRLIRDALSQAGLGAHDVDAVEAHGTGTMLGDPIEAQALAGVYSQGREPGRPLWIGSAKSNLGHTQAAAGIAGVIKMVMAMNHGHLPATLHVDAPSPHVEWAGSGVAVLSRAQAWPDAGRARRSAVSAFGMSGTNAHVILEQSVEQKGDRLGDGERWPAVVDRSTVLPVLPFTVSAPTAGALAVQVRQLLSHVSERPDTDVLDLAYSLATTRAHHAHRAVVLGRRLDELTATLARLGNDEPTPDAITGRTVPNATTAFLFPGQGSQWHRMGAELLESSAVFRDQVAACEEALAPFVDWSLTSVLRGEPQAASLERVDVLQPTLVAVMISLAELWRSYGVTPSAVAGHSQGEIAPAWLSGALSLSDAMRVVALRSRALKELSGLGGMASVALPAEQVREMLAAWGGRLEVGALNGTQSTVVSGDPDALAELLVECAARDIRAQRIPVDYASHSSQVERIRDQVVDSLEEVRPRPVEVPFVSGVTGDWVDAEAGRLDAEYWYRSLREAVRFERATRSLLADGHRVLVEVSPHPVLIGGVRETVDDGGGTASVLGTLRRDEGGMTRFLHALAEAHVAGAGVDWHAVFEGTGARRTELPGYAFQRDRYWLDSVMPAIGPTIAQAADSPGALAGRLAALSPAERADALESLIAGYVAVVLKYPSAADVPVEETFRDLGFESVTAIELRNRIAAATGVDVKLTDVLNYPTVTDLAEFVGERLPEADLAGPGLPAAADAPAESSDSIATLYLRGVEAGRTRQAMGLARAASLLRTTFGPEQDGAKASLSRLTTGTAGLPLVCTVAPVAPLTDAAYSFLASALPEPRDVWTVRPPGFGEGEPLPATLTDLFEAQRRALVEQLDGDAIVVVGYSSGGWLAHGLAAHLEAAGRPAAAVVLFDVYLPVSQLDTVWTRFLQEQASRSGTLSGGRSATLSNELSAMGGYHGLFDGWRPGRISAPTLHIRASEALPGLSLPAPDAMFPPELCHSSASLPGNHFTMLSQHSEAAAKTVNDWLAEVL	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	388.05	gnl|BL_ORD_ID|109|hsp_num:0	127			174	276	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0001072.1|Simocyclinone_18 # 26638 # 39741 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=4bp;gc_cont=0.714	BGC0001072.1|Simocyclinone_18 	26638	39741	+	Loose	750	74.7146	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	27.94	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGCGCGCGGGATCCGGTGCCGAAGGTCGTGGTCGGGCGGACGAGGTCGCGGTGGTCGGGCTCTCCTGCCGTTTCGCGGGTGCCGCAGGGCCGGACGAGTTCTGGCACCTGCTGCGGACCGGCACGAACGGCGTCACCGAGGTACCCGAGGGCCGTTGGGACTCCGAGGGGCCCGCGGAGAGTGGGACGGGCCCCCGGTGGGGCTCCTTCCTCCGGGACGTCGACATGTTCGACGCCGCCTTCTTCGGCATCTCGCCACGCGAAGCCGCCGTGATGGATCCGCAGCAGCGGCTGGCCTTGGAGCTGAGCTGGGAAGCGCTGGAGGACGCGGGAATCGTCCCGGCGACGCTCCGGGGCGCGCGCTCTGGCGTGTTCATCGGCGCGATGCGGGACGACTACGCGCGGCTGTCCCAACTCCTGGGCCAGGACGGCGGTACGCACCACTCGTTCACCGGACTCCAGCGCAGCCTGATCGCCAACCGGGTCTCGTACTTCTGCGGCCTGCGCGGTCCGAGCATGACGGTGGACACCGGGCAGTCCTCCGCCCTGACCGCCGTCCACCTGGCCTGTCAGAGTCTGCTGACCGGCGAGTCCGAGATCGTGCTCGCCGGTGGCGTGAACCTCAACCTCGTGGCCACGAGCGAAGAGGAGACGGCCAGGTTCGGCGGCCTTTCCCCGGACGGCCGCTGCTACACCTTCGACGCGCGGGCCAACGGCTTCGTGCGTGGCGAGGGCGGCGGCATCGTCGTGCTGAAGCCGCTGGCGAAGGCTCTGGCCGACGGTGACCGGATCCACTGCGTGATCAGCGGCGGCGCGGTCAACAACGACGGCGGCGGTGGCGGCCTGACCGTGCCCAGCCAGGCCGCCCAGGAGGAGCTGCTGAGGCTGGCGTACCAGAACGCCGGCGTCGATCCGGCCCGCGTCCAGTACGTCGAACTGCACGGCACCGGGACCACGGTCGGCGATCCGGTCGAGGCCGCCGCCCTCGGTGCCGTACTCGGGGCCGGCCGGGACCGCCCGCTGCCGGTGGGGTCGGTCAAGACCAACCTGGGACACCTGGAGGCCGCCGCCGGGATCAGCGGCCTGATCAAGACGGTGCTGGCCATCCGGCACCGCGAACTGCCCCCGAGCCTCAACTTCCTGACGCCCCACCCCGGCATCCCGCTGGAAGCACTGCGGCTGCGGGTCTGCACCGAGCTCGGTTCCTGGGACGATGCCGGCGGCCCGCTGGTGGCCGGTGTGAGTTCCTTCGGCATGGGTGGCACCAACTGCCACCTCGTACTCACCGAAGCCCCGGCGGGTGACGTCACCACCGTGCCGCCGACGGCCACGACCACCCCTTCCCGAGTCCCCTTCCTGCTGTCGGGCCGTACCGTCCCGGCCCTGATCGCCCAGGCCGAACGTCTGCGGGACTTCGTCGAGGACCACCCGGAGACCGATCCGGTGGACCTCGCCCACTCGCTGGCCACCACCCGTACCGCGTTCGAGCACCGTGTGGTCCTCACGGCGTCCGACCGGGACGAGTTGCTGGCGTCGTTGCGGGCGCTCGCGGCGGGCCGGCGTGCTCCGGAGGTGTCGCGCGGAGTAGCCGAGCCGGGCGCGCGTGTCGCCTTCCTCTTCACCGGTCAGGGCAGTCAGCGGCCCGGAATGGGCCGGGAGCTGTACCGTGAGTTCCCCGTGTTCGCCGAAGCCTTCGACGAGGTGTGCCGGCACCTGGACGCCCATCTGGACATGCCGGTACGGGACGTCGTGTTCGCCGCCGACGGTTCGTCCCGAGCGGCACTGCTGGATGAGACGCTGTACACGCAGGCGGCGCTGTTCGCCCTGGAAGTGGCGCTGTACCGGCTGGTGGAGTCCTTCGGTGTCCGCGCGGACCGGCTCGCCGGTCATTCGATCGGCGAGCTGGCGGCCGCCCACGTCGCCGGGGTGTTCTCGCTCCCGGACGCCGCCGCCGTGGTGGCCGCCCGGGGCCGCCTGATGCAGGCGCTGCCGGCGAACGGGGCGATGGTGGCCGTACAGGCCGCCGAGGACGAGGTGCTCGACCTGCTCGCGGGACGCGAGGACCGGGTCTCGCTGGCCGCCGTCAACGGACCGTCGGCCACGGTGCTCAGCGGCGACGAGGACGCCGTGTCCGAGCTGGTGGACGTGCTCTCGGCGCGCGGCCACCGGACCAAGCGGCTGCGGGTCGGCCGTGCCCTGCACTCCCCGCACCTCACCCCGATGCTCGCGGAGTTCCGCGAGGTCCTCGCGGCGGTGACGTTCCATCCGCCGCGCGTCCCCGTCGTCTCCACCCTCACCGGCACGCTGATCGAGCCGGAGCGGATGAGCGACGCGGAGTACTGGGTGCAGCAGGCGAGGGAGCCGGTGCGCTTCCTGGACGCGATGCGCACGCTGCGGGACTCGGGCACGACCGTGTTCGTCGAACTCGGTCCCGACGGCTCGCTGGCCGCCATGGCGCACGACTGCGTGACCTCGACGACGGTGAGCATCGCATCCGTCCTGCGGGCGGGACGACCCGAGTCACGGACCCTGCTCGCAGCCCTGGCCGCGATGCACACCCACGGCGTGCCGGTGGACTGGACGACCTTCTTCCGGGGGCACGGCGCACGGCGTGTCCAGCTGCCCACCTACAGCTTCCAGCGTGAACGGCACTGGCTGGACACCGGGGGGCAGCCGGCGGACCGGACCCCGGTGAGGCCGCCGGTCCGACCCGCCGCCGTGGCGCCGGGGAACGTTGATGCCCTGCAGACGCGGCTGGCCGGGCTCACCGCCGCCGAGCAGGAACGCGCGCTGATCGAGCTGGTGCGGGAGCAGGCCGTCCACGTGCTCGGCCACGCCGACCAGGGCGCGGTCGAGCCGGACCGTACGTTCGGTGATCTGGGCTTCGACTCGCTGATGGGCGTGGAACTGCGCGAACGACTCGGCGAGCTGTCGCAGACGCCGCTGTCAAGCACGGCGCTCTTCGACCACCCCACTCCTGCGGGGCTCGCCCGGCACCTGCACGCCCGGCTGTCCGACGCGCCGGAGGCACCGGCGACGCCCGGTACGACGCCGGCGCCGGCGCACGCACCTGATGACCCGGTCGTCATCGTGGGCATGGCGTGTCGCTATCCCGGCGGGGTGTCGGCACCGGAGGAGCTGTGGCAGCTGGCCGCATCCGGTACGGACGCGATCGGCGACTTCCCCGTCAACCGTGGCTGGGACGTCGAATCGCTCTACGACCCCGACCCCGACCGGCTCGGCAAGTCCTACACACGCCAAGGGGGCTTCCTGCACGACGCGGCGGACTTCGACGCCGCGTTCTTCGGGATCTCTCCGCGCGAGGCCCTGACCACCGACCCGCAGCAGCGACTTCTGCTGGCCACCGCCTGGGAGGCCTTCGAGGACGCGGGCATCGACCCGGCGTCGGTCCGCGACAGCCGCACCGCGGTCTTCACCGGTTCGATGCACCACGACTACGCGCCACCTTTCCGCACGGCCCCGGCCGGCGTCGAAGGACATGTGCTCGTCGGCAGCACGTCGAGTGTGGTGTCGGGCCGGGTGTCCTACACGCTCGGCCTGCACGGGCCCGCCATCTCGGTGGACACGGCGTGCTCGTCCTCCCTGGTGGCCCTGCACCTGGCGGTGCAGTCCCTGCGCCGGGGTGAAAGCTCGCTGGCCCTGGCCGGCGGCGTTTGCGTGATGGCGACTCCCGAGATGTTCGTCGAGTTCTCCAGGCTGCGCGGGCTGGCGCCCGACGGCCGGGTCAAGGCCTTCTCGGCGGCGGCGGACGGCACCGCCTGGTCCGAAGGGGTCGGGATGCTGTTGCTGGAACGGCTCTCCGACGCCCGCCGCAACGGCCACCGGGTCCTCGCGGTGATCAGGGGCTCGGCGGTGAACCAGGACGGCGCGTCCAACGGAATTTCCGCACCGAGCGGGCCGGCGCAGGAGCTGGTGATCCGGGATGCGCTGGACGACGCGGGGCTCACCACCGCCGAGGTCGACGCGGTCGAGGCGCACGGCACCGGAACGCCCCTCGGCGACCCCATCGAGGCCCAGGCCCTGCTGGCCACCTACGGCCAGGACCGCCCGGCGGACCGGCCGCTGCTGCTCGGCTCCCTCAAGTCCAACGTGGGTCACACCCAGGCCGCAGCGGGTGTCGCGGGTGTGATCAAGATGGTGTTGGCCATGCGGCACGGCTTGTTGCCGAAGCTGCTCCACTTCAACGAGCCCACCGCGCACGTCGACTGGAGCAGCGGACTGGTGACGCCACTCGCCCAGGACGCCCCGTGGCCGGAGACCGGCCGGCCCCGTCGCGCGGCCGTGTCCTCCTTCGGCATCAGCGGCACCAACGCCCATGTGATCCTCGAAGAGCCCGCCGTGGCGGAACACGACTCGAGGCAAGGCCCTGCCGAGGCACCCGGGTCGTCGCCCGTGCTGCCCTGGGTGCTCTCGGCCCGGTCCGAAGCCGCACTGCGCGACCAGGCGTCGAGACTGCGGGCGTACCTCGACCGCGATCCCGACGTGGATCTCGCCGATGTGGCGTACACCCTGGCGGCCGGCCGGTCCGCCTTCGAGCACCGCTCGGTGATCGTGGGCCGGGACCGCGAGTCCTTGCTGCCCGCTCTGGACGCGGTGTCCGCCGGTGTGCCGGCCGCGGGGCTGAGCTCCGGGCGTGTCGGCACCGGGCAGCGGCCGGTGCTGGTGTTCCCCGGACAGGGCACGCAGTGGACCGGCATGACGGTGCAGTTGCTGGCGTCCTCCCCGGTCTTCGCCGACCGGATGGCGGCGTGCCAGCAGGCCCTGGCACCGTTCGTGGACTGGTCCCTGCAGGACGTACTCGCCGATGAGGACGCCCTGGCCAGGGTCGATGTGGTGCAGCCGACGCTGTGGGCCGTGCTGGTCTCGCTGGCTGCCCTGTGGCGGTCCCACGGGGTCGAGCCGACGGCGGTCGTGGGCCATTCACAGGGCGAGATCGCGGCCGCGACGGTGGCTGGCGGACTGTCCCTGGAGGACGGAGCGCGGGTGGTGGCGCTGCGCAGCCAGGCGCTGCGCGCCCTGTCCGGTCAGGGCGGCATGGTGTCGGTGCAGCTGCCCCGGCCGGAGACCGAACGGCGGCTGCGGCCCTGGCAGGACCGCATCTCGATCGCTGCGGTGAACGGCCCCCAGTCCACCGTGGTCTCGGGCGAGCCGCAGGCGCTGGACGCGCTGTGCGAGGAGCTGTCCGGGGACGGAATCCGGGTGTCACGCCTGCCCGTCGACTACGCGTCCCACTCCGAGCAGGTGACCCAACTGCGCGAGCGGCTGCTGGCGGAGCTGGCTCCGATCGCGCCGCGCTCGAGTGAGATTCCGTTCCACTCCACGCTGACCGGTGGTCTGATCGACACCGCCGAGCTGAACGCCGACTACTGGTACCGCAATCTGCGCCACACCGTGGAGTTCGACGCCGCGATCCGTGCGTTGTCCGGGCGCGGGCATGCACTGTTCATCGAGTCCAGCCCGCGCCCGGTGCTCACCATGGACATTCAGCAGATCCTGGAGGAGACCACCGAGAACGGCACCGCGCTGGGCACCCTCCGGCGTGACGAGGACGGCATGGACCGCGTCCTGACGGCACTGGCCGAAGCGCACGTCCGCGGCGCGGACGTGGACTGGGCGCAGCTGTTCCCGCCGGGTACGGTCGAGCGCATCGAGCTGCCCACGTACGCCTTCCAGTACGAGCAGTTCTGGATGCTGCCGACCACCGGGGCGGTCGATGCCGAAGCGCTCGGGCTGCTCAGCTGTGAGCATCCCCTGCTGGGCGCGGCCGTTGCCCGGGCGGACGACGACAGTCTGGTGTTCACCGGCAGCCTCTCGCTGGGCACGCACCCATGGCTCGCCGACCACGCGGTCCACGGCACGGTTCTGCTGCCGGGGGCGGCGTTCGTCGAACTGGCCCTGCACGCCGGGGATCAGGTGGGGTGCGACCGGATCGACGAACTCGCCCTGGAGACCCCGCTGTTCCTGTCCGAGCAGGACACCGTCCAGCTCCAGCTCGTGCTCAGCGGCCCCGACGCGAACGGCCGGCGCACGGTCTCGGTGCACTCCCGGGTCGCCGGTGGCGACCCGACGGACGATCCGCAGTGGACCCGGCACGCAACTGGTTCACTGGTCAACGGCGGCACCAGGCAGCCGGATCCCGTCCAATGGCCGCCGGCTGGTGCGAAGCAGGTGGAGATCTCCGACGCCTATGAGCACCTCGCCGAAACCGGGTACGAGTACGGCCCGGCGTTCCAGGGACTCCAGGCGGTCTGGCAACTAGGCGACGAGCGCTACGCGGAGATCGTTCTTCCGGCCGAAGCGGGTGAGGACGTCACAGGGTTCGGCATTCATCCCGCGCTGTTCGACGCCGCCCTGCACGCGCTGCTGATCACCGCACCCAGGGAGGCGGACGGCGGTGCGGTTCGACTGCCCTTCTCGTGGTCAGGAGTGTCCCTGTACGCCACGGGAGCCGTGCGACTGCGCGTGCGGCTCTCGCCCGCCGGTGCCGACGCCTTCTCGGTGACGGTCGCGGACGGCGACGGCACACCGGTGGCAGCCATCGACTCCCTCACGCTGCGCCCGGTCAAGCCGGGGCGCACGGGTGCCACGGGCCGCAGCCACCACCAGTGGCTGTTCCAGGTGGAGTGGCTTGACGTGCCACTCACCACCACTGCCGACGCCGGCACCGGATGGGCGGTGCTCGGCGAAGACCTCCTCGGTCTGGACGCCACGAGCGCCCCGGTGTCGCGCCATGCGGATCTGCCGGCGCTCCGGGCGGCCGTCGAGGCCGGTGAACCCGCACCGGACTTCGTGGTCGTCGCGTGCCCGCCGGGCGTGGACGGCCAGGAGGCACCGGCGGACGACAGGGCTGCAACCGCGCCGGCCGGTCCGGCCGACCTGCCCGCCGTACTGCGCGCGGCCACGAACGAGGCTCTGGGCTTGGTGCAGAGCTGGCTGAATGACGAGGCGTTCGCCACCTCACGTCTGGTCGTCGTCACCCGGGGTGCCGTCTCCGCCGTTCCCGGTGAGGACGTGCCCGATCTGTCCCACGCGCCCGTCTGGGGCCTGCTGCGCTCGGCGCAGTCCGAGAACCCGGACCGCTTCCTGCTCGTCGACGTCGACGGCTCGTCCGTCGGGATCGACCTGCTGCGCGCCGCAGCCGAATCCGGCGAGACCCAACTCGCGGTACGCGGCGGGCGGTTGACCACTCCGAAGCTCACCAGGGCCGCCTCGGCCGGGGCCGGACATCCGGTCGAGTGGGATCCGCAGGGCACGGTGCTGATCACCGGCGGCACCGGAACCCTGGGCGGCCTCATCGCCCGGCACCTGGTCGTCGAGCACGGCGTACGACAGCTCCTGCTGACCGGCCGACGGGGGCAGGACAGTCCCGGAGCGGCCGAACTCGAAGCCGAACTGACCGCGCTGGGCGCACGGGTGACCATCGCGGCCTGCGATGCGGCCGACGCCGGACGGCTCGCCGCACTGCTGGCGGAGGTTCCCTCCGAGCACCCGCTGACGGCGGTGATCCATGCGGCGGGCGTGCTGGACGACGGCACGGTGGAATCGCTCGACGCGGGACACCTGGACTCCGTACTGCGCCCGAAGGCCGACGGTGCCTGGAACCTGCACCGGCTGACCGAGCACCTCGACCTGTCCTCCTTCATCTTGTTCTCCTCGGCCGCGGGTACGGTCGGCACTCCCGGTCAGGCGAACTACGCCGCAGCCAACACCTTCGTCGACGCGCTGGCTCACCACCGCAGGGCACGAGGGCTTCCGGCGACGTCCCTGGCATGGGGGCTGTGGGCCGTGGACAGCGGCATGACCGGGCATCTGGGCGAGAACGGCCGGGCCAGGCTGGCGCGTAGCGGACTCGCTCCCCTGAGCGAGGCGGAAGGTGTCGTGCTCTTCGACGCCGCGCTCTCGACCGGCTCCACCCTGCTGGTACCCGCCCCGCTGGACCTGGCGGCGCTGCGCCGCCAGGCCGCGGCCGGTGCGCGGAACGCGCTCTTCGCGTCCCTGCTGGGCAACACCCGGCGGGTGCTGACCGCCTCGCGTCCGGTCCCGTCGGCTCAGCACGTCGAGACCGGCCCGGTCGGCCCGTTGAGCGGCCGGGCGCTGATGGACCTGGTGCGCACCGTCGTGGCCGCCGTGCTCGGGCATGCGGCACCGGACCAGGTCGACGAGGACCGGGCCTTCCGGGACCTGGGCTTCGACTCGCTCACCGGGATCGAATTCCGCAACCAGCTCGCCGCGGCCACGGGGCTGCAGTTGCCCGCCACCCTGGTCTTCGACCACCCCACGCCGGCTGCACTGGTCGACTACCTCTCGGGTCGGTTGCCCGGTTCGGGCCGGGAGGAGGAGCCGTTGGCCGCCGCCACGAGTGATGAGGACGATCCCGTGGTGGTGGTGGGGATGGGATGTCGTTTTCCGGGGGGTGTGCGTTCTCCGCAGGATCTGTGGGAGGTGTTCGCCGAAGGCCGGGACGTCATCACCGAGTTCCCCCGGGATCGTGGGTGGGACGTTGACGCCTTGTACGACCCCGAGACGGAGGCGCCGCGTTCGGATCGGACGTATGTGCGTGAGGGCGGGTTCCTGGCCGATGCCGCCGAGTTCGATCCGGTGTTCTTCGGTATCAGTCCGCGTGAGGCTCTGGTCATGGATCCGCAGCAGCGGTTGCTGCTCGAGGTGTCCTGGCACGCGCTGGAGTCGGCCGGGATCGACCCGGCGGTTCTGCGGGGCTCGCAGACCGGGGTGTTCGTCGGTCTGATCCCGGGTGACTACGCCGTTCAGGCCGAAGGGATTCCGGCCGACCTGGTCGGGCAGGTGGGTTTCAACAACACGGGCGCCATCTCGTCCGGGCGGCTTTCCTACACGTTGGGGCTGCAGGGTCCGGCGTTGACGGTGGACACGGCGTGTTCGTCGGCCTTGGTGTCGATCCATCTGGCGGCGCAGTCGCTGCGCAGTGGCGAGTCGAGTCTGGCGTTGGCCGGCGGGGCGACCGTGATCGGCAGTCCGGCGCGGTTCGTCCAGTTCTCGCAGCAGCACGTGCTGGCTCCTGATGGTCGGTGCAAGCCGTTCTCGGCGGCGGCCGACGGCACTTCGTGGAGCGAGGGTGCGGGTGTGGTGGTGCTGGAGCGCCTGTCGGACGCCCGACGCAACGGCCATCAGGTTCTTGCCGTGGTGCGTGGTTCGGCCGTCAACCAGGACGGTGCGTCCAATGGGTTGACCGCTCCCAACGGTCAGGCGCAGCAGCGGCTGATACGTGACGCGCTTTCCCAGGCGGGTCTGGGTGCGCATGATGTCGATGCCGTTGAGGCTCATGGCACCGGGACGATGCTGGGTGACCCGATCGAGGCTCAGGCGTTGGCGGGTGTCTACGGTCAGGGGCGTGAGCCGGGCAGGCCGTTGTGGATCGGTTCGGCGAAGTCCAATCTGGGTCACACCCAGGCTGCGGCGGGTATCGCGGGTGTGATCAAGATGGTGATGGCCATGAACCATGGTCACCTTCCGGCGACTTTGCACGTGGATGCGCCGAGCCCGCATGTGGAGTGGGCTGGTAGCGGGGTGGCCGTGTTGAGCCGGGCGCAGGCTTGGCCGATGCCGGGACGTGCGCGTCGGAGTGCGGTCTCCGCATTCGGTATGAGCGGCACCAACGCGCATGTGATCCTTGAGCAGTCGGTTGAGCAGAAGGGTGACCGGCTCGGGGACGGGGAGCGGTGGCCCGCCGTGGTGGATCGGTCGACCGTTCTGCCGGTGTTGCCGTTCACGGTGTCGGCGCCCACGGCGGGGGCGCTGGCGGTGCAGGTCCGTCAGTTGCTCTCCCATGTGAGCGAGCGTCCTGACACCGATGTGCTGGACCTCGCCTATTCCCTGGCCACCACCCGTGCCCATCATGCCCATCGTGCGGTCGTGCTGGCCGGCGGTCTGGACGAACTGACCGCCACGCTCGCCCGTCTCGGCAATGACGAGCCCACGCCCGACGCGATCACCGGCCGGACCATCCCCAACGCCACCACTGCCTTCCTCTTCCCCGGCCAGGGCAGCCAGTGGCACCGCATGGGCGCCGAACTGCACCGGCTCTTCCCGGTGTTCGCCGAGGCGTTCGACGAGGTCTGCGCCGAACTGGACGGGCAGCTGGACCGGCCGTTGAAGGACGTGGTGTTCGCGGCAGACGGATCCGCCGAAGCCGGGTTGCTGACGCGGACCGACTACGCCCAGGGCGCGGTGTTCGCCACCGAGGTGGCGCTGTTCCGGTTGTTGACGGACTTCGGCGTCCGGCCGGACTTCCTGGCGGGGCACTCGGTCGGTGAGGTCGCCGCCGCGCATGTGGCCGGAGTGTTGTCGCTGGCGGATGCCTGCGTGCTGGTCGCGGCGCGGGGTCGGCTGATGCAGGCCCTGCCGTCCGGCGGGGCGATGGTCGCGCTGGCGGCTTCGGAGGAGGAGGTCAGGGCACTGATCGCCGGCCGGGAGCACGAGGTCGCGATCGCCGCGGTGAACGGATCCGAAGAGGTGGTGATCTCCGGCGACGAGCGGGCCGTCCTCGACTGCGCCAACGCGCTGGCGGCCCAGGGACGCCGTACGACCCGGCTCGCCGTGAGTCACGCCTTCCACTCCCACCACATGGACGGCATGCTCGAACCGTTCCACCAAGTGCTGACCACACTGCGGTTCCGGCCTCCGACCACGCCGATCGTGTCCGCGGTGACCGGAGAGCTGGTCTCTGCGGAAGAGCTGTGCTCGCCCGGCTATTGGACTCGCCACGCCCGTGGGACGGTCCGCTTCCAGGACAGCCTCGGCCGGCTCGCCCACGAGGGTGTGCGGATCTACGTGGAGGTGGGTCCCGGGCATGCGCTCACCGCTCTGGGGCAGCACAGCCTGGGGCAGGACCTGGGCGATTCCGGTTCCGTCGAACTGGTGCCGTGCCTGCGCGAGTCACGTCCCGAAGCGAGCACCCTGCTGACGGGACTGGCCGGCCTGCATACCCGGGGGGTACCGGTGAGCTGGGCCTCCTGGTGCGCCGGAGGCGGTACCGCCGAGCTGCCGCTGTACGCGTTCCAGCGGGACCGCTACTGGCTGCGGAGCGGTGACGACGCGGAGCGGGAGACCACGACGCCGCCACGCTCGGTGGACCCGGTGCGCTACGAGCTGGCCTGGCAGCCCTGGGCAGAACCGGCGACCGTGCCCGAGCCGGCGGCCGGTGCCTGGTTGGTCGTGGCGCCACCTCAGAGCGAGCACGACGGCACGGTTTCCGGCGTGCTGCGCGCGCTGACGGAGCGTGGTGCCACGGTCCTGGAGTCGCGCTACGACGGTACTCACCGCGAAGGTTGGGCGAAGCGCCTCATCATGACTCCGCCCACGCCGCTGGCCGGGATCGTGTCGTTGGTTTCGCTGGACGAGCGGATGGACCCCGATGAGCCGACGGTGCCCCGGGCCGTGACGGCCACTCTCGCGCTGGTCCAGGCCCTGGAGGACACCGGCATCGACGCTCCGGTCTGGAGCGTGACCAGGAGCGCGGTCAGCGTCGGCGCCGACGATCCGGTGCTCCGGCCCGGCCAAGCCGGCGTGTGGGGTCTGGGCAGGGTCATCGCACAGGAGGCCCCGCACCGCTGGGGCGGGCTGATCGATCTTCCCGAGGACATGGACGAGCACGTCCGGACCCGGTGGTGCGACGCGCTGACGGGTGTGCGCGGAGAGGACCAACTGGTTGTTCGCGAGGACGGGATGTTCGTCCCCCGGCTCACCCACGTGCCGCTCCCGTCACCGGAGCCGCTGGACTGGAAACCCCGCGGCACGGTGCTGGTCACCGGCGGGCTGGGAGCGCTCGGCGCCCACGTCTCCCGTTGGCTGGCCGGCCGGGGAGCCGAGCATCTGCTGCTCGTGGGCCGCCGCGGGCCGAGCACTCCGGGCGCGGACGCCCTGCGTGCGGAGCTCGCCGCGCTGGGGACCGAGGTCACCGTCGCCGCGTGCGACATCAGCGACCGGGACGCGCTGGACAGCCTGATCCGCAACCTGCCCGCCGACGCACCGCTCACCGGGATCGTGCATGCGGCCGGTGTGCTGGACGACGGACTCATCGAATCGCTCTCCCCGCAGCGCCTGGGCACCGTCTTCGCAGCGAAGGCCGGCGCCGCCTGGCACCTGCACGAACTCACCCGGGACCGGCCGCTGGAGCAGTTCGTCCTCTTCTCGTCCTTCGCGGGCATCGTCGGTTCGCCCGGTCAGGGCAACTACGCGGCGGCCAATGCCGTCCTCGACGCACTGGCCCACCACCGCCGCGGCCTCGGCCTTCCCGCGACCGCGCTCGCCTGGGGGCCCTGGGCCGGTGGCGGAATGTTCACGACCGTGCCGGTCCGGTCCCAGCAACTCGACGGCCTCACCGCGCTCTCCACGCCGATCGCACTCGACGCATTGGCCCGCAGCCTCGGTCGGCCGCAAGCCTCCGTGGCCGTCGCGGAGGTTGACTGGAATCATTTCGTCGGGATCCACGGGGTCACCCGCCCGAGCACCCTCTTCCGCGAGCTCACCCCCGTCGGGGACGGTGGTGCCCGGTCCGCAACCAGCGTCCTGGATGCCCTGCCGGCCGAGTACCTGGCCGGGCTGTCCGCCGACGAGATCCGCGACGCACTGCTGACCCGGGTGATCTCGCACGTGGCCGCGGTGTCCGGACACGCAGTCGAGGCCATCCCGGCGAACCGGGCGTTCCGTGAGATGGGGTTGGATTCGCTGGCCACCGTCCACCTCCGCAATCGCCTCAACGCCGAGACAGGCCTGCGACTGGCCGCCACGGTGGTGTACGAACACCCGACGCCCATGGCCCTGGCCCGTCATCTGGTGGTGTGTCTGGGCGAGAGCCGGGCGGATGACTCCACCCGGACCGTGGTGGCCGAGCTCAGGAAACTGGATGTCTCACTCGCCTCGGTTCCCCCGTCGCATGACCGCAGGGAGGAGATCACCTCACTCCTGGAAACGGTCCTGCTGAAATGGCGCGATGCGGATCGGGCCCGGGGCGGCGCGGAGGCCGGCCGCGATCTTGCCGTGGCCTCGGACGACGAAATGTTCGACATCATCGACAACGTTCTCGGTCTCACGGAGACAGATTCATGA	MRAGSGAEGRGRADEVAVVGLSCRFAGAAGPDEFWHLLRTGTNGVTEVPEGRWDSEGPAESGTGPRWGSFLRDVDMFDAAFFGISPREAAVMDPQQRLALELSWEALEDAGIVPATLRGARSGVFIGAMRDDYARLSQLLGQDGGTHHSFTGLQRSLIANRVSYFCGLRGPSMTVDTGQSSALTAVHLACQSLLTGESEIVLAGGVNLNLVATSEEETARFGGLSPDGRCYTFDARANGFVRGEGGGIVVLKPLAKALADGDRIHCVISGGAVNNDGGGGGLTVPSQAAQEELLRLAYQNAGVDPARVQYVELHGTGTTVGDPVEAAALGAVLGAGRDRPLPVGSVKTNLGHLEAAAGISGLIKTVLAIRHRELPPSLNFLTPHPGIPLEALRLRVCTELGSWDDAGGPLVAGVSSFGMGGTNCHLVLTEAPAGDVTTVPPTATTTPSRVPFLLSGRTVPALIAQAERLRDFVEDHPETDPVDLAHSLATTRTAFEHRVVLTASDRDELLASLRALAAGRRAPEVSRGVAEPGARVAFLFTGQGSQRPGMGRELYREFPVFAEAFDEVCRHLDAHLDMPVRDVVFAADGSSRAALLDETLYTQAALFALEVALYRLVESFGVRADRLAGHSIGELAAAHVAGVFSLPDAAAVVAARGRLMQALPANGAMVAVQAAEDEVLDLLAGREDRVSLAAVNGPSATVLSGDEDAVSELVDVLSARGHRTKRLRVGRALHSPHLTPMLAEFREVLAAVTFHPPRVPVVSTLTGTLIEPERMSDAEYWVQQAREPVRFLDAMRTLRDSGTTVFVELGPDGSLAAMAHDCVTSTTVSIASVLRAGRPESRTLLAALAAMHTHGVPVDWTTFFRGHGARRVQLPTYSFQRERHWLDTGGQPADRTPVRPPVRPAAVAPGNVDALQTRLAGLTAAEQERALIELVREQAVHVLGHADQGAVEPDRTFGDLGFDSLMGVELRERLGELSQTPLSSTALFDHPTPAGLARHLHARLSDAPEAPATPGTTPAPAHAPDDPVVIVGMACRYPGGVSAPEELWQLAASGTDAIGDFPVNRGWDVESLYDPDPDRLGKSYTRQGGFLHDAADFDAAFFGISPREALTTDPQQRLLLATAWEAFEDAGIDPASVRDSRTAVFTGSMHHDYAPPFRTAPAGVEGHVLVGSTSSVVSGRVSYTLGLHGPAISVDTACSSSLVALHLAVQSLRRGESSLALAGGVCVMATPEMFVEFSRLRGLAPDGRVKAFSAAADGTAWSEGVGMLLLERLSDARRNGHRVLAVIRGSAVNQDGASNGISAPSGPAQELVIRDALDDAGLTTAEVDAVEAHGTGTPLGDPIEAQALLATYGQDRPADRPLLLGSLKSNVGHTQAAAGVAGVIKMVLAMRHGLLPKLLHFNEPTAHVDWSSGLVTPLAQDAPWPETGRPRRAAVSSFGISGTNAHVILEEPAVAEHDSRQGPAEAPGSSPVLPWVLSARSEAALRDQASRLRAYLDRDPDVDLADVAYTLAAGRSAFEHRSVIVGRDRESLLPALDAVSAGVPAAGLSSGRVGTGQRPVLVFPGQGTQWTGMTVQLLASSPVFADRMAACQQALAPFVDWSLQDVLADEDALARVDVVQPTLWAVLVSLAALWRSHGVEPTAVVGHSQGEIAAATVAGGLSLEDGARVVALRSQALRALSGQGGMVSVQLPRPETERRLRPWQDRISIAAVNGPQSTVVSGEPQALDALCEELSGDGIRVSRLPVDYASHSEQVTQLRERLLAELAPIAPRSSEIPFHSTLTGGLIDTAELNADYWYRNLRHTVEFDAAIRALSGRGHALFIESSPRPVLTMDIQQILEETTENGTALGTLRRDEDGMDRVLTALAEAHVRGADVDWAQLFPPGTVERIELPTYAFQYEQFWMLPTTGAVDAEALGLLSCEHPLLGAAVARADDDSLVFTGSLSLGTHPWLADHAVHGTVLLPGAAFVELALHAGDQVGCDRIDELALETPLFLSEQDTVQLQLVLSGPDANGRRTVSVHSRVAGGDPTDDPQWTRHATGSLVNGGTRQPDPVQWPPAGAKQVEISDAYEHLAETGYEYGPAFQGLQAVWQLGDERYAEIVLPAEAGEDVTGFGIHPALFDAALHALLITAPREADGGAVRLPFSWSGVSLYATGAVRLRVRLSPAGADAFSVTVADGDGTPVAAIDSLTLRPVKPGRTGATGRSHHQWLFQVEWLDVPLTTTADAGTGWAVLGEDLLGLDATSAPVSRHADLPALRAAVEAGEPAPDFVVVACPPGVDGQEAPADDRAATAPAGPADLPAVLRAATNEALGLVQSWLNDEAFATSRLVVVTRGAVSAVPGEDVPDLSHAPVWGLLRSAQSENPDRFLLVDVDGSSVGIDLLRAAAESGETQLAVRGGRLTTPKLTRAASAGAGHPVEWDPQGTVLITGGTGTLGGLIARHLVVEHGVRQLLLTGRRGQDSPGAAELEAELTALGARVTIAACDAADAGRLAALLAEVPSEHPLTAVIHAAGVLDDGTVESLDAGHLDSVLRPKADGAWNLHRLTEHLDLSSFILFSSAAGTVGTPGQANYAAANTFVDALAHHRRARGLPATSLAWGLWAVDSGMTGHLGENGRARLARSGLAPLSEAEGVVLFDAALSTGSTLLVPAPLDLAALRRQAAAGARNALFASLLGNTRRVLTASRPVPSAQHVETGPVGPLSGRALMDLVRTVVAAVLGHAAPDQVDEDRAFRDLGFDSLTGIEFRNQLAAATGLQLPATLVFDHPTPAALVDYLSGRLPGSGREEEPLAAATSDEDDPVVVVGMGCRFPGGVRSPQDLWEVFAEGRDVITEFPRDRGWDVDALYDPETEAPRSDRTYVREGGFLADAAEFDPVFFGISPREALVMDPQQRLLLEVSWHALESAGIDPAVLRGSQTGVFVGLIPGDYAVQAEGIPADLVGQVGFNNTGAISSGRLSYTLGLQGPALTVDTACSSALVSIHLAAQSLRSGESSLALAGGATVIGSPARFVQFSQQHVLAPDGRCKPFSAAADGTSWSEGAGVVVLERLSDARRNGHQVLAVVRGSAVNQDGASNGLTAPNGQAQQRLIRDALSQAGLGAHDVDAVEAHGTGTMLGDPIEAQALAGVYGQGREPGRPLWIGSAKSNLGHTQAAAGIAGVIKMVMAMNHGHLPATLHVDAPSPHVEWAGSGVAVLSRAQAWPMPGRARRSAVSAFGMSGTNAHVILEQSVEQKGDRLGDGERWPAVVDRSTVLPVLPFTVSAPTAGALAVQVRQLLSHVSERPDTDVLDLAYSLATTRAHHAHRAVVLAGGLDELTATLARLGNDEPTPDAITGRTIPNATTAFLFPGQGSQWHRMGAELHRLFPVFAEAFDEVCAELDGQLDRPLKDVVFAADGSAEAGLLTRTDYAQGAVFATEVALFRLLTDFGVRPDFLAGHSVGEVAAAHVAGVLSLADACVLVAARGRLMQALPSGGAMVALAASEEEVRALIAGREHEVAIAAVNGSEEVVISGDERAVLDCANALAAQGRRTTRLAVSHAFHSHHMDGMLEPFHQVLTTLRFRPPTTPIVSAVTGELVSAEELCSPGYWTRHARGTVRFQDSLGRLAHEGVRIYVEVGPGHALTALGQHSLGQDLGDSGSVELVPCLRESRPEASTLLTGLAGLHTRGVPVSWASWCAGGGTAELPLYAFQRDRYWLRSGDDAERETTTPPRSVDPVRYELAWQPWAEPATVPEPAAGAWLVVAPPQSEHDGTVSGVLRALTERGATVLESRYDGTHREGWAKRLIMTPPTPLAGIVSLVSLDERMDPDEPTVPRAVTATLALVQALEDTGIDAPVWSVTRSAVSVGADDPVLRPGQAGVWGLGRVIAQEAPHRWGGLIDLPEDMDEHVRTRWCDALTGVRGEDQLVVREDGMFVPRLTHVPLPSPEPLDWKPRGTVLVTGGLGALGAHVSRWLAGRGAEHLLLVGRRGPSTPGADALRAELAALGTEVTVAACDISDRDALDSLIRNLPADAPLTGIVHAAGVLDDGLIESLSPQRLGTVFAAKAGAAWHLHELTRDRPLEQFVLFSSFAGIVGSPGQGNYAAANAVLDALAHHRRGLGLPATALAWGPWAGGGMFTTVPVRSQQLDGLTALSTPIALDALARSLGRPQASVAVAEVDWNHFVGIHGVTRPSTLFRELTPVGDGGARSATSVLDALPAEYLAGLSADEIRDALLTRVISHVAAVSGHAVEAIPANRAFREMGLDSLATVHLRNRLNAETGLRLAATVVYEHPTPMALARHLVVCLGESRADDSTRTVVAELRKLDVSLASVPPSHDRREEITSLLETVLLKWRDADRARGGAEAGRDLAVASDDEMFDIIDNVLGLTETDS	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	1049.76	gnl|BL_ORD_ID|1968|hsp_num:0	1943			474	1239	isoniazid
BGC0001072.1|Simocyclinone_19 # 39828 # 39920 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.699	BGC0001072.1|Simocyclinone_19 	39828	39920	-	Loose	600	23.483	ICR-Mo	62.5	3004569	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	ATGGCGCCGGATCTTCCCGCGCCCCGAACCAACCACAGCAGCTCGACCGCTGTCACGCACCGTCTGCCGGGCCGGCTCTCCGACCTGTACTGA	MAPDLPAPRTNHSSSTAVTHRLPGRLSDLY	MVHLDKVSNRMSVNNSRWLAWRQQGINAYVMMGIVALFLTLTANITFFDKATEVYPFAQHIGFIGSLPLVLFGVMLLVIVLLSYRYTLKAVLIFLLLTAAVTAYFTDTYGTVYDVNMLQNALQTDKAESADLFNVNFILRILLLGVLPSVWVAWQKVTFPPIKRSILQRGLTYLVSLGLVVLPILAMSKNYASFFREHKQLRSYTNPATPVYALGKLASIQLKQAQAPKTQIMHATDAVQVSNPTTRKPKLVVFVVGETARGDHVQLNGYNRTTFPQMAATAGVTNFNQVIACGTSTAYSVPCMFSYVGMKDYDVDTANYQENVLDTLHRLKVNILWRDNNSSSKGVTNRLPAADFVDYKTARNNTMCNTNPYGECRDVGMLVGLDDYVKQQANQNTLNQDTLIVLHQMGNHGPAYFKRYDKQFEKFTPVCQSNELAKCDPQSVINAFDNALLATDDFLAKTVNWLDKYDSTHQVAMLYVSDHGESLGENGIYLHGMPYKIAPKAQKHVASMFWAGKHSGIQAVPSNTELTHDAITPTLLKLFDVRAQTVQGKPLFIK	5.38	gnl|BL_ORD_ID|2714|hsp_num:0	3271			1011	1059	colistin A; colistin B
BGC0001072.1|Simocyclinone_20 # 40018 # 40788 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.684	BGC0001072.1|Simocyclinone_20 	40018	40788	+	Loose	700	25.0238	vanK gene in vanI cluster	39.58	3003727	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanK	ATGAGTGAGGTCGCTGTGGAGCAGGAACTCTGGATGCGCCGTTTTCATCCGGCGGCCAACGATTCCCCGCGTATTGTCGTCCTCCCGCACGCGGGCGGTTCCGCCAATTTCTTCGTTCCCCTCTCCAGGGCATTGTCCCCGCGCTTGGACGTGCAGGCCGTTCAGTACCCCGGGCGGCAGGACCGCCTGGCCGAGAAGGGGATCGAGGACATGGCCGAGTTCGCCGACCGGATCTTCGCCGCGATCCGGCCGCAGAGCGACCGCCCTTTGGCGCTGTACGGCCACAGCATGGGCGCCGTCGTCGCTTTCGAGGTCGCCCACCGCCTGGAGGCATCCGGAGCGGCCCCGCTCGGTGTCGTCGTTTCCGGCCGGCGCGCGCCCTCGTCCCACCGGGACGAAAAACGCCATGTGAGCGACGACGAAATTGTGGCGGAGCTGCGCGCGCTCAGCGGCACACAGGCCGGGCTCTTGGCGGACGAGGAGTTCCTGCGCATGATCCTCCCGGCAATGCGCAGTGATTACAGGGCGGTCGAGAGCTATACCTGCTCGCCGGATGCGGTCCTCTCCTGCCCGGTCCTCGCCCTGACGGGCGACGCCGACCCGAGGACCACCCTCGACGAGGTGAAGGCCTGGGCCGCGCACACCACTGGCCCCTTCGAGCTGGAGGTCTTCTCCGGCGGCCACTTCTTCATCACCGACCACCAGTCCCGGATCGCCGACCTGGTCGCGGACTTCGTCAGCCGAGCAGCGGGTGCCGCGAGGAGCAGGTGA	MSEVAVEQELWMRRFHPAANDSPRIVVLPHAGGSANFFVPLSRALSPRLDVQAVQYPGRQDRLAEKGIEDMAEFADRIFAAIRPQSDRPLALYGHSMGAVVAFEVAHRLEASGAAPLGVVVSGRRAPSSHRDEKRHVSDDEIVAELRALSGTQAGLLADEEFLRMILPAMRSDYRAVESYTCSPDAVLSCPVLALTGDADPRTTLDEVKAWAAHTTGPFELEVFSGGHFFITDHQSRIADLVADFVSRAAGAARSR	MLNVDKISEETYYAFISQADLGNFMQYPSWAKVKTEWTSDLLGWFTPDNKLAGCGLILYRKMPCLNRYLAYCPRGPLIDWQSPNLREWFEPLVAYLRSKQVFSIKIDPPVVQAKWSAPTIKTFLGQAREQGSKGKVLRDLPPDEDYTTVQQVQQQLRQMGWRKQRGDTGFAATQPQYVYRLPLEGRSLEEVFAGFHTNWRRNVKKAERLGVKVRVGTEQDLPAFYELLKVTSERDHFKVRSFSYFSNLYRSLKAEAADRIALYLAEDEEELLAATLAVHSNAHSWYLYGASSNVKREKAPNHAIQWRMIQDAYQLKAYTYDFRGISPTLDESDPLFGLLRFKLGFGGEACEMISAWDYPLQPLLYRAFQLYLKRR	68.27	gnl|BL_ORD_ID|4747|hsp_num:0	2245			495	639	vancomycin; teicoplanin
BGC0001072.1|Simocyclinone_21 # 40785 # 41048 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=4bp;gc_cont=0.720	BGC0001072.1|Simocyclinone_21 	40785	41048	+	Loose	330	23.0978	AAC(6')-Ian	26.97	3003200	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGATTCCCCGATACTGCGCCTGCCGGGGGAGTACCGGCAGGCAGCCTGGCCTGGTCGGACGAGACAATCGGCAGGCGCAGAGTCGGTCGGCCGAGGACCGTCCGCTCCTCCTCGCCATTGACCCGATCGCCCAACGCATCTTCAGCGAATACCCTGGCGGCCCCGACCGGCGCGGCCGAGGCCTCCAGACCATCACCGAGGGTCTCGCCCGCGATGGTGTCCTGCCGCCCTCCGGCCACGACCGCGCCCGCAGCCGGGGCTGA	MIPRYCACRGSTGRQPGLVGRDNRQAQSRSAEDRPLLLAIDPIAQRIFSEYPGGPDRRGRGLQTITEGLARDGVLPPSGHDRARSRG	MLVQQGRLAIRALQKSDAPVMLRWLQDERVLEFYEGRDKHFDLQTVIEVFIEDQGETTPCLVLLDDKPLGYVQFYPLDSEDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTELVSLVRDYLITDKAAQRLVLDPQSRNSRAIACYEKCGFEKLRLLPAHEMHEGQLQDCWLMQYYPARSSLMASSRPKI	45.79	gnl|BL_ORD_ID|2101|hsp_num:0	3319			135	390	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0001072.1|Simocyclinone_22 # 41230 # 41457 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.719	BGC0001072.1|Simocyclinone_22 	41230	41457	+	Loose	2130	22.3274	mtrD	64.29	3000811	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCCGCACGCTCGCCGACCTGAACTCCTGGCTGAGGCTGCTGACTTTGCACGACCAGGACGACCTCGCCGACGCCGAGCCCGACATCATGCGCTTCCGCCCCTACCACCTGCCCGCCCGACTCGCCGAACACGCGCGCTGCCGCTGGCTGCGGATCGAACGCACCTGGCCCTGGGCAGACGCGTTCGCCCTGGCCGGGCACCGTGGAAGCCCGGCGCAGCCGTAG	MRRTLADLNSWLRLLTLHDQDDLADAEPDIMRFRPYHLPARLAEHARCRWLRIERTWPWADAFALAGHRGSPAQP	MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH	7.03	gnl|BL_ORD_ID|1786|hsp_num:0	1938			1890	1932	erythromycin; penicillin; azithromycin
BGC0001072.1|Simocyclinone_23 # 41847 # 43322 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.713	BGC0001072.1|Simocyclinone_23 	41847	43322	+	Loose	600	341.658	Streptomyces venezuelae rox	45.92	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGACGCGCAGGTCATAGTCGTAGGTGCCGGCCCGGCGGGATTGATGCTCGCCGGCGAGCTCAGGCTCGCCGGAGTCGACGTCGTCGTCCTGGAACGCCTCGCGCAGCCCACCGGAGAGTCGCGAGGTCTGGGTTTCACTGCTCGCACCCTGGAGGTCTTCGACCAGCGCGGGCTGCTGCCCCGGTTGGGCGACATCGAGGTCACCGACCTCGGCCACTTCGGCGGTCTGCCACTGGACTTCAGCATCCTCGGCCCGGCGCACTCGGGTGGCGTCAAGGGCGTTCCGCAGGCGGTCACCGAGGCCATGCTGGACGAGTGGGCTCTGGAGCTCGGCGCGGACATCCGACGCGGCCACGAGCTGATCTCCTTCACCGACAACGGTGACTTCGTCGAGGTCGAGGTCGCCACCTCGGACGGTCCGCAGCGGCTGCGCACGGCCTTTCTGGTCGGCTGCGACGGTGGGCGGAGCACGGTCCGAAAGGCCGCCGGCTTCGACTTCCCCGGGACCAGCGCCACCATGGAGATGTTCCTGGGGGACGTGCGGGGCTGCGACATCACTCCGCGCATGATCGGCGAGACGGTGCCCGGCGGCATGGTGATGGCCGCACCGCTGGGCAACGGCGTCGACCGGATCATCGTGTGCGAGCACGGAACCCCGGCGCGCCGGCGGGACGAGCCGCCCTCCTGGGAGGAGGTCTCAGCGGCCTGGCAGCGACTGACCGGCCAGGACATCAGCGCGGGCGAGCCGGTCTGGCTCAGTGCCTTCGGCAACCCGGCGCGGCAGGTGACGGAGTACCGCCGCGGACGTGTGCTGCTCGCCGGTGACGCGGCCCACATCCACCTGCCCGCCGGCGGGCAGGGCATGAACACCAGCATCCAGGATGTTGTCAACCTCGGCTGGAAACTCGCGGCGACCGTGAAGGGCACCGCCCCGGAGGGACTGCTCGACAGCTACCACACCGAGCGCCACCCGGTCGGCCGCAGGCTGCTGATGAACACCCAGGCGCAGGGACTGCTGTTCCTCAGCGGCGCGGAGATGCAGCCGCTGCGGGACGTCATGTCCGAGCTGATCACGTTCGAGAACGTCAGCCGTCATCTGGCGGGTATGGTCAGCGGCCTGTCGATCAGGTACGACCTCGGCCCCGGCGACCATCCGCTGCTGGGGCTGCGGATCCCGCACCTGGAGCTGGTCGGTGACGCCGGCAAGACCAGCACCACCGAGCTGCTCCACCCGGCCCGCGGCGTCCTGCTCGACCTCGCGGACGACGCCGGGCTGCGGGAGACGGCCGCACCGTGGGCCGACCGGGTGGACGTCGTCACGGTCACCGTGCACGGCGCGGCGGACGCCCCGCAGTACGAGCCCGCCGACGCCCTCCTCATCCGCCCCGACGGCCACGTGGCGTGGGCCGCCCCTGGGCCCGTTGCGCTGTCCGAGGCACTGGCCAGGTCTTTCGGCGCTCCCCGTTCGCGCTGA	MDAQVIVVGAGPAGLMLAGELRLAGVDVVVLERLAQPTGESRGLGFTARTLEVFDQRGLLPRLGDIEVTDLGHFGGLPLDFSILGPAHSGGVKGVPQAVTEAMLDEWALELGADIRRGHELISFTDNGDFVEVEVATSDGPQRLRTAFLVGCDGGRSTVRKAAGFDFPGTSATMEMFLGDVRGCDITPRMIGETVPGGMVMAAPLGNGVDRIIVCEHGTPARRRDEPPSWEEVSAAWQRLTGQDISAGEPVWLSAFGNPARQVTEYRRGRVLLAGDAAHIHLPAGGQGMNTSIQDVVNLGWKLAATVKGTAPEGLLDSYHTERHPVGRRLLMNTQAQGLLFLSGAEMQPLRDVMSELITFENVSRHLAGMVSGLSIRYDLGPGDHPLLGLRIPHLELVGDAGKTSTTELLHPARGVLLDLADDAGLRETAAPWADRVDVVTVTVHGAADAPQYEPADALLIRPDGHVAWAAPGPVALSEALARSFGAPRSR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.15	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1416	rifampin; rifaximin; rifapentine
BGC0001072.1|Simocyclinone_24 # 43372 # 43698 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.679	BGC0001072.1|Simocyclinone_24 	43372	43698	+	Loose	400	23.0978	Erm(51)	32.65	3007033	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCACAGCACCCTGATCGTGGCTCGGATGAGCCCGAGGGACGACCAGGACGTCGCGCGGCTCTTCTCGGAGTTCGACCGCACCGAGATGCCCCATCTGATGGGCACCCGCCGCCGCCAGCTCTTCTCGTACCGCGGCCTCTACTTCCACCTGCAGGACTTCGACGACGAGCACGGCGGCGAGGCGATCGAGGCGGCCAAGTCGCACCCGTCATTCGTCCGGATCAGCGAGGACCTCAAGCCGTTCATCCAGGCGTACGACCCCGACACCTGGCGGTCCCCGGCCGACGCCATGGCCCGCCGCTTCTACCAGTGGAGCGCGCAGTGA	MHSTLIVARMSPRDDQDVARLFSEFDRTEMPHLMGTRRRQLFSYRGLYFHLQDFDDEHGGEAIEAAKSHPSFVRISEDLKPFIQAYDPDTWRSPADAMARRFYQWSAQ	MPTYRPNKGRHENGQNYLVNKSMIKKVVDLVPVSASVPVIEIGPGHGALTFPLQDRVLATGGSLTAVEIDPASVRWLEERLRPEVHLYEQDVLDFVLPDGPHVLVGNLPFHLTTAILRHVLHSPGWTHAVFLVQWEVARRRAGVGGATMMTAQWWPWFDFEQHGRIPSTHFRPRPTVDAGVLVMRRREEPLVNWSERARYASFVHAVFTGKGRGIADIVSRVVGRRRERRCAEVLREAGVPANALPKQLDAGQWATLFKAVGR	41.06	gnl|BL_ORD_ID|4752|hsp_num:0	5746			132	276	erythromycin; clarithromycin; clindamycin; azithromycin; pristinamycin IB
BGC0001072.1|Simocyclinone_25 # 43695 # 44963 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.704	BGC0001072.1|Simocyclinone_25 	43695	44963	+	Loose	750	182.185	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.47	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGGCGCCGTGTCGTCATCACCGGGGTCGGTGTCATGGCGCCGGGCGGCATCGGCGTCAAGAACTTCTGGAGCCTGCTGAGCGAGGGGCGTACCGCCACCCGCGGGATCACCTTCTTCGATCCGGCGCCCTTCCGCTCCCGGGTGGCCGCGGAGATCGACTTCTTCCCGGAGAAGCACGGCCTGGGCCCGCAGAAGATTCGTCGGATGGACCGCGCCGCTCAGCTCGCGGTGATCGCCACGCGCGAGGCCGTGGCCGACAGCGGCCTCGACCTGGACGCCACGGACCCGCACCGCAGGGGCGTGACCGTCGGCAGCGCGGTCGGTGCCACCACCGGCCTCGACCAGGAGTACCGGGTCGTCAGCGACGACGGCCGACTCGGGCTGGTCGACCACCGGTACGCGCCGCCGCATCTGTACGGCCACTTCGTCCCCAGCTCCTTCGCCGCCGAGGTCGCCTGGGCGTCCGGCTCCGAGGGGCCGAGCACCGTGGTCTCCACCGGGTGTACCTCAGGGCTGGACTCCCTGGGCCACGCTGTAGAACTGATCCGGGAAGGCAGCGCCGACGTGATGATCGCCGGAGCGACGGACGCGCCGATCTCCCCGATCACCATGGCCTGCTTCGACGCGATCAAGGCGACCACGCCGCGCAACGACGATCCGGCGCACGCCTCCCGTCCGTTCGACCGGTCCCGCAACGGCTTCGTCCTCGGCGAGGGCCACGCGGTGCTCGTCCTGGAGGAGCTCGGCGCCGCCCAGCGGCGCGGGGCGCGCATCTACGCCGAGATCGGTGGATACGCGTCGCGGTGCAATGCCTTCCACATGACTGGTCTGCGCCCCGACGGGCGGGAGATGGCGGAGGCCATCCGGGTCGCGCTGGACGAGGCCCGACTGAACCCCGAGGACATCGACTACATCAACGCCCACGGGTCCGGTACCAAGCAGAACGACCGGCACGAGACCGCGGCCTTCAAGCGCAGCCTCGGCGACCACGCGTACCGGACGCCGGTCAGCTCGATCAAGTCGATGGTCGGGCACTCGCTCGGCGCCATCGGGTCCATCGAGATCGCAGCCTGCGTCCTCGCGATGGCCGAGAGCGTGATCCCGCCGACGGCCAACCTGCACGATCCCGAGCCCGAGTGCGACCTCGACTACGTGCCGATCACCGCCCGCGAAGCGCGGCTGGACCGCGTGCTGAGTGTGGGCAGCGGATTCGGAGGCTTCCAGAGTGCCATGGTGCTCACTCGTCCGGAGAGGAACACGGCATGA	MRRRVVITGVGVMAPGGIGVKNFWSLLSEGRTATRGITFFDPAPFRSRVAAEIDFFPEKHGLGPQKIRRMDRAAQLAVIATREAVADSGLDLDATDPHRRGVTVGSAVGATTGLDQEYRVVSDDGRLGLVDHRYAPPHLYGHFVPSSFAAEVAWASGSEGPSTVVSTGCTSGLDSLGHAVELIREGSADVMIAGATDAPISPITMACFDAIKATTPRNDDPAHASRPFDRSRNGFVLGEGHAVLVLEELGAAQRRGARIYAEIGGYASRCNAFHMTGLRPDGREMAEAIRVALDEARLNPEDIDYINAHGSGTKQNDRHETAAFKRSLGDHAYRTPVSSIKSMVGHSLGAIGSIEIAACVLAMAESVIPPTANLHDPEPECDLDYVPITAREARLDRVLSVGSGFGGFQSAMVLTRPERNTA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			306	1245	isoniazid
BGC0001072.1|Simocyclinone_26 # 44960 # 46174 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.733	BGC0001072.1|Simocyclinone_26 	44960	46174	+	Loose	500	26.5646	ESP-1	35.71	3003717	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ESP beta-lactamase	ATGACCACCTCCGTCGTCGTCACCGGGCTTGGTGTCGCGGCCCCCAACGGGCTGGGCACGGCGGACTACTGGGCCGCCACCCGGGAGGGGCGCAGCGGCATCGGCCGGGTGACCCGGTTCGACCCGTCGCAGTACCCGTCCCGCCTGGCCGGCGAGGTGCCGGGGTTCGTCGCGGAAGACCACCTGCCCAGCCGGCTGCTGCCGCAGACCGATCACATGACCAGGCTCGCCCTGGTCAGCGCCGACTGGGCGTTGCAGGACGCCGGGATCCGACCGGAGGAGCTTCCGGAGTACGCCGCGGGCGTGGTCACGGCCAGTTCCGCGGGCGGCTTCGAGTTCGGCCAGAACGAGCTGCGTGCCCTGTGGAGCAAGGGCAGCCAGTACGTCAGCGCGTACCAGTCCTTCGCCTGGTTCTACGCCGTCAACACTGGTCAGATCTCGATCCGGCACGGACTGCGCGGCCCGAGCGGGGTCGTGGTGAGCGACCAGGCCGGTGGGCTGGACGCGCTCGCGCAGGCGCGTCGGCAGATCCGCCGCGGCAGCCAGGTCATCGTGTCCGGGGGCATCGACGCCTCCATCTGCTCGTGGGGCTGGGGGGCGCAACTCACCAGTGGACGGATGAGCACCGACGACGATCCGGCCACCGCCTACCGGCCCTTCGACGGAGCGGCCGCCGGGCACGTCCCGGGCGAGGGCGGTGCCCTGCTCGTCCTGGAGGAAGCGGGAGCGGCGGCCGCCCGTGGCGCCCGGGTGTACGGCCGGATCGCCGGCTATGGCACCACCTTCGACCCGAAGCCGGGAAGCGGCCGTGAGCCCGGGCTCCGTCGGGCGATCGAACTCGCGCTGACGGACGCCGGCCTCGCACCCGCCGACATCGACGTGGTGTTCGCCGACGCCGCGGCCGTCCCCGACCTCGACCGGATCGAGGCGCGGGCGCTCGTCGAGGTCTTCGGCCCCCGCGGGTTGCCGGTCACCGCGCCCAAGTCGATGACGGGCCGGCTGAATTCGGGAGCGGGCTCACTGGACGTGGCGACCGCCCTGCTGGCCATCCGGGACGGCGTCATCCCGCCGACCATCAATGTCACGGCCCAGGACGACTACGAGCTGGACCTGGTCACCGCGCAGGCCCGGTCGGCCCGGCTGCGCTCGGCTCTGGTGGTGGCGCGCGGGCACGGCGGCTTCAACTCGGCGCTGGTGGTTCAGGACGCCGCCTGA	MTTSVVVTGLGVAAPNGLGTADYWAATREGRSGIGRVTRFDPSQYPSRLAGEVPGFVAEDHLPSRLLPQTDHMTRLALVSADWALQDAGIRPEELPEYAAGVVTASSAGGFEFGQNELRALWSKGSQYVSAYQSFAWFYAVNTGQISIRHGLRGPSGVVVSDQAGGLDALAQARRQIRRGSQVIVSGGIDASICSWGWGAQLTSGRMSTDDDPATAYRPFDGAAAGHVPGEGGALLVLEEAGAAAARGARVYGRIAGYGTTFDPKPGSGREPGLRRAIELALTDAGLAPADIDVVFADAAAVPDLDRIEARALVEVFGPRGLPVTAPKSMTGRLNSGAGSLDVATALLAIRDGVIPPTINVTAQDDYELDLVTAQARSARLRSALVVARGHGGFNSALVVQDAA	MKKLTLILSLIIAFFGYAQTVTEPTNHSAEWSQPYEPFRIVGNLYYVGTYDLASYLIVTEKGNILINTGLADSYPQIKANIEKLGFKYKDTKILTLTQAHFDHMGAMADIKAETGAKLYVDEADAAELKSGGKSDYELGKYGVTFKPLTPDFLLKNNGKIKLGNTTLTLLHHPGHTKGSCSFIFETKDENRKYKVVIANMPSIIIDHKFSDVKTYPSIQKDYAYTLEAMKKLDFDVWVASHASQFDLHKKRKEGDAYNPKLFMDKENYFKRLKDLEDDYLEKVKEENKPE	139.31	gnl|BL_ORD_ID|2029|hsp_num:0	2232			315	441	
BGC0001072.1|Simocyclinone_27 # 46223 # 46489 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.682	BGC0001072.1|Simocyclinone_27 	46223	46489	+	Loose	400	24.2534	vanR gene in vanD cluster	23.26	3002923	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCAGACCACCGAGTTCACGCTGGACGACCTCCGGCGCATCCTGCGCGACGGCGCCGGCGCCTCGGAGGACGTCGACCTCGAAGGCGACATCATCGACGTCGCCTTCGAGGATCTGGGCTACGAGTCGATCGCGCTGCTGGAGACCTGCAGCCGGATCGAGCGCGAGTACGGAATCTCGCTGGACGACGACGCGGTCTCGGAGGCCCCGACGCCCCGTGCCCTGGTCGCGATCGTCAACACCCACCTCATCGCCGTTGCCGGCTGA	MQTTEFTLDDLRRILRDGAGASEDVDLEGDIIDVAFEDLGYESIALLETCSRIEREYGISLDDDAVSEAPTPRALVAIVNTHLIAVAG	MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDIDGFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYMRYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVSTEELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK	37.93	gnl|BL_ORD_ID|1052|hsp_num:0	1004			105	348	vancomycin; teicoplanin
BGC0001072.1|Simocyclinone_28 # 46509 # 47294 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.687	BGC0001072.1|Simocyclinone_28 	46509	47294	+	Loose	400	27.7202	VIM-61	28.12	3005509	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGCCCGGGCAGAAGCAGCAGGTGGCGCTTGTCACCGGCGCCACCAGTGGAATCGGCCTGGCCGTCGTGCGGGCACTCGCGGCCCAGGGACACCAGGTGTTCTTCTGCGCCCGCAACGCGGAGAAGGTCGCGGTCACGATCAAGGAACTGCGCGGGGAGGGTCTCGACGTTGACGGGACCAGCTGCGACGTGCGGTCGGTCGCGGATGTCAAGGCCTTCGTCGCGGCGGCCGTGGAGCGGTTCGGTCCGGTGGACGTGCTGGTCAACAACGCCGGCCGAAGCGGCGGCGGGGTGACCGCGGAGCTCACGGACGAGCTGTGGGCCGACGTCATCGAGACCAACCTCACCAGCGTGTTCATGGTCACCCGCGAGGTGCTCACCGCCGGCGGAATGCGCGAGAAGTCGAGCGGACGCATCGTCAACATAGCCTCCACCGCAGGCAAGCAGGGAGTTGTCCTCGGCGCGCCCTACTCGGCCTCCAAGCACGGCGTGGTCGGTTTCACCAAGGCGCTGGGCAACGAGCTGGCGCCCACTGGCATCACCGTCAACGCGGTCTGCCCCGGCTATGTCGAGACCCCCATGGCGGAGCGGGTCCGCCAGGGGTACGCGGCCGCTTACGGCACGTCCGAGGAGGCGATCCTCGAGAAGTTCCAGGCCAAGATCCCGCTGGGCCGCTACTCGACGCCCGAGGAGGTGGCCGGACTGGTCGGCTACCTGGTCTCGGACACTGCCGCCTCGATCACCGCCCAGGCACTCAACGTCTGCGGCGGGCTTGGCAACTTCTGA	MPGQKQQVALVTGATSGIGLAVVRALAAQGHQVFFCARNAEKVAVTIKELRGEGLDVDGTSCDVRSVADVKAFVAAAVERFGPVDVLVNNAGRSGGGVTAELTDELWADVIETNLTSVFMVTREVLTAGGMREKSSGRIVNIASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPTGITVNAVCPGYVETPMAERVRQGYAAAYGTSEEAILEKFQAKIPLGRYSTPEEVAGLVGYLVSDTAASITAQALNVCGGLGNF	MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQKLGDTVYSSNGLIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGVATYTSPLTRQLAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVHEASRESAGYVADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTNVVKTHKVRPVAE	98.49	gnl|BL_ORD_ID|4639|hsp_num:0	5710			258	540	
BGC0001072.1|Simocyclinone_29 # 47320 # 48267 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.691	BGC0001072.1|Simocyclinone_29 	47320	48267	+	Loose	500	29.261	PFM-1	40.0	3006965	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	PFM beta-lactamase	ATGTCCGACTCGGGCATCAGCCACGTCGAGCACACCATCGAGGTGGACGCACCGGCAACAGACGTCTACCGGCTGCTGGCGGAGGTCGAGAACTGGCCGCGGATCTTCGGGCCGACCATCCACGTGGATCACGTCGAGCGCGGTGCGCGCACCGAGCGGATCCGCATCTGGGCCACCGCCAACGGTGCGGCCAAGAGTTGGACCTCCCGGCGGGAGCTCGACCCCGAGGCGCTGCGAATCGACTTCCGCCAGGAGGTCTCCGCCCCGCCGGTGGCCGCGATGGGCGGCGCATGGATCATCGAGCCGGTGTCCGAGGGCGCCTGCCGAGTCCGGCTGCTGCACGACTACCGGGCGATCGACGACGCCCCGGAGGATCTGGCATGGATCGAGCAGGCGGTGGACCGCAACAGCCGGTCCGAGCTCGCGGCCCTCAAGGCCAACGCCGAAGTGGTGGTCGGCGCCGCCGACGAGCTGATGCTGTCCTTCCAGGACTCGGTGCGGATCGACGGCTCGGCCAAGGACGTCTATGACTTCCTGAACGAGGCGGACCGCTGGACCGAGCGGCTTCCCCACGTGGCCGAGGTCGAGCTGACCGAGCAGACCCCGGGGCTGCAGGTGCTGACGATGGAAACCCGTGCCAAGGACGGCTCCACCCACACCACCAGCTCGGTGCGCGTCTGCTTCCCGCACGAGCGCATCGTCTACAAGCAGACCGTGCTTCCGGCCCTGATGACGTTGCACACCGGGTACTGGCTGCTGGAGGAAGACGGCGAGGGCACCGTCGCGACCTCCCAGCACACCGTGATCATCAACACCGCGAACATCCGCGCGATCCTCGGCGAGTCGGCGGGCGTCGCCGAGGCGCGGCAGTACGTCCAGACCGCGCTGAGCACCAACAGCCGGGCGACCCTTGGCCACGCCAAGGACTACGCCGAGCGTCGGGACTGA	MSDSGISHVEHTIEVDAPATDVYRLLAEVENWPRIFGPTIHVDHVERGARTERIRIWATANGAAKSWTSRRELDPEALRIDFRQEVSAPPVAAMGGAWIIEPVSEGACRVRLLHDYRAIDDAPEDLAWIEQAVDRNSRSELAALKANAEVVVGAADELMLSFQDSVRIDGSAKDVYDFLNEADRWTERLPHVAEVELTEQTPGLQVLTMETRAKDGSTHTTSSVRVCFPHERIVYKQTVLPALMTLHTGYWLLEEDGEGTVATSQHTVIINTANIRAILGESAGVAEARQYVQTALSTNSRATLGHAKDYAERRD	MKVINILSAVSMFCITCQALANDINLTLTHFKGPLYIVEDKEYVQENSMVYIGAQDITIIGATWTPATAEKLEQEIRKISSLPIKEVINTNYHTDRAGGNAYWKKLGASIVSTQMTYDLEKTNWRGIVDFTRQGMEHYPVLEQSLPDQVYPGDFALQNGHVRALYLGASHTEDGIFVYFPEERVLYGNCILKEKLGNMTFANRSEYPKTLKKLQGLIRSGELSVEAIIAGHNSPIQSVELIDHYLNLLEHGEQ	124.51	gnl|BL_ORD_ID|4552|hsp_num:0	5622			498	573	
BGC0001072.1|Simocyclinone_30 # 48273 # 49757 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.739	BGC0001072.1|Simocyclinone_30 	48273	49757	+	Loose	600	286.96	Streptomyces venezuelae rox	40.82	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCGGTCCGCAGACGGACGTCCTGGTGATCGGTCCGGACCCGTGGCTGATGCTGGCCGGCGAGCTGCTCCTCGGCGGCGCCCGGGTGGTCGTTGCCGAGCGCCTGACCGAGCCGACCACCGAGTCCAGGGCTCGACGCTGCATGCCCCGCACGATGGAGATCCTCGACCAGCGAGGCCTGACCGGGCGGCTGGGCGAGGTCCCCGGTGACGGCACGGGCCACTTCGGTGGCATTCCGCTTCGGCTGGACGGGCAGCAGAGCCCGTACGCCGGCCTGTGGAAGGTCCCGCAGTCCCGGGTGGAGGAGATCCTCGGCGCATGGGCGATCGGCCTCGGGGCCGAGGTTCGACGAGGCCGGGAACTGACCGGACTGCGTGAGGACGGCGCGGTCGTGGAGGCCGAACTGTCCTGCGAGGACGGCACGCGGGAGCTGCTGCGGGCCCGCTACGTCGTCGGGTGCGACGGCGAGAACAGCACCGTCCGGCGGCTGGCCGGTTTCGAGTTCGCCGGGAGCGCCGCGAGCCGGGAGCTGATCCGGGCCGACGTGGCCGGGATTGACGTGCCCAATCGTCGGTTCGAGCGCCTGCCCGGCGGCCTCGCCATCGCGGCGCGCCGCCCGGACGGCATCACCAGGGTGATGGTGCACGAGTTCGGCCGGACGGCGACGCCGAGGCAGGCGGAGCCGGACTTCGACGAGATGGCCCGGACCTGGCAGCGCGTCACCGGCGAGGACATCAGTCACGGCACCCCGGTGTGGATCAACTCCTTCGGCGACGCCAGCCGTCAGGTGACGGAGTACCGTCGGGGCCGGATCCTGCTGGCCGGCGACGCTGCGCACGCGCAGATGCCAGTCGGCGGCCAGGCGCTCAACCTCGGCCTGCAGGACGCGTTCAACCTGGGATGGAAGCTGGCCGCAGAGATCTGCGGCTGGGCTCCGCCGGGCCTGCTGGACAGCTACCACGAGGAACGGCACGCAGTCGGCTCCCGGGTGCTGTCCGACATCGCCGCCCAGGCCCTGCTGCTGCTCGGCGGGCCGGAGGTCGAGGCGCTGCGCTCCGTCGTGGGCCGACTGCTTGGGCTCGACGCGGTCCGCGTACCATTTGGCCACCGGGGTCGGCGGCATCGGTTATCCAGTACTCCGCCCACGAGGGTGCACCACCCGCTGTTGGGGGCGCGGTTGCCCGACGCCGCGCTGGACATCGAGGCGGGCGCGGCAACGGCGTGGGCGCTGCTGCGCGCGGGGACAGGTCTGCTGCTGGACGTGGCGCCCGAGGCGCCAGGCCATGTGGACCTGCGAGCCGTCGCGGACGGCTGGGCGGACCGGGTGCGCGTAGTGGCGGCCCGGCCACGGGCGGGCGCCGTCGCGCCGACGACCGGTGCCGTGCTGGTCCGCCCGGACGGCCACGTGGTGTGGGCCGACGGCGGGGCGGACCGGCTGCGGGCCGCGCTGGTGCAGTGGTTCGGCTCGGCGGACCGCACCTGA	MTGPQTDVLVIGPDPWLMLAGELLLGGARVVVAERLTEPTTESRARRCMPRTMEILDQRGLTGRLGEVPGDGTGHFGGIPLRLDGQQSPYAGLWKVPQSRVEEILGAWAIGLGAEVRRGRELTGLREDGAVVEAELSCEDGTRELLRARYVVGCDGENSTVRRLAGFEFAGSAASRELIRADVAGIDVPNRRFERLPGGLAIAARRPDGITRVMVHEFGRTATPRQAEPDFDEMARTWQRVTGEDISHGTPVWINSFGDASRQVTEYRRGRILLAGDAAHAQMPVGGQALNLGLQDAFNLGWKLAAEICGWAPPGLLDSYHEERHAVGSRVLSDIAAQALLLLGGPEVEALRSVVGRLLGLDAVRVPFGHRGRRHRLSSTPPTRVHHPLLGARLPDAALDIEAGAATAWALLRAGTGLLLDVAPEAPGHVDLRAVADGWADRVRVVAARPRAGAVAPTTGAVLVRPDGHVVWADGGADRLRAALVQWFGSADRT	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.78	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1419	rifampin; rifaximin; rifapentine
BGC0001072.1|Simocyclinone_31 # 49836 # 50600 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.684	BGC0001072.1|Simocyclinone_31 	49836	50600	+	Loose	450	53.5286	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	25.29	3004045	protein variant model	F203V	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	GTGAAGCGACTGGCTGGCAAGACCGCGCTGGTGACCGGATCAAGCCGCGGTATCGGTCGGGCGACCGCGCTGCGGCTGGCGCGCGAGGGCGCGACTGTCGCCGTCCACTACGCCGACAACGCCGACGCCGCCAAGGCGACACTGGCCGCGATCGAGGAAGAGGGCGGCCGCGCCTTCCTGGTCCGGGCCGAGCTGGGTGTGCCGGGTGACGTCGACACCCTCTTCCAGGGTCTGACCGCAGGTCTGCGCGAGGCCACCGGGAAGGAGGAGCTCAACATCCTGGTGAACAACGCCGGTGTGATGGGCGGCGTGAAGCCCGAGGACCTCACCCCGGAGATCTTCGACCAGCTCATCGCGGTCAACGCCAAGGCTCCGCTCTTCCTGACCCAGCGCGTGCTGTCGATCATGCCGGACGGCGGACGTATCATCAACATCGGTACCGGACTGCTGCGTTACGCCAACCCCGACGAGGTCGCCTACTCGATGAGCAAGGGCGCGCTCGACCAGATCAGCCTGCACTTCGCCCGTCTGCTCGGCCCGCGCAACATCACCGTCAACACGGTGTCGCCCGGCATCACCAACAACGGCAGCCCGATCTTCGACGTCCCCGAGGCGCGGGAGTTCATGGCCAACATGAACGCCTTCAAGCGGATCGCCGAGCCCGAGGACGTCGGCGACGTGGTGGCCTTCCTCGCCTCCGACGACGCCCGCTGGATCACCGGCACCTTCGTCGACGCCAGCGGCGGCACGCTGCTGGGCGGCTGA	MKRLAGKTALVTGSSRGIGRATALRLAREGATVAVHYADNADAAKATLAAIEEEGGRAFLVRAELGVPGDVDTLFQGLTAGLREATGKEELNILVNNAGVMGGVKPEDLTPEIFDQLIAVNAKAPLFLTQRVLSIMPDGGRIINIGTGLLRYANPDEVAYSMSKGALDQISLHFARLLGPRNITVNTVSPGITNNGSPIFDVPEAREFMANMNAFKRIAEPEDVGDVVAFLASDDARWITGTFVDASGGTLLGG	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	96.95	gnl|BL_ORD_ID|4712|hsp_num:0	2666			0	750	triclosan
BGC0001072.1|Simocyclinone_32 # 50731 # 51303 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.688	BGC0001072.1|Simocyclinone_32 	50731	51303	+	Loose	200	25.0238	vanT gene in vanN cluster	52.94	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTCATCAGCACGTCTCCGTCTAGCCGTTGTCCTGGGAAGCACCCGTGAGGGCCGCCTGTGCCCGACGGTCGCGAACTGGTTCGCCGGGCAGGGCCGTCAACACGGCGGCTTCGACCTCGATCTCGTGGACCCGTACGGTCTGGACATCCCGGTCGCACCCTCCCCGGAACCGCCGGCCCAGGTGGTGGAGATCGGGCAGCGGCTGGCGGCAGCCGATGCCTTCGTGATCGTCACGCCCGAGTACAACCACAGCTTCTCGGCGCCGCTGAAGTCGCTCATCGACTGGCACTACGTGCAGTGGCGGGCCAAGCCGGTGGGCTTCGTCTCCTACGGGGGCCTGGCCGGAGGCCTTCGGGCGGTCGAGCAACTGCGGCTGGTCTTCGCCGAGTTGCACGCCGCGACGGTCAGGGACACCGTCAGCTTCCACAACGCAGCCCAACTGTTCGACGAAGCCGGCGATCCCCGCGATCCGGAGGGCTGCAACACGGCGGCGAAGACGATGCTCGACCAGCTCCACTGGTGGGGCCGGGCGCTGCGCCAGGCTCGGCTCGAACGCCCCTATCAGGGCTGA	MSSARLRLAVVLGSTREGRLCPTVANWFAGQGRQHGGFDLDLVDPYGLDIPVAPSPEPPAQVVEIGQRLAAADAFVIVTPEYNHSFSAPLKSLIDWHYVQWRAKPVGFVSYGGLAGGLRAVEQLRLVFAELHAATVRDTVSFHNAAQLFDEAGDPRDPEGCNTAAKTMLDQLHWWGRALRQARLERPYQG	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	27.14	gnl|BL_ORD_ID|4745|hsp_num:0	1983			495	546	vancomycin
BGC0001072.1|Simocyclinone_34 # 51989 # 53575 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.695	BGC0001072.1|Simocyclinone_34 	51989	53575	+	Loose	800	28.4906	msrA	28.89	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGTCTGATGTCCCTTCCATCCCGGCCGACCCGGCCCCGACCACCCGCTGTCGACTGGAGGAGCTGCGAGCGCTTAGGCAGGCGGTGGCCGACGGCCCGGACCCGAGGGCGACCGAGGCGCAGCACGCCAAGGGCAAGCTGACGGCTCGGGAGCGGGTCGAGCTGCTGCTGGACGGGGGGTCGTTCCACGAGGTGGAGCCGCTGCGCCGGCACCGCGCGCAGGGCTTCGGCTTGGAGGCCAGGAAGCCCCACACCGACGGTGTGGTGGTCGGCTGGGGCACGGTGCACGGGCGGACGGTGTTCGTGTACGCGCACGACTTCCGGATCTTCGGTGGTGCGCTGGGCGAGGCGCACGCGCAGAAGATCCACAAGATCATGGACATGGCCATCGCGGCGGGTGCACCGCTGGTGTCGCTGAACGACGGTGCAGGCGCCCGGATCCAGGAGGGCGTGACCGCGCTGGCCGGCTACGGCGGGATCTTCCAGCGCAACACCAGGGCCTCAGGGGTGATCCCGCAGATCTCGGTGATGCTGGGCCCGTGCGCGGGCGGTGCGGCGTACTCGCCCGCGCTGACCGACTTCGTGTTCATGGTCCGGGAGACCTCGCAGATGTTCATCACCGGCCCGGACGTGGTCCAGGCCGTGACCGGCGAGAAGATCTCCCAGAACGGCCTGGGCGGCGCGGACGTGCACTCCGCGGTCTCCGGCGTGTCGCACTTCGTGTACGACGACGAGCAGAGCTGCATCGAGGAGGTCCGCTACCTGCTGTCGCTGCTGCCGAGCAACAACCGGGAGATGCCGCCCGTGCAGCTCTCGGACGACCCGGTGGATCGGCGCAACGACAGCCTGCTGGACCTGGTCCCGGCCGACGGGAACCGGCCGTACGACATGCGCAAGGTGATCGAGGAGGTTGTCGACTACGGCGAGTACCTCGAGGTCCACGAGCGCTGGGCCACCAACGTGCTGTGCGTGCTGGCCCGGATCGACGGCCACGTCACCGGGATCATCGCCAACCAGCCGCAGTCCCTGGCTGGGGTCCTGGACATCAGCGCCTCGGAGAAGGCCGCGCGCTTCGTGCAGATGTGCGACGCCTTCAACATCCCGCTGGTCACCCTGCTGGACGTGCCCGGCTTCCTGCCGGGTGTGGACCAGGAGCACGGCGGGATCATCCGGCACGGCGCCAAGCTGCTGTACGCGTACTGCAACGCCACCGTGCCGCGGATCTCGCTGATCCTGCGCAAGGCCTACGGGGGCGCCTACATCGTGATGGACTCCCGCTCGATCGGTGCCGACCTCGCCTACGCGTGGCCGACCAACGAGATCGCGGTGATGGGCGCCGAGGGTGCCGCGAACGTCATCTTCCGCCGCGACATCGCCGCCGCCGAGGACCCGGACGCGATGCGCACCCAGAAGATCAAGGAGTACAAGGCCGAGCTGATGCACCCGTACTACGCGGCCGAACGCGGCCTGGTCGACGACGTCATCGACCCCGCCGAGACCCGCCAGGTGCTCACCTCCGCCCTCGCCATGCTCCGCACCAAGCACGCCGACCTGCCCAGCCGCAAGCACGGCAACCCGCCGATGTGA	MSDVPSIPADPAPTTRCRLEELRALRQAVADGPDPRATEAQHAKGKLTARERVELLLDGGSFHEVEPLRRHRAQGFGLEARKPHTDGVVVGWGTVHGRTVFVYAHDFRIFGGALGEAHAQKIHKIMDMAIAAGAPLVSLNDGAGARIQEGVTALAGYGGIFQRNTRASGVIPQISVMLGPCAGGAAYSPALTDFVFMVRETSQMFITGPDVVQAVTGEKISQNGLGGADVHSAVSGVSHFVYDDEQSCIEEVRYLLSLLPSNNREMPPVQLSDDPVDRRNDSLLDLVPADGNRPYDMRKVIEEVVDYGEYLEVHERWATNVLCVLARIDGHVTGIIANQPQSLAGVLDISASEKAARFVQMCDAFNIPLVTLLDVPGFLPGVDQEHGGIIRHGAKLLYAYCNATVPRISLILRKAYGGAYIVMDSRSIGADLAYAWPTNEIAVMGAEGAANVIFRRDIAAAEDPDAMRTQKIKEYKAELMHPYYAAERGLVDDVIDPAETRQVLTSALAMLRTKHADLPSRKHGNPPM	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	108.20	gnl|BL_ORD_ID|1105|hsp_num:0	1200			42	177	erythromycin; quinupristin
BGC0001072.1|Simocyclinone_36 # 53850 # 54623 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.722	BGC0001072.1|Simocyclinone_36 	53850	54623	+	Loose	800	25.0238	APH(4)-Ib	32.65	3002656	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	ATGCACTCACCGTTCGAATGGACCGTGCGGCTGCGTCCCGCGACCGGCTGTCGTTCCAGGGTCGTCGTCTTCCCGCACGCCGGTGCGGGGCCGCGGACCTACGCTCGTCTGCTGTCCGGGCTGCCCGAGGACGTCGAGCTGATCGGCGTCACCCTCCCAGGTCGCGAGCACCGCGCCGACCTACCGCCCGGTGGCGCGCTCTGCGAGGTCGTCGAGGGGACAGGCCGGGAGCTGGCCGCACTCCCGGTGCTTCCCACCGTCTACTGGGGCCACAGCATGGGCTCGCTGCTGGCCGTCACGGTGGCCGGCACCCGCGACTGCTCCGTCGATGCCCTGGTCCTGTCGGCGGCCCTGCCGGGTGCCGATGCGGTCGACTTCGCGGTGCCGCTGGACACCCCCGAGGGGCTGAGCCTGATGTTCGACCGGCACCGGCTGCCCCTGACCGCCCTGGACGCCGACAGCGGCCGTCCGCGAGCCGACTTTGTGCTGGCCCACGACTTGGTGCTGGCGCGCAGCGCCCTGCTCGAGGTGGGCGGTGTCCGGCTCGGCCTGCCGCTCAGCGTCTTCGCCGGCGCCCACGACCCCCTGGTTCCCATGTCGACCCTGCCGAAATGGCGGGACTTCACCACGGGCCCGTTCCGCACCGAGGTGTTCGAGGGCGCCCACTTCTTTCCCTTCCTCCCGGGCAACGGCCGTGCACTCCTGGCGGAGATCACAGGGCTGCTCACGGCAGCCGCCGAGACCCGGAGCACGACGAGCGGAGCAAGCCGATGA	MHSPFEWTVRLRPATGCRSRVVVFPHAGAGPRTYARLLSGLPEDVELIGVTLPGREHRADLPPGGALCEVVEGTGRELAALPVLPTVYWGHSMGSLLAVTVAGTRDCSVDALVLSAALPGADAVDFAVPLDTPEGLSLMFDRHRLPLTALDADSGRPRADFVLAHDLVLARSALLEVGGVRLGLPLSVFAGAHDPLVPMSTLPKWRDFTTGPFRTEVFEGAHFFPFLPGNGRALLAEITGLLTAAAETRSTTSGASR	MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCVSLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQCVCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMHRRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMCNRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAADLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWAEDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW	61.19	gnl|BL_ORD_ID|1547|hsp_num:0	1681			369	513	hygromycin B
BGC0001072.1|Simocyclinone_37 # 54620 # 55990 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.701	BGC0001072.1|Simocyclinone_37 	54620	55990	+	Loose	400	28.1054	ErmA	24.14	3000347	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGCACCAGGCGTCCGTACCAGGGGGCGTTCACCCCGGTCGACCAAGAGGTCACCGCCTTCGACCTGCCGGTCACCGGGCGGATCCCCGCCGAACTCCGCGGCCGCTACCTGCGTAACGGTCCGAACCCCTTGCGGCTGGACGACCCGCGCGCCCATCTGTTCCTCGGCGAGGGCATGGTCCACGGCGTCCGGCTGCGGGACGGCCGTGCCGAGTGGTACCGCAACCGGTGGGTCCGATCCGCCGCCGTGGCCCGCTCCCTCGGTGAGAAGCCGCGTCGCGGCACGCGCTTCGCGGGCGCCGAGTTCGCCCCCAACACCCATGTCATCGGGCATGCCGGGCGGACCCTGGCCCTGGTCGAGAACGGGTTCCGGCCCTACGAGCTGACCGAGGAGCTCGAAACCGTCGGCCCGTGCGACTTCCGGGGCACTCTCCAGGCCGGCTACGTGGCCCACCCAAAGCTTGACCCGCACACCGGGGAACTCCATGCCGTCTCCTATGCGACCCGCTGGGAGTTCGTCCAGTACTCGGTGATCTCGCCCACCGGCATGGTCACCAGGACGGTGAACATCCCTGCACCGCACCGGCCGGTGATGCACGACTTCGCGCTGACCGCCTCGTACGTCGTCCTCTACGACCTCCCTGTGGTCAACAGCCTGGCCGCCGCGGCCGCCGGTGCGCCGATGGTGTACGACTGGCAGGAGAACCGGGGGGCCAGACTGGGGCTCCTGCCAAGGAACGGCACGGAGGTCCGCTGGTTCGACATCTCCCCGTGCTGGGTCTTCCACACCCTCAACGCGTACGAGGACGGCGACCGGGTGGTCGTCGACGTCATCCGCTATCCCCGAATGTTCACAGGCCTGCGACTGGACGGCAACTCCACTCCTACGATGGACCGTTGGGTGATCGACACGGTGAGCGGCCGGGTCACCGAGACCCGCCTGGACGATCGGGCCCAGGAGTTTCCCGGGGTCAACCCGGCCGTGGTCTCCGGCCCGCACCGCTACGGCTACGCCGCCGTCGTTCCGGACATGCACACCTACTTCGGCCCCGACGACGACCTGGACGACCTGCCCGACCAGGCGTACAGCGACGCGCTGATCAAGCACGACTTCTCCGCTGGGAGCTCATCGGTCCGCCCCCTCGGGCGCGGCCACTACACCGGCGAGCCGGTCTTCGTCGCCACCGCGTCCCCGGCGGCGGAGGACGACGGCTACCTGTTGGCCTACGTCCACGACCCCGACCGGGGCGCGAGCGATCTGGTCATTCTGTCCGCCCAGGACTTCACCGGCGAACCCGTGGCCACCGTGCACCTGCCCGCGCGGGTCCCGCTCGGCCTGCACGGGAGCTGGATCGCCGATCCGGCCTGA	MSTRRPYQGAFTPVDQEVTAFDLPVTGRIPAELRGRYLRNGPNPLRLDDPRAHLFLGEGMVHGVRLRDGRAEWYRNRWVRSAAVARSLGEKPRRGTRFAGAEFAPNTHVIGHAGRTLALVENGFRPYELTEELETVGPCDFRGTLQAGYVAHPKLDPHTGELHAVSYATRWEFVQYSVISPTGMVTRTVNIPAPHRPVMHDFALTASYVVLYDLPVVNSLAAAAAGAPMVYDWQENRGARLGLLPRNGTEVRWFDISPCWVFHTLNAYEDGDRVVVDVIRYPRMFTGLRLDGNSTPTMDRWVIDTVSGRVTETRLDDRAQEFPGVNPAVVSGPHRYGYAAVVPDMHTYFGPDDDLDDLPDQAYSDALIKHDFSAGSSSVRPLGRGHYTGEPVFVATASPAAEDDGYLLAYVHDPDRGASDLVILSAQDFTGEPVATVHLPARVPLGLHGSWIADPA	MNQKNPKDTQNFITSKKHVKEILNHTNISKQDNVIEIGSGKGHFTKELVKMSRSVTAIEIDGGLCQVTKEAVNPSENIKVIQTDILKFSFPKHINYKIYGNIPYNISTDIVKRITFESQAKYSYLIVEKGFAKRLQNLQRALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQPLISKKDYKKYRSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYKLFH	187.65	gnl|BL_ORD_ID|912|hsp_num:0	985			12	186	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001072.1|Simocyclinone_38 # 56007 # 57347 # 1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.708	BGC0001072.1|Simocyclinone_38 	56007	57347	+	Loose	700	26.1794	Escherichia coli mdfA	44.44	3001328	protein homolog model	n/a	n/a	tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCACCCCGTACCCGCTCCGGAACAGCCTGGAGAACTGATCGCCCGGCTCCGGGCCGCGAGCCGAACCGGCCGCCCGCGGTCCCTGGAGTGGCGGACCGAGCAACTGACCCGACTGCGCTCCCTGTTGCAGGAGCACACGGACGCGCTCGCGGAAGCCCTTTTCGCGGACCTGCACAAGAGCAGGTCCGAGGCCCATGCGGCTGAGATCGGGTTCACGGTCCGCGAGATCGACCACCTGTTGGAGAACCTGGAGGAGTGGCTCCGGCCGCAGCCGGCGGCCGTGCCCGGCTGCCCGGCGGGCTCGACGGCGTACGTCCAGTACGACCCGTTGGGCGTCGTGCTCGTGATTGCCCCGTGGAACTACCCGGTGCAGCTGCTGCTCGTTCCCGTCGCCGGCGCGCTGGCCGCCGGGAACACGGTCGTGGCCAAGCCGAGTGAGGTGGCCCCGGCTTGTTCGGCGCTGCTCGCCCGGCTGATCCCGCAGTATCTCTCCCGGGACGCCGTCGCCGTAGTCGAGGGGGGCGTCGCGGAGACGACCGCCCTGCTGGCGCAGCGCTTCGACCACATCTTCTACACCGGCAACGGGACTGTCGGCCGGATCGTGATGCGCGCCGCGGCCGAGCACCTGACTCCGGTCACCCTGGAGCTCGGCGGCAAGTCACCGGTGTTCGTCGACCGCGGAACGAATCTCGCGGATACGGCGACCCGGCTGGCCCGGGCCAAGTTCGCCAACGCCGGCCAGACCTGTGTAGCCCCCGACTACGTGCTGACCGACCCTGATACGGCGCGGGGCCTCGTGGCGGAGATCGCCCGGTCCGTCCGGAGGATGTTCGGCTCCGAACCGGAGCTGGCGCGCGGGTATGGGCGGATCGTCAACCTGCACCACTTCGACCGGGTCGTCCGCCTGCTCGGCTCGGGACGGATCGTTCTCGGCGGCCGGCATGACCGCGAGAACCGGTACATCGCCCCGACGGTCCTCGCGGACGTGGCGGCCGAGTCGCCGGTGATGCGGGAGGAGATCTTCGGCCCGGTGCTGCCGATAGTCGAGGTGCCCGGAGTCGACCAGGCGATCTCGTTCATCAACGACCGGGACAAGCCCCTCGCGGTGTACGGCTTCACCGCACGCGAGGAGGTCCCGCGCAGGCTCGCCGAGGAGACGACCTCGGGAGGCCTTGTACTCGGCATGCCGATGGCCCAGGTCCTGGACCCCGGGCTGCCCTTCGGCGGTGTGGGGGAGAGCGGTACGGGCAGCTACCGCGGTGCCCACTCCCTCGCCGCCTTCAGCCACCTCAAGCCAGTGCTGGACGTTCCGATGCGGCCGACCGGCCCGGTGGGCTGA	MHPVPAPEQPGELIARLRAASRTGRPRSLEWRTEQLTRLRSLLQEHTDALAEALFADLHKSRSEAHAAEIGFTVREIDHLLENLEEWLRPQPAAVPGCPAGSTAYVQYDPLGVVLVIAPWNYPVQLLLVPVAGALAAGNTVVAKPSEVAPACSALLARLIPQYLSRDAVAVVEGGVAETTALLAQRFDHIFYTGNGTVGRIVMRAAAEHLTPVTLELGGKSPVFVDRGTNLADTATRLARAKFANAGQTCVAPDYVLTDPDTARGLVAEIARSVRRMFGSEPELARGYGRIVNLHHFDRVVRLLGSGRIVLGGRHDRENRYIAPTVLADVAAESPVMREEIFGPVLPIVEVPGVDQAISFINDRDKPLAVYGFTAREEVPRRLAEETTSGGLVLGMPMAQVLDPGLPFGGVGESGTGSYRGAHSLAAFSHLKPVLDVPMRPTGPVG	MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG	108.78	gnl|BL_ORD_ID|2419|hsp_num:0	37			759	840	tetracycline; benzalkonium chloride
BGC0001072.1|Simocyclinone_39 # 57298 # 58077 # -1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.699	BGC0001072.1|Simocyclinone_39 	57298	58077	-	Loose	400	39.6614	tetR	24.44	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACGAGAACGAACCCGTCAGCATCTGGATGCACCCGGAGCCCGCCGGCCGGCGGTCGGCGCGGTCGCACCGGACGCTGAGCCGTGACCAGATCGTTCGGGCGGCCGTCAAGGTGGCCGACACCGAGGGTGTCGAGGCGGCGTCGATGCGCCGGGTCGCGGCCGAACTCGGCGCCGGCACGATGTCCCTCTACTACTACGTCCCCACCAAAGAGGACCTCGTCGAGCTGATGGTCGACGAGGTCATCGGCGAGACCCGGCTCCCGGACCGGCCAGGCCCTGACTGGCGGGCCGCGTTGACCCTGGCCGCCAACGAGAAACGCGCCCTGTGGCTGCGCCACCCGTGGCTGGCCACGGCCTGGAGGAACGGCCACCCGGTCTGGGGGCCGAACTCATTGCGCCAGCAGGAGTTCGTGCTCGGCACGCTCGGCGTCTTCGACCTCCAGGTCGACGAACTGCTCAGCCTGATCGGCCTCTACAACGGCTACGTCGAGAGCTTCGTCCGCAACGAGGTCGGCTGGCTGGAGGAGGCGCGCCGCACCAAGGTGGACATGCGGGAATGGATGCGGCGGAGCGGGCCCTACGCCCAGCAACTCGTCGACAGTGGCGAGTACCCGATGTTCGCGCGGGTGCTCGCCGAGACCGTGGCCCCGCACATGGGGCCCGACCAGCGTTTCCGGTCCGGTCTCGAGCGACTACTGGACAGCATCGGTGCCAGCCTCGACCGCCTCAGCCCACCGGGCCGGTCGGCCGCATCGGAACGTCCAGCACTGGCTTGA	MNENEPVSIWMHPEPAGRRSARSHRTLSRDQIVRAAVKVADTEGVEAASMRRVAAELGAGTMSLYYYVPTKEDLVELMVDEVIGETRLPDRPGPDWRAALTLAANEKRALWLRHPWLATAWRNGHPVWGPNSLRQQEFVLGTLGVFDLQVDELLSLIGLYNGYVESFVRNEVGWLEEARRTKVDMREWMRRSGPYAQQLVDSGEYPMFARVLAETVAPHMGPDQRFRSGLERLLDSIGASLDRLSPPGRSAASERPALA	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	124.52	gnl|BL_ORD_ID|442|hsp_num:0	276			12	282	tetracycline
BGC0001072.1|Simocyclinone_40 # 58180 # 59784 # 1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.706	BGC0001072.1|Simocyclinone_40 	58180	59784	+	Loose	950	191.815	tcr3	35.19	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCAGATGAGGATGCCGTTGCGGTCGAAGCCCGTCCGGAGGCTCCGCGCAGGCCGGCGCCGAGGTACCGCGGCCTCGGGGTGCTGGCCGTACTGCTCGGCCTGGCGCTGTCCATGCTGGACCAGGTGATCGTCGGTACGGCGCTGCCGACGATCGTCGGAGAGCTCGGTGGACTTGACGAACTGTCCTGGGTCGTCACCGCCTACATGGTGGCCAGCGCCGCTGTGATCCCGATCTGGGGCAAGTTGAGCGACCTCTACGGCCGCCGCGGCACGTACATCACCGCCCTCGTCATCTTCCTGGCCGGCTCCGTGCTCGCGGGTATGGCGCAGAACATGACGGAGATCATCGTCTTCCGCGCGCTGCAGGGTCTCGCCTCCGCCGGCCTGATGGTCGGTACGTTCACGCTGATCGGCGTCCTGGCGACCGGCCCGGCCGACCGGATTCGGATGCAGACCATGATCGGCATCGTCATGCCGGTCGCGCTGGGGGCCGGGCCGCTGTTGGGCGGCCTGCTCACCGAACACGTCGGCTGGCGCTGGTCGTTCTTCATCAACGTCCCGCTGTGCCTGGTCGCGCTGGTGGCGAGCGCGCTGGGCATCCCGCGCAGCCCCCGGCGCGAGAAGGTCCGTATCGACGTCCTCGGCAGTGTGCAGCTCACCGGCGGAGTCGTGGCGCTCACCCTGCTGCTGAGCTGGGCGGGCACGCGCTACGACTGGATCTCGGCGCCGATCCTCGGCCTGGCCGCGGTCAGCGCCGCGCTGCTCGCCACCCTGGCGCTGACCCAGCGCCGGGCCGTGGAACCGATCCTGCCGTCCCGGCTGTTCCGCACCAGGGACTTCACGCTCGCCCAGGTGGTGGGTCTGCTGGTAGGAGCCGGCCTGCTGGGCGTCCTGGTGTACTTCCCGCAGTACCTGCAGCAGGTCCTGGGCGTCACGCCCACTTCCAGCGGACTGCTGCTGCTGCCGTTCCTGATCGGAATGATCGTCATGGAGCTGGCCGTCGCCCGACGGGTCGTCAAGACCGGTCCGCTCCCCGTCTACCCGATTGCCGGTGGCGTGGTCGCGGTGGTCGGTGCGCTCGCCATGCTGGCGCTCGGTACCGGTACCAGCGTCCTCGCCGCGGCGCTGATCCCGCTGGCGGCCGGGCTCGGCATCGGGGTGCTGATGCAGAGCTCGCTGATCATCTCCTTCGCCTGCCAGACCGACCAGCGCGACCTGGGGGCGGCCAGCGGCGTGCTCAACCTGTTCCGTACGATCGGCGGCTCGCTCGGCGTCGCGGTGCTCGGTTCGCTCTTCAGCGCCCGGGTCGAGCACGTGCTCACAGAGCGGATCGGCGCCCACGCCGGGCGCTCGCTCGCCGCGGCCAGCGGTCGGAGCACCCCGGCCGACATCCGCGCCCTGCCGGCGCCGGTCCGCGACGCCTTCCAGTCCGCCGTGGTGGGAGGGCTGCACAGCGTGGTCATCGGCATGGTGGTGATTGGCGTGCTGGCCCTGGCGACCTCGTTCTTCTTCCGCCGGCTGAATATTCCGGGGCCGTTCGGTCAGGGCCCGGGCCCGCGCCCTGACGGGAATACCGTGTCGTCGGCTCGGAATGCCGGATAG	MPDEDAVAVEARPEAPRRPAPRYRGLGVLAVLLGLALSMLDQVIVGTALPTIVGELGGLDELSWVVTAYMVASAAVIPIWGKLSDLYGRRGTYITALVIFLAGSVLAGMAQNMTEIIVFRALQGLASAGLMVGTFTLIGVLATGPADRIRMQTMIGIVMPVALGAGPLLGGLLTEHVGWRWSFFINVPLCLVALVASALGIPRSPRREKVRIDVLGSVQLTGGVVALTLLLSWAGTRYDWISAPILGLAAVSAALLATLALTQRRAVEPILPSRLFRTRDFTLAQVVGLLVGAGLLGVLVYFPQYLQQVLGVTPTSSGLLLLPFLIGMIVMELAVARRVVKTGPLPVYPIAGGVVAVVGALAMLALGTGTSVLAAALIPLAAGLGIGVLMQSSLIISFACQTDQRDLGAASGVLNLFRTIGGSLGVAVLGSLFSARVEHVLTERIGAHAGRSLAAASGRSTPADIRALPAPVRDAFQSAVVGGLHSVVIGMVVIGVLALATSFFFRRLNIPGPFGQGPGPRPDGNTVSSARNAG	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	104.30	gnl|BL_ORD_ID|592|hsp_num:0	652			135	1479	tetracycline
BGC0001072.1|Simocyclinone_41 # 59996 # 60877 # 1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0001072.1|Simocyclinone_41 	59996	60877	+	Loose	900	25.0238	lsaD	23.12	3005121	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	ATGTTCTGTGAGGGGGCGGGGCAGGTGACAACACGGGGCAGCCTGGTGGGCATCAGCGACCTGCACGTCCACTACGAGGACAACCGGAGGGTTGTCGAGCGCTGCGCCCCCGAGTCGGCCGACGACTGGTTGCTGCTCGCCGGGGACGTCGCCGAGACCGTCGAGGACATCGCGTGGGCCATGGACCTGCTCCGCGGAGCTTCGCGAAGGGTGGTGTGGGCCCCGGGCAATCACGAGCTGTGGACCCCGCCGTACGACCAGGTGCAGCTGCGCGGCGAGGCCCGCTACCGGCACCTCGTCGAGCTCTGCCGGGGGCTCGGCGTGGTCACCCCCGAGGACCCGTACCCGGTCTGGGACGGGCCCGGCGGCCCGGTGGCGATCGCACCGCTCTTCGTGCTCTACGACTACAGCTTCCGATCCGACGGTGCCCGGGATGAGCAGGACGCCCTGGCGCTCGCCGAGGACGCCGGGGTGATCTGCACGGACGAGTTCATGTTGCACGCCGACCCGTTCCCGAGCCGTGCGGACTGGTGCCGCGCCAGGGTCGAGTACACCGAGGCGCGGTTGGCTGCCGTCGACGAGGCGCTGCCGACCGTGCTGGTCAACCACTATCCGCTGGTTCGGACGCCCACCCGGGTGCTCCGCCATCCGGAGTTCGCGCTCTGGTGCGGTACCGAGGCCACGGCGGACTGGCACCGACGGTTCCGCGCGGCCGCTGTCGTCTACGGCCACCTGCACATCCCTTCGCTCCTGTACGAGGACGGTGTGCCGCACCACGAGGTCTCCCTCGGTTACCCGAGCGAGTGGCAGCGCCGCCCCGCCGCCCCGGGCCGCCTGGTGCGGATTCTTCCGGAGCCGGCCGCCACCGGGAGCCGGGCGTGA	MFCEGAGQVTTRGSLVGISDLHVHYEDNRRVVERCAPESADDWLLLAGDVAETVEDIAWAMDLLRGASRRVVWAPGNHELWTPPYDQVQLRGEARYRHLVELCRGLGVVTPEDPYPVWDGPGGPVAIAPLFVLYDYSFRSDGARDEQDALALAEDAGVICTDEFMLHADPFPSRADWCRARVEYTEARLAAVDEALPTVLVNHYPLVRTPTRVLRHPEFALWCGTEATADWHRRFRAAAVVYGHLHIPSLLYEDGVPHHEVSLGYPSEWQRRPAAPGRLVRILPEPAATGSRA	MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV	58.95	gnl|BL_ORD_ID|4773|hsp_num:0	3847			114	495	lincomycin; clindamycin; virginiamycin M1; tiamulin
BGC0001072.1|Simocyclinone_42 # 60874 # 61536 # 1 # ID=1_42;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.719	BGC0001072.1|Simocyclinone_42 	60874	61536	+	Loose	450	24.2534	KBL-1	43.24	3007206	protein homolog model	n/a	n/a	penam	antibiotic inactivation	KBL beta-lactamase	GTGATCGAACACGTGCTGTCGCGGCCGGTCGTAGCCGTCGACACTTTCACCGATCCGGTGGAACCGCCGGTGCTCTTCCGTGAGGAGGAGGAGCTGATCGCGCGGGCGGTGAACGCCCGGCGCAGCGAGTTCGGCACCGTACGCGCCTGTGCCCGCGCTGCCCTGGCAGTGCTCGGTATCGATGCGGTGCCCATCTTGCGCGGGCCGTGCGCCGAGCCGGTGTGGCCCGCGGGAGTCGTCGGCTCCATGACGCACTGTGAGGGCTACCGGGCAGCCGCCGTCGCACGCGAGGGCGAGCTGGCGGCCGTGGGCATCGACGCCGAGCCCCATCGGCCGCTCCCGGGCGACGAACTGGACGTGATCGCTCGTCCCGAGGAGCTCGGCCCGCTGTCCGGACTGCGGGTCCGGTGGCCGGAGATCTGTTGGGACCGGCTGTTGTTCAGTGCCAAGGAGAGCGTGTACAAGGCCTGGTTCCCGCTCACCGGGCGATGGCTGGGCTTCGAGGAGGCGCTGATCGACTTCGACCCGGAGGCCGGCTCCTTCCGGGCCCGGCTGCTGGTTCCGGGGCCGACCGTCGGGGGCCGCCGGCTGCCGGGCTTCGACGGTCACTGGCTGGCCCGGGACGGGCTCCTGCTGACGGCGGTCGCAGTACCCTCCGACTGA	MIEHVLSRPVVAVDTFTDPVEPPVLFREEEELIARAVNARRSEFGTVRACARAALAVLGIDAVPILRGPCAEPVWPAGVVGSMTHCEGYRAAAVAREGELAAVGIDAEPHRPLPGDELDVIARPEELGPLSGLRVRWPEICWDRLLFSAKESVYKAWFPLTGRWLGFEEALIDFDPEAGSFRARLLVPGPTVGGRRLPGFDGHWLARDGLLLTAVAVPSD	MRLTFPFAAAVSILFALPLHAETVAEAARALEAELGGRIGVVLRAPEDDPLAVWRGDEAFPMASTFKVPLCGAVLARIDAGEEQAARILPVETAALVEWSPVTEQQAGRGMSIADLCHATITMSDNTAANLLLDTVGGPAGLTAFLRDIGDATTRLDRTEPALNEALPEDMRDTTTPAAMADTLELLLFSELLSPEARAQLESWMRQDAVADDLLRASLPEGWMIGDKTGAGGNGSRSIIAVLRGPAGEPWLATVYMTQTGGDMDKRNAAIARIGAAMIGEIQARR	76.92	gnl|BL_ORD_ID|4832|hsp_num:0	5818			717	825	amoxicillin; piperacillin; benzylpenicillin; ampicillin
BGC0001072.1|Simocyclinone_43 # 61682 # 62392 # 1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.719	BGC0001072.1|Simocyclinone_43 	61682	62392	+	Loose	400	25.0238	IND-4	38.71	3002260	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGGCTCCTGTCGCGATTGTGGCCGGCGCTGTCCGTGGTACGGGGTCTGTTGTCGCAGTGCGGCTGGCGGAGGCCGGCTGGGATGTCGCGGTGCTCTGCGCCGACGGTGCCGGGAACGCGGACACCGTGCACAGGGTGCGGGCGGTCGGCCGACGGGCGCTGGCGGTCGAGACCGACGTCACCGATGCGGTGTCGGTCCAGGCGGCTCTCGACCGGGTGTGCGCTGAACTCGGCGATCCGGGCGTTCTGGTGAACAGCGTCGGGGTGATCGCCTGCGGCGCGCCGGGGGAGGCCTCCGAGGAGGACTGGAACGCGGTGGTCGGCCGTTCGCTGCGAGGGTTGTTCGTCACCAGCCGGGCGGTCACCGATCTGATGATCAGGCAGGGTCGAGGTCGCATCGTCACCATCGCCAACCTGCTGGGTCCCGCCGAGGGCGGGCCACACGATCACGCGACGGTTCTGGCCGGCATGGCGGGCTTCACCAGGACGGTCGCACTCGAGCTGCGCGCCTTCGACATCACGGTGAACGCCGTCGCGCCGGCACCTCCCGTCGTCGGCATGCAGGCGCCGGCGGCCCCGACCGCAGCGGACCCGGAAGGTTCGCGGTGCGCGACGCAGGCTGCCGAGGCAGTGCTGTTCCTGGTCGGTGGCGGGGCGTCATCGGTGACCGGTCAGACCGTCCAGGTGGGCGACGAGGAAGCGGCCGCCTGA	MAPVAIVAGAVRGTGSVVAVRLAEAGWDVAVLCADGAGNADTVHRVRAVGRRALAVETDVTDAVSVQAALDRVCAELGDPGVLVNSVGVIACGAPGEASEEDWNAVVGRSLRGLFVTSRAVTDLMIRQGRGRIVTIANLLGPAEGGPHDHATVLAGMAGFTRTVALELRAFDITVNAVAPAPPVVGMQAPAAPTAADPEGSRCATQAAEAVLFLVGGGASSVTGQTVQVGDEEAAA	MRKNVRIFTVLSLFLINFFNAQARDFVIEQPFGKQLYLYKTFGVFDGKEYSTNALYLVTKKGVVLFDVPWQKTQYQSLMDTIKKRHNLPVIAVFATHSHSDRAGDLSFYNKKGIPTYATAKTNELLKKEGKATSSKLTKIGKKYKIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSSAAVDLGYTGEANVEQWPATMKKLQAKYPSTAKVIPGHDEWKGNDHVKHTLELLDQQKQ	97.52	gnl|BL_ORD_ID|1589|hsp_num:0	1734			525	618	
BGC0001072.1|Simocyclinone_44 # 62429 # 63988 # 1 # ID=1_44;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.707	BGC0001072.1|Simocyclinone_44 	62429	63988	+	Loose	1000	45.8246	almE	24.45	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	TTGGAAGGCAACGAGCACTACGTCCGGCAGATCCTGAACACCCTCCGCGCCGACCCCTCCGGCGTGGCGCTGGTGCATCGGGACACGCCCGTGATTGCCGGCGACCTGGCTGACTCGATCACGTCGGCGGCGGAGGCGATGCGCGGAAGCGGTGTCGGCGTCGGGAGCGTGGTCGGGATCCTGACCGACCCCAACACGCCCGCGACCCTGGTGGCACGCTATGCCGCCAACCTGCTCGGTGCGACCGTGGTCCACCTCTTCGGTGTCAACGCCGCCAACCCGTCCGACCTGCTCTCGGCGGAGGCGCAGGGCGGCATCGTCGCTGAAGCGTTGCCGGCAATGGTGGTCGTGGACGCGGCCAACCTCGAGCGCGCGCGGGCGATCCGCGAGGTGCCGTCCGTCCGCCCGGTGCTCTCCGGATTGGGCGAACTCGGCCACGACGTCATCGACCTGACGGACAGTCCGGCAGGCGCCTTCCGCCCTGACGCGGCGCGCGACGGTGACACCGCCGTGGTCACCTTCTCCAGCGGTTCCACCGGTCGGCCCAAGGGAACGGCCTGGTCATTCAGGGTGAAGGCCGACATGGTCGCGGCCTCCGCGCGCCGTGCCCAGAAGGCGACCGCCCTGGTCACCGCGCCCCTGACGCACTCGAACGGCTTCGTCGCGGACGACGTGCTGGTCTCCGGTGGAACGGTCGTGCTGTTGCCCGGCTTCGACGAGACCGAGGTCCTGCGCAGCGTGGCCCGATACCAGGTCAACCGGCTGGCGGTGTCCGCTCCCCAGCTGTACGCGCTGGCCGACCACCCAGAGACCACCCGGACCGATCTGTCGAGCGTGCGCGACCTCTTCTACACCGGGGTCGCAGCCTCGCCGGAGCGCGTCGCGGTGGCCGAGAAGGTCTTCGGCTCGGTGCTCATGCAGGTCTACGGCACGAGCGAGACCAACATCATCAGCTGGCTCATCGCGGGCGAGCACACGGACGCCGGCCTGCGCGCCACGGTGGGGCGTCCCCTCGAATGGCTTCGGGTGACCATCCGCGACCCCCAGGACGAGCGGGTGCTGCCGACCGGCGAGACCGGTGAGGTGTGGGTCAACTCGCCGTGGCGAATGGACCATTACTGGAACGACCCGGAGCAGACCGCGCGCACCGTCCGGGACGGGTGGATCCGCACCGGGGACGTCGGACACCTCGACGACGCGGGTTACCTGCACTTGCACGGCCGGCTCGCGGGCGTGATCAAGACCAACGGCATCAAGGTCTACCCGGTCGCGGTCGAGCGTTCGCTGCTGGACCACCCGGACGTCGCCGAGGCGGCCGTGTTCGGGGTGGAGAACAGCGACCGGGTCGAGCGGATCCATGCGGTGGTCGTGCTGCGCGAGGGCGCCGGGGCCGGCCCCGAGGACCTCCGACAGCACGTGAGCTCCCACCTGTCCCCCAACCACGCTCCGGCCGACATCGAGCTGCGGTCCAGCCTCCCGCTCATCGGCTTCGGCAAGCCGGACAAGCTGCGGCTGCGCGCGGACGCGATGGCGCGTCGGGAGGCCACCCATGGCGAATGA	MEGNEHYVRQILNTLRADPSGVALVHRDTPVIAGDLADSITSAAEAMRGSGVGVGSVVGILTDPNTPATLVARYAANLLGATVVHLFGVNAANPSDLLSAEAQGGIVAEALPAMVVVDAANLERARAIREVPSVRPVLSGLGELGHDVIDLTDSPAGAFRPDAARDGDTAVVTFSSGSTGRPKGTAWSFRVKADMVAASARRAQKATALVTAPLTHSNGFVADDVLVSGGTVVLLPGFDETEVLRSVARYQVNRLAVSAPQLYALADHPETTRTDLSSVRDLFYTGVAASPERVAVAEKVFGSVLMQVYGTSETNIISWLIAGEHTDAGLRATVGRPLEWLRVTIRDPQDERVLPTGETGEVWVNSPWRMDHYWNDPEQTARTVRDGWIRTGDVGHLDDAGYLHLHGRLAGVIKTNGIKVYPVAVERSLLDHPDVAEAAVFGVENSDRVERIHAVVVLREGAGAGPEDLRQHVSSHLSPNHAPADIELRSSLPLIGFGKPDKLRLRADAMARREATHGE	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	93.35	gnl|BL_ORD_ID|4935|hsp_num:0	5928			576	1374	colistin A; colistin B
BGC0001072.1|Simocyclinone_45 # 63978 # 67010 # 1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.718	BGC0001072.1|Simocyclinone_45 	63978	67010	+	Loose	1000	146.362	almE	30.5	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGCGAATGAGAGTCCTGTGATGACCTTGGAGAACAACATGGCCATGCCATCCGGCAGTGTGGTGTCGGTGGTTGAGGTCGAGGGCCTCGTCGACTCGGTGGTCTTCGCGGCCGCCGTCGACGTCCTGCTCAAGCGCCATCCCGCGCCTACGGCGGGGCTGTCCTGGCGCGAGGTCGACCGGAGCGGTCCGGACCAGGACAGCCGCAGGACCGGGCTGGACCGGCTCGCGACCGAGGACGGAGAAGCGGTAGTCGTCGGCGCCCCGCCCCGGCTGACGCTGGTGCGACTGCGAGCCGACGCCTTCCAGCTTCGGCTCGCAAGTGACCGTGCCGTCCTGGACGCCCCGTCCCACCGGGTGCTGCTCGGCGAGCTGCTCGAAGAGTGTGCCGCGCCGGCCGGGGCGGTGGGCCCCGCGCCCGTCGAGGACCGCGTCGCGTGGACGGCGGAAGGGGAGCGCGGCGAGGCCGAGCGCGCGTGGCGCATCCGGCTCGCGGAGGTGGACGAACCCACCCTGGTGGCACCGGCGGGATCGGCCGGGTATTCACAGCGCCCGGAGCGGGTCGAGAGCGAGCTGCCCACGGACCTGGCCGAGCGCCTGCTCGTCCGCACGGACGACCGCCGGCTGTCGCTCGACACCATCGTGCACGCCGCGTGGGGCCTGGTGTTGAGCTGGCTGACCAACCGTCGCAACGTCGTCTTCGGCGGCCTCCGTTCGGACCGGTCCCGGTTTCCTGTGGCAGAGACGGCGGTGGGCGGCTTCTCCGAGATCGTGCCGGTGCCCTGCGCGGTGAACCCGGCGGAGCCGATCGCGGACCTGCTCTCCCGCACCGAGCTGGACGGCACCCTGATCGCGGAGTACAGCGCCCTCGGCGCGGCGGAGATCCACGCCCTCGTCGGCCTGCCGCGGCTGTTCGACACCGTCGCCGTCGTGGAGGACGCCGGCCTCGACCCGGTCCCGGCGCCGGAGGGCCTGCCCGGGCTGCGGGTTGTCGCCCAGGAGCAGTGGGAGGACTTCGGCAGCGCGCTTGCGCTGGTCGTGCGCCGGTCCGAGGGTGGACTGCGGCTGAACCTGGACTTTCGGCCGGAGCTGTTCACTCAGGCCGACGCGGAGCGGATCCTGGCGGCGTTCAGCCGGACCTTCCGGACGATCGCCGACGAGCCGAACCAGCCCGTCGGCCGGGTGCAGCTGCTCGACGACCACGAGCAGCGCAGGATCCTGGCCCACTCGGACGCCACCGCCGACGGGGTTCCCGCGGTCACGCTGGTGGAGCTGCTGGAGCAGACGGTCGCGCGGACCCCCGGCAACACGGTGGTGTCTTTCAGCGGCCAGCACATCTCCTACGACGAGCTGAATCGTCGCGTCAACCGGCTTGCCCGGCTCCTGGCCGATCGGGGCGCCGGCCCGGAGCAACTGGTCGCGCTGGTCGTGCCCCGGTCGATCGAGATGGTGACCGCGGTACTCGCGGTGGCCAAGACGGGCGCCGGATTCCTTCCGATCGACCCCGGCTACCCCGCGGACCGCATCGCCTACATGCTCGGCGACGCCGGCCCCGCGGTGGTGTGCACCACTCGGACGGCCGCGGCCGTGCTGCCGCAGGACGTCAGCGGGATCGTCCTCGACGATCCGGCGGTCGCCGCCGAGGCGGCCGGCTTGTCCGACGAGGATCCGGTGGCCTCCGAGCACTGGGCTCCGGTGCCGCCTGCCGCGCTGGCCTATGTCATTTACACCTCCGGATCGACCGGGCGGCCCAAGGGCGTGGCCGTCACGCACGCCGGTCTCGCCAACCTGGTGGCGGCCAAGGTCGAGCGAATGGACGTCGACGAGCAGAGCCGGATCTTGCAGTTCGCGTCGCCCAGCTTCGATGCCTTCATGACCGAGTTGCTGGCGACCATCGGGGCCGGTGCCACGCTGGTCGTTCCACCGCCCGGGATCCTCGCCGGGGACCACCTCGCTGAGGTCCTCGTCGCGGAGCGCATCACCCACGTGGTGCTTCCGCCGGTTGCCGCAGCGAGCGTGTCTCCCGAAAGTCTGCCGGACCTGCGCTCCCTGGTCCTGGCCGGCGAGGCGTCCTCCGGGGACCTCATAGCGCGCTGGGCGCCCGGCCGCCGCGTGATCAACGCTTACGGCCCGACCGAGGCGACCGTCTGCGCCACCATGAGCGAACCGCTCTCGGCTGATGCGACGCCGCCGATTGGCGGACCGATCCCCGGTGCAGCCTGCTACGTCCTTGATGAGGCCTTGCGCCCGGTGCCTGCGGGGGTGCCCGGTGAGCTGTACCTCGGCGGCGCCGGCCTCGCCCGCGGCTACCTCGGGCGACCGGGGATGACGGCCGAGAGGTTCGTCGCCAACCCGTTCGCCGGCGACGGGTCCCGCATGTACCGGACGGGTGACCTGGTGTCCTGGCGGTCAGACGGTGGTCTTGACTTCCTCGGCCGCTCGGATGAGCAGGTGAAGCTCCGCGGGTTCCGGATCGAGCTCGGTGAGGTGGAACGGGTCCTGACAAACCACCCGGGTGTCGACCGCGCGGTCGCCGTGGTCCGGGAGGACGGGGCCGGCGGTCGTCGGATCGTGGTCCACCTGATCCCCTCGGCGGGCGCCGCACCGACCATGGCGGAGCTGCGTGAACACGCCGGGCGCTTCCTGCCCGACTTCATGGTTCCGGGCGCCTTCGTCCTGCTCGACGCCTTCCCACTTACGCCGAACGGCAAGCTCGACCGCCGTGCGCTGCCCGAGCCGGACGCGGCGCCGGCGCCGAGCGGGCGAGCACCCAGTACCCCGGAGGAGATCGCCCTGAGCAGGATCTTCAGTGAGGTGCTCGGGGTGGCCGAGGTGGACGCCGACCGGAACTTCTTCGAGCTCGGAGGCAACAGCATGGTGGCCATCACCGTGATCCAGAAGGCCCGGAAGGCGGGCCTGGCGATCTCGCCGAAGGACCTCGTCATGAACCCGACCGTGGAGGCACTTGCAGCGATAGCGGGCCGTACCGACCAGGCGCCGAGGCGCGCCGAGGCCACAACGGCCGTGAAGTGA	MANESPVMTLENNMAMPSGSVVSVVEVEGLVDSVVFAAAVDVLLKRHPAPTAGLSWREVDRSGPDQDSRRTGLDRLATEDGEAVVVGAPPRLTLVRLRADAFQLRLASDRAVLDAPSHRVLLGELLEECAAPAGAVGPAPVEDRVAWTAEGERGEAERAWRIRLAEVDEPTLVAPAGSAGYSQRPERVESELPTDLAERLLVRTDDRRLSLDTIVHAAWGLVLSWLTNRRNVVFGGLRSDRSRFPVAETAVGGFSEIVPVPCAVNPAEPIADLLSRTELDGTLIAEYSALGAAEIHALVGLPRLFDTVAVVEDAGLDPVPAPEGLPGLRVVAQEQWEDFGSALALVVRRSEGGLRLNLDFRPELFTQADAERILAAFSRTFRTIADEPNQPVGRVQLLDDHEQRRILAHSDATADGVPAVTLVELLEQTVARTPGNTVVSFSGQHISYDELNRRVNRLARLLADRGAGPEQLVALVVPRSIEMVTAVLAVAKTGAGFLPIDPGYPADRIAYMLGDAGPAVVCTTRTAAAVLPQDVSGIVLDDPAVAAEAAGLSDEDPVASEHWAPVPPAALAYVIYTSGSTGRPKGVAVTHAGLANLVAAKVERMDVDEQSRILQFASPSFDAFMTELLATIGAGATLVVPPPGILAGDHLAEVLVAERITHVVLPPVAAASVSPESLPDLRSLVLAGEASSGDLIARWAPGRRVINAYGPTEATVCATMSEPLSADATPPIGGPIPGAACYVLDEALRPVPAGVPGELYLGGAGLARGYLGRPGMTAERFVANPFAGDGSRMYRTGDLVSWRSDGGLDFLGRSDEQVKLRGFRIELGEVERVLTNHPGVDRAVAVVREDGAGGRRIVVHLIPSAGAAPTMAELREHAGRFLPDFMVPGAFVLLDAFPLTPNGKLDRRALPEPDAAPAPSGRAPSTPEEIALSRIFSEVLGVAEVDADRNFFELGGNSMVAITVIQKARKAGLAISPKDLVMNPTVEALAAIAGRTDQAPRRAEATTAVK	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	181.65	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1647	colistin A; colistin B
BGC0001072.1|Simocyclinone_46 # 67022 # 68272 # 1 # ID=1_46;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.670	BGC0001072.1|Simocyclinone_46 	67022	68272	+	Loose	1100	25.7942	salA	24.36	3003749	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGAACCCGCGACCGATGCTCTCGCCGGACGTCCTCGAGGACATCGACCTCAACGACCGGCAACTGCACGCGGACTACGACCTCAGCGAGGTCTGGCGCTACCTGCGGGCCGAGCGTCCCTTCTACTACCAGACCGCGCGCGGATCCCAGCCCGGCTTCTGGGTGGTCACCCGGCACGCCGACTGTACGGCGGTCTACAAGGACAAGACGAACTTCACCGCGGAGCGGGGCAACGTGCTGCCGACGCTGCTCGCCGGGGGTGACTCGGCGTCCCGGACGATGCTCGCGCTGACCGACGGCGACCGCCACACCCAGGTACGCAACCTGCTGATGAAGGCGTTCTCGCCCAAGATGCTGAGCAACATCGGGCAATCGCTTCGCACCACCGTTGACGGACTGTTGCGGGACGCCATCGAGAAGGGCGAGTGCGACTTCGCGCGCGATGTCTCCGGCAAGGTCCCGTTGGTCGCGATCTGCGATCTGCTGGCGGTGCCGCAGGAGGACCGCGAGTACCTGCTCAGCCTTACCGCGCACGCACTGAGCGCCGACGAGGCCGACGCCACGGCAGAGGACAACTGGACCGCGAAGAACGAGATCCTGCTGTACTTCGCAGACCTCGCCGAGAGCCGCCGGTCCAGCGGGCACAACGACGTGGTCAGCCTTCTGGCGACCAGCAGCATCGAGGGCGAGCCGCTCTCCGACGGCGAGCTGATGGCCAACTGCTACGGCCTGATGATTGGCGGCGACGAGACCGGCCGGCACGCGATCACCGGCGGTCTGCGCGCCCTGATCCATCACCCGGACCAGTGGCGGATGCTCCGCAACGGTGAGGCAGATCTCCAGACCGCCACCGAGGAGGTGCTGCGGTGGACTGTGCCCTCGCTGCACGGTGCCCGCACCGCAACCGCCGACGTCGTGGTCAACGGCAAGCAGCAGATCCGGGCCGGTGAGATCGTCAGCGTCTGGTTCGCCTCGGCCAACCGGGACGAGGAGGTGTTCCGCGACGCGGACCGATTCGATCTGAACCGGACCCCCAACAAGCACCTCACCTTTGCCTTCGGCTCGCACTTCTGCCTTGGCCACTACCTGGCGCGCATGGAGGTGGAGGCGATCCTCGACGGCCTGCGGCGGATGGTCGACGACATCCAGCAGACCGGTCCGGAGAAGCTGATCTACTCCAGCATCCTGCAGGGAATCAGTTCGTTCCCCGCTCTCCTCAAGCCCGATCGCCGCGTCCCGCCGCAGACCTGA	MNPRPMLSPDVLEDIDLNDRQLHADYDLSEVWRYLRAERPFYYQTARGSQPGFWVVTRHADCTAVYKDKTNFTAERGNVLPTLLAGGDSASRTMLALTDGDRHTQVRNLLMKAFSPKMLSNIGQSLRTTVDGLLRDAIEKGECDFARDVSGKVPLVAICDLLAVPQEDREYLLSLTAHALSADEADATAEDNWTAKNEILLYFADLAESRRSSGHNDVVSLLATSSIEGEPLSDGELMANCYGLMIGGDETGRHAITGGLRALIHHPDQWRMLRNGEADLQTATEEVLRWTVPSLHGARTATADVVVNGKQQIRAGEIVSVWFASANRDEEVFRDADRFDLNRTPNKHLTFAFGSHFCLGHYLARMEVEAILDGLRRMVDDIQQTGPEKLIYSSILQGISSFPALLKPDRRVPPQT	MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMMEQDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIKEEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAILFVSHDRTFLNETPDAILELSLDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAIEETIKKYKAWYQKAEQSASVRSPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIPNPHKKEKTFSIQHHNFKSHYLVQFNHVSFAYDNRKIFDDVSFYIKRNQNVIVEGRNGTGKSTLIKLILGELEPTKGDITVHPELEIGYFSQDFENLNMHHTVLDEILEIPEMKEADARTILASFYFDKDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSFQGSVLIVSHDNYFKSQIKDQTWTIKNHQMTHENVQVKDPINTESMKHHLKELEQYTDERNRETEF	76.89	gnl|BL_ORD_ID|2051|hsp_num:0	2265			177	411	lincomycin; clindamycin; virginiamycin M1; tiamulin; retapamulin
BGC0001072.1|Simocyclinone_47 # 68348 # 68521 # 1 # ID=1_47;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.707	BGC0001072.1|Simocyclinone_47 	68348	68521	+	Loose	350	23.483	BcIII	80.0	3007101	protein homolog model	n/a	n/a	cephalosporin; penem	antibiotic inactivation	class A Bacillus cereus Bc beta-lactamase	GTGCTGCGCAACGCCGAGGAGCAGGTCTCGCTCTGGCCGGCATTCGCCGGTGTGCCGACCGGATGGCAGGTCGCCAAGGGGCCGAACAGCCGGGCAGCGTGCCTGGCGTACATCGAGGAGGCGTGGACCGACCTGCGCCCGAAGAGCCTGATCGACGCGACGGACCCCAGCTGA	MLRNAEEQVSLWPAFAGVPTGWQVAKGPNSRAACLAYIEEAWTDLRPKSLIDATDPS	MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTNQVKQENIGNHAFAKLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITYTREDLSNYNPITEMHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGDTVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTGNKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLIADATKIVLETLKVTNK	18.04	gnl|BL_ORD_ID|4780|hsp_num:0	5775			735	765	
BGC0001072.1|Simocyclinone_48 # 68595 # 69353 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.706	BGC0001072.1|Simocyclinone_48 	68595	69353	+	Loose	450	53.5286	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	28.52	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGAGCCTCGGGGCCGACACCGTCGCGATCGTCACCGGAGCCGGACGGGGCATCGGCGCCGCCACGGCGCAGCGGCTCGCCGCGGAGGGCGCGACCGTGGCAGTCGTCGACCGGACCGAGGCGGACACGGCCGACACCGTGGCGTCGATCCGGGCGGCCGGTGGCCGCGCCCTCGGCATCGGGTGCGACGTGACAGTCACCGACCTGGTCGAGGCGGCGGTCGACCGCACGGTCGCGGAGTTCGGTCGTCTGGACGTCCTCGTCAACAACGCCGGGGTAACCCGGGACAGCCTCGTCTTCATGATGGGCGACGAGGACTGGGATACGGTCATCGACGTGCACCTGAACGGCGCCGCCCGGACCGTCCGCGCGGCACGGCGCCAGATGGTGCGTCAAGGTTCCGGGCGGATAGTGAACTTGAGCTCGATCGCGGCTCTGGGCAACCAGGGGCAGGCCAACTACGCCACTGCCAAGGCCGCGATCCAGGGCTACACCCGCACCCTGGCCGTGGAACTTGGCCCGCACGGTATTACGGTCAATGCGATCGCGCCTGGGTTCATCGCCACGACCATGACGGACGACACGGCTCGCCGGATGGGCTCCGATCCGGTGGCGCTGCGGAAGGCGGTGGCGTCGCGGGTGCCGATGCGCAGGGTTGGCAGGCCGGAGGACATCGCCGGCCTGGTGGCCTTCCTGGCCGGGCCTGATGCGAGCTATCTCACAGGGCAGACGATCTACGTCGACGGCGGACCGCAGTGA	MSLGADTVAIVTGAGRGIGAATAQRLAAEGATVAVVDRTEADTADTVASIRAAGGRALGIGCDVTVTDLVEAAVDRTVAEFGRLDVLVNNAGVTRDSLVFMMGDEDWDTVIDVHLNGAARTVRAARRQMVRQGSGRIVNLSSIAALGNQGQANYATAKAAIQGYTRTLAVELGPHGITVNAIAPGFIATTMTDDTARRMGSDPVALRKAVASRVPMRRVGRPEDIAGLVAFLAGPDASYLTGQTIYVDGGPQ	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	96.18	gnl|BL_ORD_ID|4712|hsp_num:0	2666			27	750	triclosan
BGC0001072.1|Simocyclinone_49 # 69772 # 70278 # 1 # ID=1_49;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0001072.1|Simocyclinone_49 	69772	70278	+	Loose	410	110.153	arlR	35.9	3000838	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCCGATCATTGTCGTGAGTGCGCGGGATGACGAGCTCGATCAGATTCTGAGTCTCAAATTGGGAGCCGACGACTATATCGTGTGGCCGTGCGGCATGCGCCAGTTGGTGGCCCGGATGGAGGCGCTCATTCGGCGTGCCAGAAATGCCTGGGAGTCCTGGGGTGTTCCGTTGGCGTCGCCCGAGCCCGGAGTTCGCCAATTTGGCCCGGTCCGTATCGATCTACAGCGCCGGTCAGTGACCCGGGACGGCCATGAGGTCCCGCTGACCCGCAAGGAGTTCGACATGCTGGCGCTGCTGGCGACCGACCCCGGCCGAGTGTTCACCCGTGAGCAGATCATGTTCGAGGTGTGGGGGCATGACGGAGCCGGGGACACTCGGACTCTCGGCGTGCACGTGACGGGCATCCGCAAGAAGCTGCGGATGCCGGAGCTGGTCGAGACGGTCCGCGGCGTCGGATTCCGGCTGGCCAACCACACGTTGTCGGAGGATCAGGCAGCGGCCTGA	MPIIVVSARDDELDQILSLKLGADDYIVWPCGMRQLVARMEALIRRARNAWESWGVPLASPEPGVRQFGPVRIDLQRRSVTRDGHEVPLTRKEFDMLALLATDPGRVFTREQIMFEVWGHDGAGDTRTLGVHVTGIRKKLRMPELVETVRGVGFRLANHTLSEDQAAA	MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSINGLEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQPQKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYNSEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR	76.71	gnl|BL_ORD_ID|1274|hsp_num:0	1390			219	648	ciprofloxacin; acriflavine; norfloxacin
BGC0001072.1|Simocyclinone_50 # 70697 # 71341 # 1 # ID=1_50;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.637	BGC0001072.1|Simocyclinone_50 	70697	71341	+	Loose	1400	26.9498	Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid	26.39	3003392	protein variant model	A431V	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant katG	GTGGCGTTCTGCTATCAGCGCGAAGCCGTGGCCGCAGCCGATCTGGAGAAGGCTGTGGCCGAATTGGGTGGCCGCGTCGCGCACCGACGGGTGGACGTTTCCGATGCCGTTCAGGTCAAGGAATGGGTGCGTGACGTAGAGAGCGAACTCGGGCCTGTCGAGGTCGTGGTGACTTCCGCCGGAATTGTGCGGGACGGGCCCCTCGTCATGATGCAGGACAAGGACTGGCAGGACGTCATCGACGTCAATCTCAACGGCACGTTCAACGTCTGCCGGGCCGCTGTCTTCGGCATGATGAAGCGCAAATCCGGATGCCTCATCAACCTTTCCTCGGTGGCCGGCGTGAGCGGTCATGCCACCCAGTCGAACTATTCTGCCTCGAAGGCCGGGATCATCGGATTCACGAAGTCCCTCTCGAAGGAACTCGGCCGATACGGAATCCGGGCCAATGTGGTGGCGCCGGGGTTCATCGACACAGATATGGTCGCCGGGATTTCCGACGGGCTGCGGACCAAGGCCGTCGCAGGCGTTGCACTCGGCCGTTTCGGCCGACCCGACGAGGTGGCGGACGCGGTTGCCTACCTGGCGTCGGCGGAGTACGTCACCGGCGCGGTGCTTCAGATCGACGGCGGCCTTTCGATCTGA	MAFCYQREAVAAADLEKAVAELGGRVAHRRVDVSDAVQVKEWVRDVESELGPVEVVVTSAGIVRDGPLVMMQDKDWQDVIDVNLNGTFNVCRAAVFGMMKRKSGCLINLSSVAGVSGHATQSNYSASKAGIIGFTKSLSKELGRYGIRANVVAPGFIDTDMVAGISDGLRTKAVAGVALGRFGRPDEVADAVAYLASAEYVTGAVLQIDGGLSI	MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGAAFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRGGAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKTFGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPDPMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGWKSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAGAGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDMGPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAASSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSFADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGKGNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVNLLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKFVQDFVAAWDKVMNLDRFDVR	28.92	gnl|BL_ORD_ID|1955|hsp_num:0	1176			1134	1326	isoniazid
BGC0001072.1|Simocyclinone_51 # 71408 # 72856 # 1 # ID=1_51;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.676	BGC0001072.1|Simocyclinone_51 	71408	72856	+	Loose	550	28.1054	KPC-51	26.85	3005380	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGAGCCCCACTATGACACTCCGCCCGGAGCGCGTTGAGCCGGCCGTCGTCGGCGCGGGTCGCCGCTTCACGAGGTCGGCGTCCCTCATCGACTCCACGGTGACACCGAACCACGTCTTCGACCGGTGGTTCGCCGAGCAGCGGATACGCAACCGGTTCGAGGTCGACCGCATCCCCTTCAACCGGCTGCGGAGCTGGCGCTTCCACCCGGAGACCGGGAACCTGGGGCACGACAGCGGCCGGTTCTTCACCGTCGAGGGCCTCCACGTCGAGACCAACTGGGGCCACCACCCGTCCTGGACGCAGCCGATCATCAACCAGCCCGAGATCGGGATCCTCGGGATCGTGGTCAAGGAGTTCGACGGTGTCCTGCACTGCCTGATGCAGGCCAAGATGGAGCTGGGGAACCTCAACACCATCCAGCTCTCGCCCACAGTCCAGGCGACCCGCAGCAACTTCACCGGTGTCCACGGCGGACGCGGGATCACCTTCATCGAGTACTTCAGGGACACCGAGCGCAGCCGGGTGCTTGTCGACTCGCTGCAGTCCGAACAGGCGTCGTGGTTTCTGCGCAAGCGCAACCGGAACATGATCGTCGAGGTGACCGAGGACATCCCACCGCACGAGGACTTCGTCTGGCTGACCATCGGGCAGATCCACCGGCTCTTGCTCCAGGACAACGTCGTCAACATGGACGCCCGGACGGTGATGTCCTGCATTCCGTTCGACGCGCCCAACGGCGGCTCCCGGTGGGACGCGCCGCGCGACTTCCGGGAGAGCTTGGTGGCCTCGATGTCGGGGGAGCACAGGTCCCTGCACAGCACCGGCGAGATCCTGAGCTGGCTGACCGACCTCCGGACCCGGCACGCGCTGATCCAGCGCAGTGTGCCGCTCAAGGACGTCGAGCACTGGCAGGTCGGGGCCGAGGAGATCGCCCACGAGACGGGGAAGTACTTCTCCATCATCGCGGTCGACGTCCAGGCCCCCAACCGGGAGGTCGCCAGCTGGACCCAGCCCCTGCTCGCCCCGGTCGAGTGCGGCCGGGTCGCGATGATCGTCCGGCGGATCGGCGGAGTGCTGCACCTGCTGCTCCGGGCCCGGCTGGAGGCCGGGGTGCTCAACGTGGCGGAGATCGGCCCGACGGTTCAGTGCCTCCCAGGCAACTACCGCGACGTGCCGGAGGAGGAGCGGCCGCCCTACCTCGACCTGGTGCTGGCGGCCGGCCCGGAGCTGCTGCGCTACGACGCCGTGCAGTCGGAGGAGGGCGGGCGGTTCTACCAGGCCGACAACCGCTACCAGATCATCGAGGTGGGCGAGGAGTTCGACATCGACGTCGCGCCCGGATTCCGGTGGATGACTGTGGAGCAGGTGACCCGTCTGCTGTCGCACAGCAACTACCTGAACATCCAGGCCCGGAGCATGCTGACCGGCCTGCACACCAGCTGGTGA	MSPTMTLRPERVEPAVVGAGRRFTRSASLIDSTVTPNHVFDRWFAEQRIRNRFEVDRIPFNRLRSWRFHPETGNLGHDSGRFFTVEGLHVETNWGHHPSWTQPIINQPEIGILGIVVKEFDGVLHCLMQAKMELGNLNTIQLSPTVQATRSNFTGVHGGRGITFIEYFRDTERSRVLVDSLQSEQASWFLRKRNRNMIVEVTEDIPPHEDFVWLTIGQIHRLLLQDNVVNMDARTVMSCIPFDAPNGGSRWDAPRDFRESLVASMSGEHRSLHSTGEILSWLTDLRTRHALIQRSVPLKDVEHWQVGAEEIAHETGKYFSIIAVDVQAPNREVASWTQPLLAPVECGRVAMIVRRIGGVLHLLLRARLEAGVLNVAEIGPTVQCLPGNYRDVPEEERPPYLDLVLAAGPELLRYDAVQSEEGGRFYQADNRYQIIEVGEEFDIDVAPGFRWMTVEQVTRLLSHSNYLNIQARSMLTGLHTSW	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARNTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVHGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKNSEAVIAAAARLALEGLGVNGQ	164.51	gnl|BL_ORD_ID|3085|hsp_num:0	4113			507	807	
BGC0001072.1|Simocyclinone_54 # 74618 # 75379 # 1 # ID=1_54;partial=01;start_type=ATG;rbs_motif=AGGA;rbs_spacer=3bp;gc_cont=0.642	BGC0001072.1|Simocyclinone_54 	74618	75379	+	Loose	475	25.409	AAC(6')-Ib7	31.58	3002578	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCGAGAGGAGAAACAAGTGAGGGGCATCATTCTCGCCGGTGGCAACGGCACTCGTCTGGCGCCGATGACCAGCGTCGTCTCCAAGCAGTTGCTGCCGGTCTATGGCAAGCCGATGATCTACTACCCGTTGTCGGTGCTTCTTTCGGTAGGGATCACCGACATCCTGGTCATTGCCCGCCCGCAGGACCTACCGCTGTTCGAGCGACTGCTCGGCGACGGCAGCCGCTTCGGCGCTTGCTTCGACTATGCGGAGCAGGAAACCCCCCGTGGCCTGGCGGACGCGCTCATCGTCGGCCGGGAGCACGTCGGTGACGACGATGTCGCCCTCATCCTCGGGGACAACATCTTCCACGGTCACGACTTCGGCTCCATCGTGGCCGACGCCATCAAGAACAACGTCGGCGCGACGCTGTTCGCCTATGAGGTCTCTGAACCGGAACGCTACGGGGTTGTCCGGGTCGACCGCTTCGGCACGCTGCTCGACGTGGTCGAGAAGCCGAGCAACCCCCCGAGCAACCTGGCGATAACCGGCTTCTACCTGTTCGACAACGACGCGCTCGATGTTGCGGCCGGCCTTTCACCCTCGCCCCGTGGCGAGTTGGAGATCACGGATGTGATCAAGCACTTCGTCGACCGGGGCCTCGCTCGGGCGGTTCCGCTGACCGACGGCTTCGTCTGGCTGGACGCCGGTACCCCGGACTCCTATGTCGACGCCTGCAACTACGTGCAGGCCATCGAGACCCGGCAGGGACGCATGATC	MREEKQVRGIILAGGNGTRLAPMTSVVSKQLLPVYGKPMIYYPLSVLLSVGITDILVIARPQDLPLFERLLGDGSRFGACFDYAEQETPRGLADALIVGREHVGDDDVALILGDNIFHGHDFGSIVADAIKNNVGATLFAYEVSEPERYGVVRVDRFGTLLDVVEKPSNPPSNLAITGFYLFDNDALDVAAGLSPSPRGELEITDVIKHFVDRGLARAVPLTDGFVWLDAGTPDSYVDACNYVQAIETRQGRMI	MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	97.32	gnl|BL_ORD_ID|1914|hsp_num:0	2117			129	243	amikacin; kanamycin A; tobramycin
BGC0001072.1|Simocyclinone_16 # 15868 # 22506 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.723	BGC0001072.1|Simocyclinone_16 	15868	22506	+	Loose	660	80.4925	MexS	34.51	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTCGAACGACGATGACAAGCTTCGGCAGTATCTGAAGAAGGTGACGGCCGACCTGCTCCGCACCCGCGAGCGGTTGCGCGAGGTCGAGCAGCGAAGCGATGACCCCATCGTCGTGATCGGGATGGGCTGCCGCTACCCCGGAGGGGTCGGTTCAGCCGAGGACCTGTGGGATCTGGTCGCGCGGGGTGTGGACGCGATATCGGACTTCCCCGACGACCGGTACTGGGATCTCGACACCCTGTACGACCCTGACCGGGAGCCCGGCAAGCTGCTCCGGAGCTATGTCCGTGAGGGGGGGTTCCTCGCCGACGTGGGCCACTTCGACGCCGGCTTCTTCGGGATCTCGCCGCGCGAGGCCCTGCTGATGGATCCCCAGCAGCGGGTGCTGCTCGAGGTGGCCTGGGAGACGCTGGAATCCGCCGGAATCAGGCCGGAGACGCTGCGCGACAGCGACACCGGGGTCTTCGCGGGGGCGGGCGCCGCCGAATACCCGACGCTGTGGGCGACGACGAAGGAGTACTCGCCGCACAGCGTCACCGGAAAGACCGCCAGCGTCATCTCCGGCCGGGTCTCCTACTGCTTCGGCTTCAAGGGCCCGGCGGTCACCATCGACACCGCGTGTTCCTCCTCGCTGGTCTCGCTCCACCTGGCCGCACAGGCGCTACGCGCGGGTGAGTGCTCGCTGGCGCTGGCCGGTGGTGTGACGGTCATGTGCGATCCGGCCATCTTCGTCGAGTTCTGCGGGCAGGGTGCGACCTCCCCCGATGCCCGCACCAAGTCCTTCGCGGCCGCGGCGAACGGGGTGATCTGGTCGGAGGGCGCCGGGCTGCTGCTGCTGGAACGCCTGTCGGACGCCCGCCGCCACGGTCACCGGGTGCTCGCCGTCCTGCGGGGCTCCGCGGTCAACCAGGACGGCGCGAGCAACGGACTGTCCGCACCCAACGGCGCGGCGCAGCGCGCGGTGATCAGGGCGGCGCTGGCCGACGGCGGTCTGCTGCCGCAGGACGTCGCCGCGGTGGACGGGCACGGCACGGGCACTGTGCTGGGGGATCCCATCGAAGGGGACGCCCTGGTCGCGACCTACGGCCAGGACCGGGCCGCGGACCGGCCGCTGTGGTTGGGTTCGGTGAAGTCGAACATCGGCCACACGCAGGCCGCCGCGGGGATCGCCGGCGTCATCAAGATGATCATGGCTATGCGGCAGGGCCGCCTGCCGAAGACCCTCCACGTCGACGCACCCACGCCGAAGGTGGAATGGGGGACCGGCTCGGTCAGACTCCTCACCGAGCCGGTCGAGTGGGGCCGGAGCGCCGTGCCGCGCCGCGCCGGAGTCTCGGCCTTCGGCATCAGCGGCACCAATGCCCACGTCATCCTGGAAGAGGCCCCCACCGAGTCCGGTCCCGCCGAGGGCGTGGCCCCCGGTGCCGCCTCTGCCGAGAGCACCACCCCGCCGCTGGTGCCGTGGGTGGTCTCCGGCAAGACCAGGCAGGCCCTGCGCGCCCAGGCCGAGCGGCTGCTGACCTTCGCCGAGAAGTCCGCGGCGCAGCCCGACGCACCGGGCCTTCTCGACGTCGCCTGCTCCCTGGCCACCACCCGGGAGGGTTTCCGGTACCGCGCGGTGGTCCTGGGACAGGAGCGAGCCGCGCTCACCCGCGGGCTGCGCCACCTCGCCGAGGGGACGCCGGACGCGAACGTGATCGAGGGCGTGGCCGCAGCCCGGTCGCTCGGCGTCCTGTTCACCGGCCAGGGCTCTCAGCGGCTGGGCATGGGGCGGCGGTTGGTCGAGGTGCAACCGGCCTTCGCGGCCGCCTTCGACACGGTGTGCGAAGAGCTGGACAAGTATCTGGACCGACCGGTGCGGGAGGTGCTCCTCGCCCCGGCCGGCTCCGACGACGCACGGCTGCTGGACCGGACCGACTACGCGCAGGCTGCGTTGTTCGCCGTCGAGGTCGCCCTGTTCAGGCTGTTCCAGTCCTGGGGTGTGCGGCCGAAGGCACTGCTCGGGCATTCCATCGGCGAGGTCTCCGCGGCGTACGCGGCCGGGCTGTGGTCGCTGGAGGATGCCTGCCGCCTGGTCGCGGCCCGCGGCCGGCTGATGCAGGCGCTGCCCCCCGTCGGCGCGATGCTGTCGGTCCGGGCCTCCGAGGACGAGGTCATGCCCTTGCTGGCGGGCCGCGAAGACCGGATCTCCGTCGCGGCCGTCAACTCCGCGAACTCCGTCGTGGTCTCCGGTGACCTGGCGGAGGTGGAGCGGCTCGAACGGTTCTGGGCGAAGGAGGGCCGCCTCAGCAAGCGGCTCGCGGTCAGCCACGCCTTCCACTCTCCCCACATGGAGCCGATGCTCGAGGACTTCGCCAAGGTCGTGGCGGACCTGACCTTCCACCGGCCGGATCTTCCCGTGGTGTCCAACGTGACCGGCGAGGTCGCCTCGGCCGAGGAACTGTGCTCGGCGCAGTACTGGGCCGACCACATCCGGCGGGCCGTGCGCTTTCACGACGGTGTCCGGACCCTGCGGGCCCGTGGGATCGACGTGCTGCTGGAACTCGGCCCGGACGGCGTGCTCTCCGCGCTGGTCCAGGGGGGTTCCGGCGCGGAGGGAATCGTCGTCGCTCCGACACTGCGCAAGGACCGGGACGAGAACGAGAGCGTCGTGCGGGCCCTGAGCACGCTGCACGCCCACGGGATCGACGTCGACTGGGAGGCCGTGTTCGCCCCCGCCGGGGCGCGCGGTGCGGAGCTGCCGACCTATGCGTTCCAGCGGGAGCGCTACTGGCTCGCCCCCGCCCCCGCCTCCGCCGCCGGCGCCGGGGTGGAATCGGCGGGGCTGGCCCGCGCCGGTCACCCGTTGCTGGCCGCGGTGGTCGACCTGGCGGACGGTGAGGGCTCGGTCCTCACCGGCACCCTGTCCCTGCAGGCGCAGCCGTGGCTGGCCGGGCACCGGGTGCTGGACACGGTGCTCCTGCCCGCCGCAGCCCTGATCGACATGGTGCTGTGTGCCGGCGAACGGTTCGGTTGCGATCTGGTCGAGGAACTCACGCTGGAAGCCCCGCTGGTGCTGCCCGCGGAGGGCGGAGTCCGCGTTCAGCTCCTGGTCGGCTCCCCGGACGGGACCGGACGGCGTTCGGTACGGGTGTTCGCGCAGCCTGAAGACGCCGAGTACCCGGGCGATGCGAAGTGGCAGACCCACGCCACTGGTTTCCTGGCGGTCCGGGGGGTTCTCCCCGAGCCCGAACTGGTCGCCTGGCCGCCGCTCGGCGCCGAAGAGGTGGCCATCTCGGACATCTACCTCCAGGCTGATCACCAGGGCAGCTTCACCTACGAGGGCGCGTTCCGGGGTCTGCGGAAGGTCTGGCGCAAGGCAGCCCCGGACGGCGGCACCGAGTTGTTCGCCGAGGTCGCGCTTCCCGCCGAGGCGGCCGAGGGCGCCGAGCAGTACGCGTTGCATCCGGCGCTGCTCGACGCGGCGCTGCACGGAGTCGGCTACGGTCCGTTCCTCCCCTCGGGCGACAACGGCAATGGCGGCATGCCGTTCACCTGGTCGGGGGTGTCGCTGTACGCGTCGGGCGCCTCGATGCTGCGCGTACGGATCCGGGGTGCGGACGGACATCTGCAGCTGACCCTCGCCGACGGCGACGGCGCCCCGGTGGCGACGATCGACTCCCTGATCCTTCGGCCGGTCCCCCTGGAGCGGTCGCAACTGATCGGCCAGCTCACCGACGAGTCCCTGTTCGGGCTGGACTGGGTCCCGGTGCCCACAGCAGCGGCAGCCGTCCCCGCCCGCTGGGCCGTGCTCGGTGGCTCCTTGGAGGGCGCGGACTCCTTCGCGGACCTGGCGGCGCTGTCCGCCGCGATCGATGCGGGCTTGGCCGTGCCGGACGTGGTGCTCTGTCCCGTTCTTCCGGCGGCGGACCGCGCGGACGCAGGTGACCTGCCGGTGCACGTACGCACCGTGCTCACTGCCGTGACCCAGGAGCTGGCGACCTGGCTGGCCGACGAGCGGTTCACCCCGGCGCGCCTGGTCGTCCTGACCCATGGGGCGGTGGCCACCTCGGAACGGGGTCCGGTCGACCTGGCCGCCGCTCCGGTCTGGGGCATGGCCCGGTCGGCGCAGGCCGAACACCCGGGCCGGCTGCTGCTCGTGGACACCGACGATCCGGCCTGTCCGGCGAGCACCGTGCGATCCGCTGTCGCCACCGCCCTGAGCGCGGGCGAGTCACAACTGGTGTTGCGCGCGGGTGACCTGTTCGCCCCTCGGCTGCACCCGGTGGCGTCCGATGCGCTGCTGTCCGTACCTCCCGGTGAGCCGGCCTGGCGGCTGGACACCACCGCTCCGGGAACGCTCGACAACCTCGCGCTGCTCCCCTGTCCCGAAGCACTCGAGGCCCTGGGGCCGGACGAGGTGCGGGTGGAGGTGCGCGCGGCGGGGGTGAACTTCCGCGATGTGCTGATCGCCCTGGGCGTGTACCCCGGCCGGGCCGTTCCGGGTTCCGAGGCCGCCGGTGTGGTCCGGGAGGTCGGTTCCGCGGTGACCGGCCTGCGCCCGGGGGACCGCGTGTTGGGTGTCTTCGCCGGCGCGCTGGGCCCGCTGGCCGTCACCGACCGCAACTTGATCGCGCCGCTGCCCGAGGGCTGGTCCTTCGAGGGCGCCGCATCAGTGCCGATCGCCTTCCTGACCGCCTACTACGGGCTCACGGATCTGGCCGGGATGCGGTCGGGCGAGTCCGTGCTGATCCACTCCGGCGCGGGCGGCGTGGGCATCGCGGCCATCCAGATCGCCCGACACCTGGGCGTCGAGGTCTTCGCCACCGCCAGCCCCGGCAAGTGGGACGATCTGCGGGCCCTGGGCCTGGACGACGCACACATCGCGTCCTCCCGTACGGTCGAGTTCGAGCAGCGGTTCCGTGCGGCCACCGGTGGCCGGGGCGTGGACGTCGTCCTGAACTCGCTCACGGGGGAGTTCGTGGACGCGTCACTGCGCCTGCTCGCCCGGGGCGGACGGTTCATCGAGATCGGCAAGGCCGACATCCGGGACCCCGAGGAGACCTCCGCCGTTCACGGGATCAGCTACCAGGCGTTCGATCTGGTCGCGTCGGCGGGACTGCAGCGAATCCAGGAGATGCTGCACGAGCTCTTCGCGCTGTTCCGTCAGGGTGCGCTCACCATGCCGCCCCGCCGGGACTGGGACATCCGGCGGGCCAGGGAGGCGCTGCGGCACGTGAGCCAGGCGCGGCACGTGGGCAAGGTGGTGCTCACCGTCCCGCGCGCGGCCGACCCCGAGGGCACGGTCCTCGTCACCGGTGGTGCGGGGTGGCTGGGTGGGCTGATCGCACGTCACGTCGTTCAGCAGGGCGCGGAACGGCTGGTCCTGCTCAGCCGCCGGGGTCCCGACGCACCGGGCGTCCGCGAGCTGACGGCCGAGCTGGCCGCGGCGGGCGCCGAGGTATCGGTCGCCAGGGGCGATGTCGCCGACCGGCGCGATCTGGCGCGGATCCTGGCGGAGATCCCAGCCGAGCACCCGCTGACCGCGGTCATCCATACCGCGGGGGTGCTGTCCGACGCGGTCGTCGAGTCGGTGACGGCCGATCAGATCGACGCGGTCCTGCGGCCCAAGGTGGACGGGGCGTGGCACCTGCATGAGCTGACCCGGGACCTGGGCCTGTCGGCGTTCGTGTGCTTCTCCTCGGCGGCCGGGATATTCGGCTCGGTCGGGCAGGGCGCCTACGCGTCGGCCAACTCCTTCATGGACGCGCTGATGGCGTACCGCCGCAGCGAAGGTCTGGTGGGCAGCTCACTGGCGTGGGGTCTGTGGGCCCCCGGCCTCGACGACGCGTCCGGCGGCGGCATGGCGAGCGGTCTTGCGGCTGCCGACTGGGCGCGGATGAGCCGTACCGGCGTGCTGGCCCTCACCGTCGATCAGGGTCTCGCACTCTGGGACGCCGCACGGGAGAGCGACCGGGTGCTGCTGGCTCCCGTTCGGCTCGATCGCGGCACCATCGCCGGATTCGGCGAGGCGGTCCCGTCACTGCTCCGGGACATGGTGCGGACGTCGGCGCGCCGCAGGGTCGCCGGCGGCCAGGCCTCCGCGCCGTCCGAGTCCCCCGAGGCGCTGGCGAGCAGGTTGAACGCCCTGCCGCCCGCACAGCGGGACCGCAGGCTCGTGGATCTCGTGCGAGGTCATGTCGCGGCGGTACTGGGGTACACCTCGCCCGAGGACCTGCCCGCGGACGCGGCTTTCCGTGATCTGGGTTTCGATTCGCTCACCTCGGTTGAGCTGCGCAACCGGATCAACGGTGCGACCGGTCTGCGGTTGCCCGCCACCCTCGTGTTCGACAATCCGACGCCGATCGCCCTGGCTGAGCACGTGGGCGCGGAGATCGCGGTGAACGCCCCCGGCGCCCCTGCGGCCGGGCCCGACACGTCCGTGTCCGTGCTGACGGAACTGAGCGCGTTCGAGCGAAGTCTGGCCGAGCTGGCCGCCGACGACGATCTGCGCGGCGTGGTTCGCAACCGACTGCGCGCGCTGATGGTGCGGCTGGACGACGGCCCGGGCATCGACGCCGCGCAGGCGGACGCCCTGCAGTCGGCGACGGTGGACGAGCTCTATGACTTTGTGGACCGGGAGTTCGGAAATGCGTAG	VSNDDDKLRQYLKKVTADLLRTRERLREVEQRSDDPIVVIGMGCRYPGGVGSAEDLWDLVARGVDAISDFPDDRYWDLDTLYDPDREPGKLLRSYVREGGFLADVGHFDAGFFGISPREALLMDPQQRVLLEVAWETLESAGIRPETLRDSDTGVFAGAGAAEYPTLWATTKEYSPHSVTGKTASVISGRVSYCFGFKGPAVTIDTACSSSLVSLHLAAQALRAGECSLALAGGVTVMCDPAIFVEFCGQGATSPDARTKSFAAAANGVIWSEGAGLLLLERLSDARRHGHRVLAVLRGSAVNQDGASNGLSAPNGAAQRAVIRAALADGGLLPQDVAAVDGHGTGTVLGDPIEGDALVATYGQDRAADRPLWLGSVKSNIGHTQAAAGIAGVIKMIMAMRQGRLPKTLHVDAPTPKVEWGTGSVRLLTEPVEWGRSAVPRRAGVSAFGISGTNAHVILEEAPTESGPAEGVAPGAASAESTTPPLVPWVVSGKTRQALRAQAERLLTFAEKSAAQPDAPGLLDVACSLATTREGFRYRAVVLGQERAALTRGLRHLAEGTPDANVIEGVAAARSLGVLFTGQGSQRLGMGRRLVEVQPAFAAAFDTVCEELDKYLDRPVREVLLAPAGSDDARLLDRTDYAQAALFAVEVALFRLFQSWGVRPKALLGHSIGEVSAAYAAGLWSLEDACRLVAARGRLMQALPPVGAMLSVRASEDEVMPLLAGREDRISVAAVNSANSVVVSGDLAEVERLERFWAKEGRLSKRLAVSHAFHSPHMEPMLEDFAKVVADLTFHRPDLPVVSNVTGEVASAEELCSAQYWADHIRRAVRFHDGVRTLRARGIDVLLELGPDGVLSALVQGGSGAEGIVVAPTLRKDRDENESVVRALSTLHAHGIDVDWEAVFAPAGARGAELPTYAFQRERYWLAPAPASAAGAGVESAGLARAGHPLLAAVVDLADGEGSVLTGTLSLQAQPWLAGHRVLDTVLLPAAALIDMVLCAGERFGCDLVEELTLEAPLVLPAEGGVRVQLLVGSPDGTGRRSVRVFAQPEDAEYPGDAKWQTHATGFLAVRGVLPEPELVAWPPLGAEEVAISDIYLQADHQGSFTYEGAFRGLRKVWRKAAPDGGTELFAEVALPAEAAEGAEQYALHPALLDAALHGVGYGPFLPSGDNGNGGMPFTWSGVSLYASGASMLRVRIRGADGHLQLTLADGDGAPVATIDSLILRPVPLERSQLIGQLTDESLFGLDWVPVPTAAAAVPARWAVLGGSLEGADSFADLAALSAAIDAGLAVPDVVLCPVLPAADRADAGDLPVHVRTVLTAVTQELATWLADERFTPARLVVLTHGAVATSERGPVDLAAAPVWGMARSAQAEHPGRLLLVDTDDPACPASTVRSAVATALSAGESQLVLRAGDLFAPRLHPVASDALLSVPPGEPAWRLDTTAPGTLDNLALLPCPEALEALGPDEVRVEVRAAGVNFRDVLIALGVYPGRAVPGSEAAGVVREVGSAVTGLRPGDRVLGVFAGALGPLAVTDRNLIAPLPEGWSFEGAASVPIAFLTAYYGLTDLAGMRSGESVLIHSGAGGVGIAAIQIARHLGVEVFATASPGKWDDLRALGLDDAHIASSRTVEFEQRFRAATGGRGVDVVLNSLTGEFVDASLRLLARGGRFIEIGKADIRDPEETSAVHGISYQAFDLVASAGLQRIQEMLHELFALFRQGALTMPPRRDWDIRRAREALRHVSQARHVGKVVLTVPRAADPEGTVLVTGGAGWLGGLIARHVVQQGAERLVLLSRRGPDAPGVRELTAELAAAGAEVSVARGDVADRRDLARILAEIPAEHPLTAVIHTAGVLSDAVVESVTADQIDAVLRPKVDGAWHLHELTRDLGLSAFVCFSSAAGIFGSVGQGAYASANSFMDALMAYRRSEGLVGSSLAWGLWAPGLDDASGGGMASGLAAADWARMSRTGVLALTVDQGLALWDAARESDRVLLAPVRLDRGTIAGFGEAVPSLLRDMVRTSARRRVAGGQASAPSESPEALASRLNALPPAQRDRRLVDLVRGHVAAVLGYTSPEDLPADAAFRDLGFDSLTSVELRNRINGATGLRLPATLVFDNPTPIALAEHVGAEIAVNAPGAPAAGPDTSVSVLTELSAFERSLAELAADDDLRGVVRNRLRALMVRLDDGPGIDAAQADALQSATVDELYDFVDREFGNA	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	652.51	gnl|BL_ORD_ID|1039|hsp_num:0	1041			15	672	ciprofloxacin; trimethoprim; chloramphenicol
